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ABSTRACT 
 
The Effect of Stress on the Neuropathogenesis of Theiler’s Virus Induced 
Demyelination  
as an Animal Model of Multiple Sclerosis. (August 2005) 
Wentao Mi, M.S.; M.D., Tianjin Medical University, China 
Chair of Advisory Committee: Dr. C. Jane R. Welsh 
 
Stressful life events have been associated with the onset and/or exacerbation of 
multiple sclerosis (MS). To investigate the effects of stress on the pathogenesis of MS, 
we employed restraint stress (RST) in the Theiler’s virus-induced demyelination 
(TVID) model, an animal model for human MS.  Intracerebral inoculation of 
susceptible strain of mice with Theiler’s murine encephalomyelitis virus (TMEV) 
results in a biphasic disease – an acute encephalomyelitis and chronic demyelination. 
The establishment of persistent viral infection is critical in inducing immune-mediated 
demyelination during the chronic disease. The exposure of mice to RST prior to viral 
infection produced a stress response as evidenced by elevated circulating corticosterone 
(CORT). To further study the effect of stress on the immune response to TMEV 
infection and demyelination, we first examined the cytokine and chemokine response 
during the acute TMEV infection. We demonstrated that RST down-regulated the 
virus-induced expression of chemokines, Ltn, IP-10, RANTES, and pro-inflammatory 
cytokines, TNF-, IFN- and LT- in both the brain and spleen during early infection. 
Histologically, a decreased pattern of inflammation was observed in the brain of 
restrained mice as compared to non-restrained mice.  The increased viral titer was 
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noted in the CNS of restrained mice and was correlated with the decreased production 
of pro-inflammatory cytokine, suggesting an impaired immune response by RST.  
Secondly, the duration of stress on the late demyelination was investigated.  Repeated 
and chronically stressed SJL/J mice developed an early onset of clinical signs and a 
delayed onset was observed in acutely stressed mice. Both acute and chronic RST 
suppressed the antibody response to TMEV and stressed displayed a higher incidence 
of demyelination than non-restrained mice. Axonal loss was also noted in chronic 
stressed mice.  Additionally, RST caused an increased systemic viral infection in 
extraneural organs during the acute infection and cardiotropic TMEV was isolated 
from the heart of stressed mice.  Taken together, stress resulted in profound 
immunsuppression during acute infection, which may consequently increase the 
incidence of demyelination.  The present study may be generalized in human MS 
which is potentially triggered by viral infection.  
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I    INTRODUCTION 
 
1.   Multiple sclerosis  
Multiple sclerosis (MS) is the most common autoimmune diseases involving the 
central nervous system (CNS) and it affects approximately 250,000 to 350,000 
individuals of the US population. MS afflicts females twice as often as males.  The MS 
patients usually experience chronic, progressive, intermittent episodes of neurological 
dysfunction resulting from demyelination and/or axonal damage.  The most common 
symptoms may involve deficits of sensation, motor, autonomic and neurocognitive 
function.  Based on clinical manifestation, the course of MS can be classified as 
relapsing-remitting MS (RRMS) or primary progressive MS (PPMS).  RRMS accounts 
for the majority of MS patients (85-90%), and is characterized by recurrent attacks of 
neurological dysfunction, persisting for days or weeks and then gradually waning.  For 
some RRMS patients, the extent of recovery from each flare-up decreases with time, thus 
leading to a worse disability with each attack. 10-15% MS patients may present as PPMS, 
which initiates as a subtle onset but with steady progress and a gradual clinical decline 
(Hafler, 2004; Sospedra and Martin, 2005). 
The etiology of MS remains unclear, but it may result from a complex interplay of 
environmental and genetic factors.  The most persuasive genetic evidence comes from 
twin studies showing a higher incidence of MS in monozygotic twins than dizygotic pairs.  
Also, first-degree relatives of MS have an increased risk of MS affliction. Human
______________ 
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Leucocytes Antigen (HLA)-DR and DQ genes have been associated with MS, suggesting 
an immunological related pathogenesis of MS (Sospedra and Martin, 2005).  In addition, 
epidemiological studies showing the discordance of MS in monozygotic twins indicate an 
acquired nature of the disease. Infectious agents, such as virus and Chlamydia, have been 
implicated in MS, as evidenced by the consistent finding of oligoclonal bands, high 
concentrations of IgG in MS patients with activity against several viruses.  However, no 
virus has ever been consistently isolated from the brain of MS patients; and viral and 
bacterial infections are often thought to be environmental inciters of MS (Hartung, 2005).  
Therefore, MS affects genetically predisposed individuals and is triggered by 
environmental factor such as infection. Gender, stressful life and geographic gradients 
also played a role in the disease.  
The pathology of MS includes demyelination, variable degrees of axonal damage 
(axonal loss and transection), perivascular inflammatory infiltration and astrogliosis 
(plaque).  The multiple sharply demarcated plaques in the white matter of the CNS (brain 
or spinal cord) are the hallmark of MS.  The inflammatory infiltrates consist of 
oligoclonal T cells, monocytes with occasional B cells and infrequent plasma cells.  
Macrophages are frequently found in the center of active plaques and contain myelin 
debris, accompanied by decreased numbers of oligodendrocytes.  Whereas inflammation 
is less prominent and is mainly located at the rim of the plaque in the chronic-active 
lesions (Halfer et al., 2004).  Lucchinetti et al. (2000) described four different patterns of 
lesions in acute demyelinating pathology, suggesting more than one mechanism 
contributes to pathology. All patterns displayed prominent inflammation with T cells and 
macrophages.  Pattern I and II both showed perivenular distribution of demyelinated 
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areas with sharply demarcated edges, accompanied by remyelination.  Variable 
oligodendrocyte losses were seen, but apoptosis was rare. The major feature 
distinguishing pattern I and II was the prominent deposition of immunoglobulin and 
complement C9neo throughout the lesion.  In pattern III, preservation of a rim of myelin 
was frequently seen around the inflamed vessels, and the plaque border was ill defined.  
Concentric alternating rings of demyelinated and myelinated tissue were found at the 
periphery of the lesion. Within the lesion, there was pronounced loss of 
oliogodendrocytes with apoptosis, and preferential loss of myelin-associated glycoprotein 
(MAG) relative to other myelin proteins, such as myelin basic protein (MBP) and 
proteolipid protein (PLP).  In pattern IV, demyelination was associated with the death of 
oligodendrocytes at the plaque edge, but no morphological features of apoptosis.  No 
remyelination or Ig deposition was observed in pattern II and IV.  
The immunological mechanism involved in the pathogenesis of MS primarily 
involves CD4+ autoreactive T cell-mediated inflammation of the CNS and subsequent 
damage to myelin. Other immunological components, such as CD8+ T cells, antibodies, 
complement also contribute to the pathogenesis of MS (Sospedra and Martin, 2005).  
Therapies for MS are derived from understanding the immunopathophysiology of MS, 
including immunosuppressive drugs, such as cyclosphosphamide (Cytoxan), cladribine 
(2-CdA, Leustatin), mitoxantrone, interferon-, corticosteroids; MHC-binding protein 
that engages T cell receptor, glatiramer acetate (GA) etc (Hafler, 2004).    
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2.   Theiler’s virus induced demyelination (TVID) as a viral model for MS  
2.1 Theiler’s virus and TVID 
Theiler’s murine encephalomyelitis virus (TMEV or Theiler’s virus) was first 
isolated by Max Theiler in 1930, from the CNS of mice with spontaneous flaccid 
paralysis of the hind leg (Theiler, 1934; Theiler and Gard, 1940).  Theiler’s virus is a 
natural enteric pathogen of mice with a rare incidence of spontaneous CNS infection.  It 
is an RNA virus and a member of the Cardiovirus genus in the Picornaviridae family. The 
genome of Theiler’s virus consists of single-stranded RNA of positive polarity 
comprising approximately 8,100 nucleotides.  It codes for 12 proteins arranged in the 
order 5'-L, VP4, VP2, VP3, VP1, 2A, 2B, 2C, 3A, 3B, 3C, 3D-3'.  The 76-amino-acid 
long L protein is a zinc-binding metalloprotein (Chen et al., 1995).  The expression of L 
protein has been shown to interfere with immediate-early interferon production (Delhaye 
et al., 2004; van Pesch et al., 2001); and the mutation of L protein is associated with 
attenuated neurovirulence in mice (Calenoff et al., 1995), suggesting its critical role in the 
virus-host interaction. VP4, VP2, VP3, and VP1 are capsid proteins.  Proteins 2A, 2B, 2C, 
3A, 3B, 3C, and 3D are required, either directly or indirectly, for viral RNA replication 
(reviewed by Oleszak et al., 2004). Theiler’s virus is divided into two subgroups based on 
differing biological characteristics: (i) the highly virulent strains, such as GDVII and FA, 
produce a fatal encephalitis in all strains of mice; and (ii) the less virulent, known as 
Theiler’s originals (TO), such as BeAn and DA, cause a chronic, immune mediated, 
inflammatory demyelinating disease in susceptible strains of mice, such as SJL/J and 
CBA mice, known as Theiler’s virus-induced demyelination (TVID), which resembles 
human MS in (i) white matter demyelination of CNS with inflammation; (ii) recurrent 
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demyelination in certain strains of mice; and (iii) demyelination related spastic paralysis 
(Lipton et al., 1986). 
Experimentally, TVID is induced by intracerebral inoculation of less virulent 
Theiler’s virus into susceptible strains of mice, such as SJL/J and CBA, and is 
characterized by a biphasic disease.  During the early phase TVID, TMEV preferentially 
infects neurons within gray matter, causing acute encephalomyelitis which lasts about 1-2 
weeks.  In the later demyelinating phase, TMEV predominantly persists in CNS 
macrophages/microglia and to a lesser extent in oligodendrocytes and astrocytes, and 
eventually leads to demyelination, which usually occurred at 3-4 week post infection.  
The model for MS derived from the chronic disease, known as Theiler’s virus-induced 
demyelination, has been widely used in the study of MS (Lipton et al., 1986; Oleszak et 
al., 2004). 
The susceptibility or resistance to TVID is genetically determined by both major 
histocompatibility complex (MHC) and non-MHC genes.  Using morphological criteria 
in congenic strains of mice to define the resistance or susceptibility, mice with f, p, q, r, s, 
or v haplotypes on a C57BL/10 background are susceptible to TVID. SJL/J, DBA/1, 
DBA/2, SWR, PL/J, and NZW strains of mice are susceptible to TVID. Whereas b, d, or 
k haplotypes on the same background are resistant and BALB/c, C57BL/6, C57BL/10, 
C57/L, and 129/J are resistant to TVID (Lipton and Melvold, 1984; Rodriguez and David, 
1985). 
Host responses to TMEV during early infection are also critical in determining 
either successful viral clearance or persistence of virus in the CNS with the development 
of demyelination, which requires (i) effective immune response in clearing the virus from 
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the neurons to prevent fetal encephalitis; (ii) incomplete elimination and persistence of 
virus in the CNS; (iii) induction of immune response to myelin damage due to viral 
persistence (Drescher et al., 1997).  
 
2.2. Immunopatholgy of TVID  
2.2.1.  A timely and effective cytotoxic T cells (CTL) mounted by a resistant strain of mice   
The resistance to TVID is closely related with cytotoxic T cells (CTL), as evidenced 
by a passive transfer of CD8+ T cells from resistant mice to susceptible mice, which 
protected the latter against demyelinating disease (Nicholson et al., 1996).  The functional 
CTL is highly dependent on the recognition of class I MHC complex on antigen 
presenting cells (APC) by CD8+ lymphocyte.  The K and D loci of mouse MHC encode 
proteins which comprise the classical class I molecules involved in antigen presentation, 
and the susceptibility of TMEV infection and demyelination has been mapped to the D 
loci.  Lipton et al. (1995a) showed that mutation in H-2Db loci resulted in decreased 
resistance, and inactivating H-2Db gene of resistant C57BL/6 mice altered the resistance 
and made them susceptible to infection.  The introduction of the H-2Db gene of C57BL/6 
mice into the genome of susceptible H-2q FVB mice also confers the latter resistance and 
decreased inflammatory lesions (Azoulay et al., 1994; Mendez-Fernandez et al., 2003).  
Moreover, recognition of predominant H-2Db–restricted viral peptides, VP2121-130, VP165-
173, and VP110-120 has been identified in BeAn or DA infected C57BL/6 (H-2Db) mice, 
which are resistant to viral persistence and demyelination (Lyman et al., 2002).  In 
contrast, a lower CTL response was detected in susceptible mice, suggesting an 
ineffective CTL-mediated viral clearance in these mice (Dethlefs et al., 1997).  Although 
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both H-2K and H-2D were expressed in the CNS, and both K- and D-restricted virus-
specific CTL were generated in the spleen of susceptible and resistant mice, only the D 
restricted CTL response was detected in the CNS following TMEV infection (Lin et al., 
1997). Therefore, H-2D region is closely related with early viral clearance in TMEV 
infection. 
Experiments with knockout mice further indicated the importance of CTLs in 
resistance to TVID. 2-microglobulin (-2m)-deficient mice on an H-2b background, 
derived from a C57BL/6 and 129/Ola cross failed to eliminate the virus and developed 
demyelination (Fiette et al., 1993).  β2m-deficient SJL mice displayed similar disease 
incidence rates to wild-type controls; however, the mice demonstrated earlier onset of 
clinical disease, significant elevation in persisting viral titers, elevated in vitro responses 
to TMEV and myelin proteolipid (PLP) epitopes, and significantly higher levels of CNS 
demyelination (Begolka et al., 2001). Disruption of β2m gene in resistant (C57BL/6F 
129/J) (H-2b) mice rendered susceptibility to demyelination, but also resulted in 
extensive remyelination of oligodendrocytes and Schwann cells as compared to wild type 
(Miller et al., 1995).  These results suggest a potential role of β-2m in the susceptibility to 
TMEV due to a decrease in class I MHC molecule expression and CTLs, and the 
development of demyelination and remyelination, which are primarily mediated by CD4+ 
T cells, but the role of CD8+ T cells was noted as well.   
Perforin is a glycoprotein whose expression is mainly confined to CD8+ T cells and 
NK cells. Upon cell-cell contact, perforin is released onto the target cell, causing 
permeabilization of membrane, which leads to the death of the cell. Disruption of 
perforin gene in C57BL/6 mice results in high mortality of mice which died of 
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encephalitis due to high viral titers, suggesting that the early disease is perforin dependent 
(Rossi et al., 1998). Taken together, an early and rapid CTL, versus a delayed and 
insufficient CTL response, account for, in part, the differing susceptibility/resistance to 
TVID in the different stains of mice. 
 
2.2.2. Both CD4+ and CD8+ T cells contribute to the demyelination in susceptible strain 
of mice  
Flow cytometry and histopathology revealed that CD4+T cells are one of the major 
cell types infiltrating into the CNS in TVID.  MHC II-restricted CD4+ T cells that 
recognize both viral peptides and myelin peptides were identified, and were associated 
with DTH, indicating the role of CD4+ in myelin damage by epitope spreading (Borrow 
et al., 1998; Miller et al., 1997; Welsh et al., 1987 and 1989).  Deletion of CD4 gene 
(CD4-/-) in B6 mice results in viral persistence and demyelinating disease (Murray et al., 
1998), implying that CD4+ T cells are one of the principle factors contributing to the 
resistance and that the impaired viral clearance may be due to decreased neutralizing 
antibody secretion of B cells, because class II MHC is required for activation of B cells 
by CD4+ T cell.  Class II MHC-deficient mice (RHA-/-) exhibit susceptibility to 
persistent infection and demyelination, with diminished lesion size as compared to SJL 
mice (Fiette et al., 1996), which is possibly explained by reduced CD4+ mediated DTH 
response as a result of the absence of MHC II.  
The role of CD8+ T cells in demyelination is controversial: depletion of CD8+ T 
lymphocytes resulted in reduced myelin damage in the CNS of TMEV-infected mice 
(Rodriguez and Sriram, 1988).  Demyelination was detected in resistant B6 mice 
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deficient for either the CD4+ or the CD8+ T cells, accompanied by deficient viral 
clearance; however, CD4+-deficient mice developed delayed DTH to viral antigen, 
increased demyelination and severe neurological deficit, whereas these changes were 
minimal in CD8+-deficient mice (Murray et al., 1998).  Thus, the discrepancy in the role 
of CD4+ and CD8+ T cells reflects differential underlying mechanisms, of which the 
elimination of virus is mainly CD8+-dependent, and the demyelination is primarily CD4+-
determined, but both arms of the immune response contribute to the pathogenesis of 
TVID.   
 
2.2.3. NK cell protects against acute encephalitis  
The NK cell activity is mediated by nonclassical MHC I molecule, CD1.  A higher 
level of NK cell activity was found in resistant C57BL/10 mice than susceptible SJL/J 
mice, which was negatively correlated with viral titers in the CNS.  However, depletion 
of NK cells using NK 1.1 resulted in increased inflammation at early disease, but no 
changes in demyelination (Paya et al., 1989).  Therefore, as innate immunity, NK cell 
plays a major role in protecting against gray matter disease and a minimal role in 
demyelination. 
 
2.2.4. Macrophage/microglia habors virus and mediates myelin damage in susceptible 
mice 
Macrophage/microglia serves as a reservoir for TMEV with limited replication, and 
is responsible for viral persistence in the CNS of susceptible mice (Clatch et al., 1990).  
The virus can be located in the cytoplasm, but not in phagolysosomes, suggesting that 
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virus has effectively infected the macrophage, rather than being phagocytocized by 
macrophages (Lipton et al., 1995b).  Activation, as evidenced by TNF- production, is 
required for macrophage/microglia infection (Shaw-Jackson and Michiels, 1997).  
Microglia, as the resident CNS macrophages, can be activated into professional antigen 
presenting cells (APCs) following TMEV infection and present viral or myelin epitopes 
to CD4+ T cells, thus leading to demyelination (Olson et al., 2001).  During the chronic 
phase, foamy macrophage can be seen in the demyelinating region of susceptible mice, 
indicating a phagocytosis of myelin by macrophage/microglia (Oleszak et al., 1997). 
 
2.2.5. Cytokines, adhesion molecules and other soluble factors serve as mediators in the 
viral clearance and demyelination 
A broad spectrum of cytokines has been implicated in the early viral clearance and 
late demyelination in TVID.  For example, IFN-γ may play a critical role in protection 
from virus infection.  Genetic mapping studies have identified the ifng locus on 
chromosome 10, a non-H-2 region.  Using depletion or neutralizing antibody to IFN-γ, or 
IFN-γ receptor knockout mice, these studies demonstrate IFN-γ is required for viral 
clearance (Fiette et al., 1995). TNF-α, a strong inducer of inflammatory cytokines, 
appears to be responsible for direct destruction of myelin and oligodendrocytes (Selmaj 
and Raine, 1988).  Soluble mediators, such as nitric oxide (NO), are produced by 
activated microglia in both acute and chronic phase.  Recent studies have shown the 
toxicity of NO to oligodendrocytes (Baud et al., 2004) and axons (Garthwaite et al., 
2002).  Unlike the function of other immune cells, such as CTL, where deletion or 
transfer can dramatically alter the resistance or susceptibility, these soluble mediators 
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play a regulatory role, and especially, cytokines may function as a network in the 
pathogenesis of TVID.  
 
2.2.6. Humoral responses in susceptible strains of mice contribute to ameliorating the 
onset of demyelination 
The involvement of humoral response in TVID is evidenced by the detection of 
antiviral antibodies in the CNS of TMEV-infected SJL mice and the presence of B cells in 
the demyelinating lesions as revealed by histopathology.  Antibodies were found at a 
higher level in the CNS than in the serum, suggesting a local response.  Neutralizing 
antibody is predominantly targeted to the VP1 and VP2 viron capsid.  The epitope of the 
antibody differs in resistant and susceptible strains of mice, with efficiency in 
neutralizing virus and thus helping to eliminate TMEV from the CNS in resistant mice 
(Oleszak et al., 2004). It has also been demonstrated that passively transferred anti-
TMEV antibody could successfully protect CD4+ T cell-deleted CBA mice from lethal 
during the acute disease (Borrow et al., 1993). These results indicate the role of humoral 
response in the viral clearance of resistant mice. However, the antibody response alone is 
not sufficient in clearing virus, which is predominantly mediated by cellular immunity, 
such as CTL.  
Depletion of B cells by goat anti-µ (anti-IgG), or depletion of complement by 
treatment with cobra venom factor, leads to more severe demyelinating lesions in SJL 
mice.  Resistant strains of mice (C57BL/10, C57BL/6, and B10.D2) did not develop 
demyelinating disease after treatment with goat anti-µ. These findings suggest that 
humoral responses in late chronic demyelinating stage in susceptible mice contribute 
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more to ameliorating or delaying the onset of demyelination than to clearing the virus 
(Oleszak et al., 2004). 
 
2.3. CD4+ T cell mediated demyelination by epitope spreading  
TVID is an autoimmune CNS disease mediated by virus-specific and/or myelin-
specific CD4+ T cells-induced delayed-type hypersensitivity (DTH) to myelin 
components via epitope spreading (Borrow et al., 1998 Miller et al., 1997; Welsh et al., 
1987 and 1989). Epitope spreading is an acquired T cell autoreactivity generated in a 
manner of de novo priming of T cell to damaged tissue caused by other stimuli, such as 
viral infection. In TVID, virus-specific Th1 cells recognize virus epitope presented as a 
result of persistent CNS infection and initiate self tissue destruction, including myelin, 
through an inflammatory response known as the bystander effect.  Damaged myelin 
components are released as novel antigen is presented to T cells, resulting in the priming 
of myelin-specific CD4+ T cells, which mediate demyelination.  The evidence of epitope 
spreading was extensively documented by Miller and colleagues.  Virus-specific CD4+ T 
cells are observed as early as 1 week post infection and chronically persist in the CNS.  
While myelin-specific T cell responses first appear approximately 50-60 days post-
infection and persist throughout the chronic disease.  Further kinetic and functional 
studies rule out the theory that T-cell responses to the immunodominant myelin 
proteolipid protein epitope (PLP139-151) result from cross-reactivity between TMEV 
and self epitopes (Miller et al., 1997). The T cell response also displayed an ordered 
progression throughout the disease process, in which a sequential DTH by virus-specific 
T cell to immunodominant VP270–86, VP324–37, then myelin-specific PLP139–151 and other 
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myelin components is documented (Katz-Levy et al., 2000). The clinical symptoms first 
appeared at 30-40 day post-infection, a time frame between the first detection of virus-
specific and myelin-specific T cells, indicating demyelination in TMEV-infected mice is 
triggered by virus-specific CD4+ T cells targeting virus, and T-cell responses to multiple 
myelin autoepitopes may play a pathologic role in chronic disease (Miller et al., 1997).  
 
3. Stress  
3.1. The development of the concept of stress   
Stress is an ever-changing, evolving concept since it was first introduced in the field 
of biology and medicine.  In 1930s, Dr. Hans Selye first described general adaptation 
syndrome (GAS) when he injected rats with various impure and toxic gland preparations.  
He observed a triad syndrome, which includes enlargement of adrenal cortex, atrophy of 
thymus and lymph nodes, and gastrointestinal ulcers.  The same responses were also 
observed when animals were exposed to other stimuli and toxin (Selye, 1936). According 
to his theory, GAS has three stages: the alarm, resistance, and exhaustion stages.  When 
an organism is confronted with stress, the immediate response is alarm-the adrenocortical 
secretion increased with general sympathetic arousal.  The resistance stage begins 
following the alarm reaction and is characterized by decrease in adrenocortical secretions 
and a return to normal body functioning.  The exhaustion stage will follow if stimuli 
persist.  Adrenocortical secretions rise again and may be totally depleted and eventually 
lead to “exhaustion”, even death (Selye, 1976). Selye “create a neologism and introduce 
the word ‘stressor’ for the causative agent” and introduced the word “stress” from physics 
for the resulting condition (Selye, 1974).  
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Chrousos proposed four key concepts that are closely associated with the 
comprehensive understanding of stress: homeostasis, stressor, stress and adaptive 
response.  Homeostasis is described as an essential, complex dynamic equilibrium for 
maintaining life, and is constantly challenged by a variety of intrinsic and extrinsic 
adverse stimuli or stressor, which could potentially disrupt the equilibrium; stress, is 
referred to as a state of threatened homeostasis, either real or implied, which is 
reestablished by physiological and behavioral adaptive response (Chrousos, 1998).   
McEwen introduced the terms “allostasis” and “allosatic load” into stress research. 
Allostasis is an essential component of maintaining homeostasis and an active process of 
adaptation by production of various mediators such as adrenal steroids, neurotransmitters, 
cytokines and tissue mediators.  Allostatic load refers to the wear and tear on the body 
and brain resulting from chronic overactivity or inactivity of physiological systems that 
are normally involved in adaptation to environmental challenge.  Allostasis emphasizes 
on the relatively large range of activities, functions and the duration of all the body 
systems in response to internal and external demands (McEwen, 1998).  
Compared to the homeostatic mechanism, allostatic regulation (allostasis) is a 
broader and dynamic, rather than a set-point concept, which is also consistent with 
Selye’s “alarm” stage.  Allostatic load can be interpreted as the cost of adaptation 
(allostasis), the price of adaptation to adversity.  The systems involved in the stress 
response or adaptation can be either rapidly mobilized and turned down or reactivated 
when necessary while dealing with stress (like Selye’s resistance), and body remains in a 
relatively good state.  In some cases, when they are not able to shut off or turn down 
these systems in response to stimuli, the excessive response will do harm to health (a 
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mechanism of autoimmune disease); or the inability to mount a response, the stressor will 
take over the body systems (a mechanism for infectious disease).  Both situations produce 
a load on the body, because the normal protection afforded by these systems is lacking or 
exhausted (as in Selye’s theory). 
 
3.2. Stress response and individuals  
The determinants of stress responses basically rely on two aspects: how the 
individual interprets stressor and the conditions of the individual when challenged by a 
stressor (McEwen, 1998).  
1) Interpretation of stress by individuals varies among the population. The situation 
of threat may be viewed as a true stressor by some people, whereas it may not be 
perceived as a threat by other people.  Quantitative genetics revealed that about two-
thirds of reliable variance in measured personality traits are inherited (Chrousos, 1998).  
In addition, it is conceivable that biological and psychological maturity, social experience, 
and early training of an individual can affect how individuals interpret the situation, such 
that an older, matured and socially experienced person will more likely adapt to the stress, 
while the younger, immature and inexperienced individual may exhibit increased 
vulnerability to maladaptive stress response.   
   2) Conditions of the body.  Obviously, people who are healthy or in good physical 
condition can more easily handle strenuous stress than those that are not in shape.  
Nevertheless, people who are already in a pathological state or at a critical state, will 
have an increased vulnerability to stress or/and exacerbation of disease (McEwen, 1998).  
For example, individuals suffering from long-term hypertension and hyperglycemia 
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(metabolic imbalance as a stressor) are more likely to develop type II diabetes.     
 
3.3. Stressor and stress response   
Stressor or stimuli include pathogens (bacteria, viruses, parasites etc.), toxins, 
irradiation, and various physical stimuli such as surgery and muscular exercise.  
Additionally, Cannon recognized the importance of the psychological response during 
stress (reviewed in Pacak and Palkovits, 2001).  Currently, stimuli can be divided into 
four groups: 1) physical stressors that include cold, heat, noise and radiation. 2) 
psychological stressors, such as anxiety, fear or frustration. 3) social stressors, including 
dominance of animal, unemployment and divorce in humans. 4) stressors that challenge 
cardiovascular and metabolic homeostasis, such as exercise, orthostasis, heat exposure, 
hypoglycemia and hemorrhage (Pacak and Palkovits, 2001).  
The body responds both behaviorally and physiologically to challenge by these 
stressors by mobilizing and incorporating endocrine, nervous and immune systems to 
maintain health state (homeostasis).  In fact, almost all the body systems could be 
involved in the response. Behavioral adaptation includes improved cognition, focused 
attention, enhanced arousal, alertness and vigilance increased analgesia, elevations in core 
temperature, as well as concurrent inhibition of vegetative functions, such as appetite, 
feeding, and reproductive function.  Concurrently, physical adaptation changes are 
primarily to promote an adaptive redirection of energy, such that oxygen and nutrients are 
shunted to the sites where they are needed the most, the CNS and the stressed body sites, 
by increasing cardiovascular tone (heart rate, cardiac ejection fraction, blood pressure), 
respiratory rate, and intermediate metabolism (gluconeogenesis, lipolysis) (Chrousos, 
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1998).  If the adaptive response works in concert and is timely and adequate, health will 
be attained and the chance of survival will be increased; otherwise, either inadequate or 
excessive and prolonged response will lead to a disease. 
 
3.4. The stress system   
The stress system consists of central and peripheral limbs.  The central part includes 
corticotropin-releasing hormone (CRH) neurons located in the paraventricular nuclei 
(PVN) of hypothalamus and paragigatocellular nuclei of medulla, and arginine-
vasopresin (AVP) neurons of the hypothalamus, as well as catacholamine neurons of the 
locus ceruleus (LC) in medulla and pon.  The peripheral stress system is composed of 
hypothalamus-pituitary and adrenal (HPA) axis and sympathetic nervous system (SNS) 
axis (Chrousos, 1998).  The two systems receive information from the higher center of 
CNS and environment to produce the stress response.  
When an organism encounters stress, both axes are activated. CRH secretion is 
increased, and is followed by elevation of ACTH from the pituitary and glucocorticoids 
(GCs) from adrenal cortex. GCs are the final effectors of HPA axis and exert their 
pleotropic effects on target tissues.  CRH, ACTH and GCs interact with hypothalamic-
gonadal axis by inhibiting gonadotropin hormone releasing hormone (GnRH), resulting 
in decreased production of luteinizing hormone (LH) and testosterone in males or 
estrogen in females and down-regulation of reproductivity.  The activation of HPA axis 
also suppresses the secretion of growth hormone (GH) and insulin-like growth factor-1 
(IGF-1) via inhibitory somatostatin (STS) stimulated by CRH.  This alteration in growth 
axis may contribute to the development of psychological dwarfism, which is manifested 
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by delayed puberty due to emotional deprivation or psychological harassment during 
childhood or adolescent stage.  Hypofunction of the thyroid can be induced by stress 
activated HPA axis.  STS suppress the secretion of hypothalamic thyrotropin releasing 
hormone (TRH) and pituitary thyrotropin stimulating hormone (TSH). TSH, the synthesis 
of T4 and the conversion of inactive thyroxine (T4) to active triidothyronine (T3), are 
inhibited by GCs.  Thyroid function profoundly influences other organ functions, such as 
on cardiovascular system and metabolism.  Moreover, high GCs, GCs-induced low GH 
and/or IGF-1, as well as cytokines induced by stress, may further interfere with 
metabolism, resulting in gluconegenesis (hyperglycemia and insulin resistance) and 
visceral adiposity (Chrousos, 1998).  
Compared to the HPA axis, the SNS provides a more rapid response that mostly 
controls the acute response to a stressor, as well as a wide range of functions.  
Sympathetic innervations of these peripheral organs are derived from the efferent 
preganglionic fibers, whose cell bodies are lined at the intermediolateral column of the 
spinal cord.  The nerve fibers of the sympathetic postganglionic neurons innervate 
vascular smooth muscle, skeleton muscle, kidney, gut, fat and many other tissues and 
organs.  Activation of SAM results in the secretion of norepinephrine (NE) and 
epinephrine (Epi), acetylcholine (Ach) as well as neuropeptide Y (NPY), STS, enkephalin 
and nitric oxide (NO) etc.  Additionally, circulating NE and Epi also comes partly from 
humoral secretion by the adrenal medulla during stress.  SNS, together with the HPA axis, 
participates in the regulation of adaptation to the stressor in reproduction, growth and 
metabolism as described above.  Furthermore, the SNS plays a role in gastrointestinal 
function during stress.  Activation of the SNS enhances sacral parasympathetic neural 
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activity, thus increasing colonic motility; it also inhibits gastric motility, gastric acid 
secretion, empting of the stomach, with the assistance of CRH.  Therefore, stressed 
people may exhibit chronic gastrointestinal pain and irritable bowel (Elenkov et al., 2000).  
 
3.5. The interaction between behavior, brain and immunity   
Two potential pathways are known for the connection between the nervous system 
and immune system.  First, immune organs, such as the thymus, spleen and bone marrow 
are innervated by sympathetic nervous system via catecholamines, while the immune 
cells carry catecholamine receptors.  Another pathway is mediated by hormones released 
from the nervous system and endocrine system.  Likewise, the immune cells contain 
receptors for these hormones, such as GCs.  In contrast, the immune cells can secrete 
soluble molecules, such as cytokines, which act on the nervous system through receptors.  
Thus, a bidirectional communication is established for the regulation between the two 
systems in response to a variety of stimuli, for example, stress (Maier et al., 1994; Prutte, 
2003).  
 
4. Stress and multiple sclerosis 
The linkage between stress and the exacerbation of MS was first noted by Charcot, 
one of the earliest investigators of MS, in his publication “Lectures on the Disease of the 
Nervous System” in 1877.  In his book, the emotions of grief, vexation, and adverse 
changes in social circumstances were attributed to MS.  The phenomenon has been 
noticed by other investigators and since that time, the potential association between 
psychological stressor and clinical onset or exacerbation has been investigated based on 
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case-control and longitudinal studies (reviewed in Mohr and Cox, 2001).  
It has been shown that chronic psychological stressors, such as interpersonal 
conflicts, low perceived social support, anxiety and depression episodes, are potential risk 
factors for the exacerbation of MS (Strenge, 2001).  A significant positive correlation was 
also suggested between postpartum emotional distress and MS symptoms in mothers with 
MS (Gulick and Kim, 2004).  Moreover, it was observed that stressful life events usually 
precede the exacerbation of MS in relapsing-remitting MS patients (Ackerman et al., 
2002; Bach and Wild, 1990).  The most complete data to date was reported by Mohr et al. 
(2004) using a meta-analysis on 14 previous studies, in which the data sources were 
related with “stress”, “trauma” and “MS”.  The results strongly suggest an association 
between stressful life events and MS exacerbation.  The relationship between stress and 
MS exacerbation was further supported by MRI scans, which showed that stress was 
significantly correlated with the development of new gadolinium enhancing (Gd+) brain 
lesions, 8 weeks after stress (Mohr et al., 2002). 
However, the notion that stress may exacerbate MS has been controversial due to 
inconsistent observations.  For example, a study conducted in Israel during the Gulf War 
documented a lower frequency of relapses in MS patients exposed to the threat of missile 
attacks (Nisipeanu and Korczyn, 1993).  Sibley (1997) noticed clinical exacerbation 
following martial and job-related stress, but not negative life events, such as a death in 
the family. This indicates that different types of stressor may impact the disease course 
differently.  Others argue that the studies have a critical limitation in “recall bias”, so that 
the patients may be more likely to recall such events as stressful episodes when searching 
their memories for associations between stressor and MS attack (Galea et al., 2004).  In 
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addition, MS patients display psychological symptoms, such as depression, anxiety and 
anger (Mohr and Cox, 2001).  Therefore, “psychological stress” and neurological relapse 
may be different temporal manifestation of the same disease process (Galea et al., 2004).  
 The conundrum has led to further research on the alteration in immune and 
endocrine parameters of MS patients following stress.  Heesen et al. (2002) reported 
elevated baseline levels for catecholamines, prolactin and IL-6 in relapsing-remitting MS 
patients as compared to healthy controls, suggesting an altered stress hormone system in 
MS, a deficiency in regulatory feedback mechanisms; and a marginal hyporesponse of 
TNF- and IL-10 was noted as well (Heesen et al., 2003).  Furthermore, Ackerman et al. 
(2003) noted that MS patients with higher cardiovascular reactivity to stressors and 
higher baseline heart rate demonstrated increased frequency in exacerbations, indicting a 
potential role of autonomic tone and stress reactivity in stress-related exacerbations.  
Although the current literature is limited, it is becoming one of the most prospective areas 
in MS investigation. Unquestionably, stress is regarded as one of the triggering factors in 
the pathogenesis of MS.     
 
5. Stress and infectious disease  
5.1. Early research on the relationship between stress and infectious disease 
The stress effect on the progression of disease has been noticed for decades. Most of 
the observations were based on longitudinal or retrospective studies, which were less 
convincing and more at descriptive level. In the early 1990s, Cohen et al. (1991) 
established experimental methodology in humans for the exploration of the relationship 
between stress exposure and the susceptibility to infectious disease, which led to the 
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boost in the development of a new interdisciplinary area – psychoneuroimmunology 
(PNI).  Recently, the impact of stress on the infectious diseases caused by viruses, 
bacteria, and parasites has been extensively investigated by dissecting immune 
parameters at both the cellular and molecular levels.  
Upper respiratory infections are very common in humans with a higher incidence in 
persons under stress.  In a study of 394 volunteers conducted by Cohen et al. (1991, 
1993), all the healthy subjects were given nasal drops containing one of five common 
respiratory viruses (rhinovirus type 2, 9, or 14, respiratory syncytial virus, or coronavirus 
type 229E) after completing questionnaires assessing degrees of psychological stress, and 
then the subjects were quarantined and monitored for the development of evidence of 
infection and symptoms.  It was demonstrated that stressful life events, perceived stress 
and negative effect predicted a linearly greater probability of developing a cold across the 
five different viruses.  In the following experiment, Cohen et al. (1998) identified 
different types of stressor impact on the susceptibility at various degrees.  He found that 
severe chronic stressors (1 month or longer) were associated with an increased risk of 
developing colds after inoculation with common cold viruses; whereas severe acute 
stressful life events (less than 1 month long) were not.  He also noted that this relation 
was attributable primarily to under- or unemployment and to enduring interpersonal 
difficulties with family or friends.  Although the differential susceptibility to the common 
cold could not be explained by differences among stressors, these experiments avoided 
methodological pitfalls such as “recall bias” and gave rise to convincing evidence of the 
link between stressful life events and susceptibility to infectious disease. 
The Herpesviridae family includes eight viruses that may cause acute and recurrent 
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disease. Herpes simplex virus type-1 (HSV-1) causes encephalitis, keratitis and stomatitis; 
and herpes simplex virus type-2 (HSV-2) is the pathogen for genital herpes. Many studies 
have been focused on the relationship between stress and recurrent herpes infection. 
Hoon and colleagues conducted a study of 125 college students who were seropositive 
for genital herpes, and found that psychosocial stressor increases herpes recurrence, as 
well as the vulnerability to nonherpes, and general illness (Hoon et al., 1991).  
The role of stress and negative effect on the progression of HIV infection has been 
investigated. It was shown that depression predicted a more rapid decline in CD4+ T cell 
counts and this association was not attributable to baseline physiological difference 
(Burack et al., 1993).  However, in another study, Kessler et al. (1991) showed that 
stressful life events did not correlate with T cell count and disease course. This 
contradiction, in fact, may reflect the inconsistencies in the assessment or quantitation of 
the stressor. It was greatly reconciled with the establishment of animal models for the 
study of stress, which allowed conceptualizing and measuring the stressor, and by 
examining immune parameters, shedding light on the underlying mechanisms that 
mediate the interaction between stress and susceptibility of disease.   
 
5.2. Experimental models for stress 
Restraint stress, or immobilization, is a stressor that limits the movement of animals 
to induce stress response.  It was originally used as a basic technique for the investigation 
of pharmacological, physiological or pathological phenomena or with restraint stress 
itself serving as the object of the study.  Recently, researchers extended the application of 
restraint stress to investigate CNS mechanisms in peripheral disease.  Since then, the 
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restraint technique has evolved as a standard laboratory procedure for studying stress, so 
that restraint has become a synonym of stress (Glavin et al., 1994).  Basically, the 
restraint procedure involves confining the animal in a cylindrical, plastic tube for time 
periods ranging from minutes to hours.  The stress response was validated by observing 
an increase in plasma corticosterone and cortisol secretion following restraint stress in 
primates and rodents; however, a slightly different response was noted in rats and mice 
(reviewed in Glavin et al., 1994).  Murison and Overmier (1993) reported that restraint 
induced gastric and duodenal ulcerations in conscious rats, but not in unconscious rats, 
suggesting the involvement of CNS in the stress response.  Restraint stress has been used 
as a valuable tool mimicking psychological stressors, such as anxiety or distress, in the 
study of stress. 
Social disruption is another stress procedure by introducing an animal (intruder) into 
another animal (resident)’s territory to produce confrontation response. This procedure is 
based on the establishment of a territory, usually by a male animal, and defense against 
an unfamiliar male intruder (Stefanski et al., 2003), thus disrupting the established 
hierarchy in the territory, which generalizes in human as social distress. Maternal 
separation stress is evoked by taking the baby animals away from their mother, produces 
offspring with behaviors reminiscent of the cardinal features of anxiety and affective 
disorders. This stress paradigm also produces persistent hyperresponse in hypothalamic-
pituitary-adrenal axis activity secondary to hypersecretion of corticotropin-releasing 
hormone and is used as laboratory tool for psychological stress studies (reviewed in 
Newport et al., 2002).  
Other stress models, such as electric foot shock, applying electric stimuli via the foot 
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of the animal; swimming stress, by placing the animal in a “swimming pool”; cold or 
thermal stress, by exposing the animal in a cold (15-200C) or heat (38-390C) environment, 
as physiological and psychological stressors,  are also applied in the study of stress and 
infectious disease.   
 
5.3. Stress increases the susceptibility to infectious disease by suppressing immune 
function 
The stress-induced viral pathogenesis has been extensively investigated using a 
restraint stress model with influenza and herpes simplex virus infections.  It was shown 
that both HPA and SNS axes are activated following restraint stress evidenced by 
increases in plasma glucocorticoids (GC) and catecholamines (Hermann et al., 1994a & 
b).  Influenza-infected mice, when subjected to restraint stress display marked a 
decrement in the immune response to viral infection, including decreased NK cell activity, 
which is mediated by GC and opiods and a delayed recruitment of cells to the lung 
(Hunzeker et al., 2004; Tseng et al., 2004); decreased infiltration and pro-inflammatory 
cytokine response (Konstantinos and Sheridan, 2001; Sheridan et al., 1991; Sheridan et 
al., 2000) in the lung.  A series of gene microarray expression experiments in this restraint 
and influenza model showed a reduced and delayed expression of genes that are 
responsible for cell adhesion, cell trafficking, MHC and antigen presentation, and 
chemotaxis (Engler et al., 2005).  These results demonstrate a significant suppressive 
effect of restraint stress on the antiviral immunity to influenza, which illustrates at the 
cellular and molecular level, the mechanism behind increased susceptibility to common 
cold in stressed humans.  In addition, restraint stress has a greater suppressive effect on 
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aged mice than young mice (Padgett et al., 1998a), which correlates with a greater 
vulnerability to infection in elders.  
Furthermore, the stress-induced effect on HSV-1 infection has been studied using a 
restraint stress model. NK cell and HSV-specific CTL were depressed by restraint stress 
(Bonneau et al., 1991a; Bonneau et al., 1993), and both the HPA and SNS axes 
contributed to the suppressive effect (Dobbs et al., 1993).  In this model, restraint stress 
was shown not to inhibit the generation of virus-specific memory CTL (CTLm), but it did 
suppress CTLm by inhibiting the activation of CTLm to become the lytic phenotype 
(Bonneau et al., 1991a), or proliferation of CTLm as a result of decreased IL-2 
production in restrained mice (Bonneau et al., 1991b) in lymph nodes.  Splenic HSV-
specific CTLm was also reduced, accompanied by a decrease in cytokine production 
following restraint stress, suggesting that a reduced availability of cytokines which drive 
the activation of CTLm may be responsible for the suppressed CTLm function (Bonneau, 
1996).  As a neurotropic virus, the consequence of restraint stress on the CNS infection 
was investigated.  It was demonstrated that stress causes severe HSV encephalitis and 
higher mortality, and decreased cellularity (DeLano and Mallery, 1998) and a delayed 
HSV-specific CD8+ infiltration (Anglen et al., 2003) in the CNS.  Additionally, restraint 
stress decreases the clinical severity of primary, local HSV-1 infection in the skin by 
down-regulating interferon production (Ortiz et al., 2003).  Thus, stress-induced 
dysregulation appears to be systemic in HSV infection, not only limited to local infection. 
This model provides us another example illustrating the mechanisms by which stress 
increases the incidence of infection.  
However, the reactivation of HSV infection was not induced in this herpes-restraint 
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stress model; yet disruption of the social hierarchy within colonies of mice increased 
aggression among cohorts and caused reactivation of latent HSV-1 in 40% of latently 
infected animals (Padgett et al., 1998b).  Therefore even though the HPA axis is activated 
in both models, the outcomes are different. Likewise, the differential outcomes on the 
antiviral response by the two models were also observed in the influenza model. Sheridan 
et al., (2000) documented a diminished infiltration in the lung by restraint, but an increase 
by social disruption.  This is due to the elevation in circulating nerve growth factor (NGF) 
released by social disruption, which may negatively regulate the expression of type II 
glucocorticoid receptors and hence the induction of steroid insensitivity.  It was also 
recorded that exposure of mice to immobilization stress and subsequent inoculation of 
influenza virus does not significantly influence gastric ulceration, and cold stress resulted 
in a decrease in the index of stomach ulceration.  However, the simultaneous application 
of cold-restraint stress and influenza virus infection exacerbated ulceration (Mileva et al., 
2003).  It is conceivable that the intrinsic machinery involved in regulating the stress 
response varies in different stress paradigms; the virus-induced immune response also 
differs due to the properties of virus.  Therefore, it is always important to choose a proper 
model in order to uncover the mechanism of the interaction between stress and infectious 
disease.  
In order to investigate the effect of stress on pathogenesis of MS, we utilized a 
restraint stress model mimicking anxiety and distress, which are common psychological 
stressors in MS patients; and a Theiler’s virus model, which is based on the hypothesis 
that virus is a potential etiological agent of MS.  A previous study has shown that restraint 
stress results in higher mortality, increase in circulating corticosterone, lymphopenia 
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(Campbell et al., 2001) and decreased NK cell activity (Welsh et al., 2004).  In this 
current study, we continued to study the acute infection by further dissecting pro-
inflammatory responses following stress, and we explore how stress impacts the 
development of demyelination in the chronic disease.  We hypothesize that stress-induced 
immunosuppression raises the susceptibility to acute viral infection, thus resulting in 
persistent virus infection and facilitation of demyelination.   
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II   THE EFFECT OF RESTRAINT STRESS ON THE CLINICAL 
SIGNS, CNS INFLAMMATION AND CHEMOKINE EXPRESSION 
DURING THE ACUTE TMEV INFECTION* 
 
1. Introduction 
 In recent decades, accumulative data from both clinical and experimental 
observations have indicated that stressful life events may be potential risk factors 
contributing to the onset and progression of autoimmune diseases such as multiple 
sclerosis (MS) (Ackerman et al., 2002; Grant et al., 1989; Warren et al., 1982; Warren et 
al., 1991). Exposure to physical or/and psychological stressors can result in the 
exacerbation of clinical signs in MS patients, such as an increase in degree of disability, 
worsening of cognitive difficulties and an increase in severity of brain lesions (Mohr et 
al., 2002; Zorzon et al., 2001). The mechanism by which stress regulates susceptibility 
and severity of autoimmune diseases has been extensively investigated. The biological 
impact of stress is exerted via a feedback regulatory loop within a network consisting of 
the central nervous system (CNS), the endocrine system and the immune system. The 
stress response is initiated in the CNS by the limbic-hypothalamic-pituitary adrenal axis, 
and by the locus coeruleus-norepinephrine autonomic system. The stress-induced release 
of hypothalamic corticotropin-releasing hormone (CRH) ultimately results in the 
production of adrenal glucocorticoids. Additional activation of the sympathetic nervous  
_____________________________ 
*Reprinted and revised in part from “Alterations in chemokine expression following 
Theiler's virus infection and restraint stress” by Mi, W., Belyavskyi, M., Johnson, R., 
Sieve, A., Storts, R., Meagher, M., Welsh C.J. with permission from Journal of 
Neuroimmunology 151, 103-115, copyright © 2004 by Elsevier.  
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system (SNS) causes the production of catecholamines. The end-point products from both  
systems further affect host defense and the immune system.  
Behaviorally, restraint stress (RS) causes anxiety and hyperactivity, followed by 
lethargy (Faith et al., 1999). RS has frequently been used experimentally as a stressor to 
examine the influence of stress on the immune response. Previous studies have revealed 
that RS can have a profound influence on the immune responses by increasing the 
susceptibility to viral infection, delaying virus-specific antibody production in influenza-
infected mice, suppressing NK cell and herpes simplex virus (HSV)-specific cytotoxic T 
lymphocytes activities and by prolonging wound-healing time. (Zwilling et al., 1990; 
Bonneau et al., 1991 and 1993; Sheridan et al., 1991; Padgett et al., 1998).  
Intracerebral inoculation of Theiler’s murine encephalomyelitis virus (TMEV) 
produces a biphasic disease consisting of an acute polioencephalitis in all strains of mice 
and chronic inflammatory demyelination in genetically susceptible strains of mice 
(Theiler, 1934; Lipton, 1975). Theiler’s virus-induced demyelination (TVID) has proved 
to be a valuable experimental animal model for the study of multiple sclerosis. The acute 
infection normally lasts approximately two weeks and the virus preferentially infects 
neurons within gray matter. In the later demyelinating phase, TMEV predominantly 
persists in CNS macrophages/microglia and in oligodendrocytes and astrocytes to a lesser 
extent, and is accompanied by flaccid paralysis and demyelination. Host responses to 
Theiler’s virus during early infection are critical in determining either successful viral 
clearance or persistence of virus in CNS with the development of demyelination. 
Inflammation is mediated by virus specific CD4+ T cells targeting infected CNS-resident 
antigen presenting cells (APCs), and is followed by activation of myelin-specific 
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autoreactive CD4+ T cells via epitope spreading and myelin reactive antibodies, which 
eventually results in demyelination (Miller et al., 1997; Welsh et al., 1987 and 1989; 
Borrow et al., 1998).  T cells are initially activated peripherally in lymphoid tissues 
following infection and then traffic back into the CNS to effect viral clearance (reviewed 
in Tompkins et al., 2002). 
Recruitment of inflammatory cells into the CNS is a crucial step in establishing the 
host’s defense and ultimately viral clearance. Chemokines are a family of low molecular 
weight (8-10 kDa), inducible, secreted, pro-inflammatory cytokines that serve as potent 
chemoattractants for immune cells in response to a myriad of immune and inflammatory 
responses. Additionally, they are important regulators of leukocyte recruitment, 
trafficking and activation. To date, over 40 chemokines are classified into four 
subfamilies (C-X-C, C-C, C, C-X3-C) according to the configuration of cystein residues 
near the N-terminal. C-X-C chemokine, also known as  chemokine, include GRO 
(growth-related oncogene), PF4 (platelet factor 4), IL-8 (interleukin 8), Mig (monokine 
induced by interferon ), IP-10 (interferon-inducible protein 10), BCA-1 (B-cell-
attracting chemokine 1), etc.  chemokines are chemotactic mainly for neutrophils and 
lymphocytes; C-C or  chemokines preferentially attract monocytes, eosinophils, 
basophils and lymphocytes, over 20 chemokines belong to this subfamily, such as MCP-
1,2,3,4 (monocyte chemoattractant protein 1,2,3,4), MIP-1, (macrophage inflammatory 
protein 1 and ), RANTES (regulated on activation, normal T-cell-expressed and –
secreted), Eotaxin; C consist of two chemokines: lymphotactin/SCM-1 (single C motif-
1) and SCM-1. The only member of C-X3-C chemokine family is fractalkine (available 
at http://www-ermm.cbcu.cam.ac.uk/02005318a.pdf).  
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It has been suggested that chemokines are involved in T cell (both CD4+ and CD8+)-
mediated viral clearance following viral infection, such as Theiler’s virus, mouse 
hepatitis virus and herpes virus etc. (Theil et al., 2000; Hoffman et al., 1999; Murray et 
al., 2000; Melchjorsen et al., 2002; reviewed by Glass et al., 2002).  The role of 
chemokines in one of the autoimmune diseases, experimental autoimmune encephalitis 
(EAE), has been extensively studied. A broad profile of chemokines consisting of MCP-1, 
RANTES, IP-10 and MIP-1α was detected in the CNS (e.g. Sorensen et al., 1999; 
reviewed by Karpus, 1998; Eng et al., 1996); moreover, the chemokine patterns exhibit 
temporal and spatial difference with respect to the progression and activity of disease and 
lesion development (see reviews by Karpus and Ransohoff, 1998). This phenomenon has 
also been observed in the biphasic phase of TVID (Hoffman et al., 1999). In addition, a 
recent clinical study has demonstrated an up-regulation of IP-10 in cerebrospinal fluid 
(CSF) of patients with relapsing-remitting multiple sclerosis, which was correlated with 
lesion activity as detected by MRI scans (Mahad et al., 2002; Sindern et al., 2002). 
Furthermore, neutralizing antibody against certain chemokine or chemokine receptor 
antagonist proved effective in reducing both the accumulation of inflammatory cells and 
in ameliorating clinical signs of disease (Fife et al., 2001; Karpus et al., 1995; reviewed 
by Ransohoff et al., 2000). Taken together, these data implicate the involvement of 
chemokines in the pathogenesis of MS.  
We have previously shown that RS increases the mortality during the acute stage of 
Theiler’s virus infection by corticosterone-induced immunosupression and impaired viral 
clearance mechanisms (Campbell et al., 2001; Welsh et al., 2004). It has also been 
demonstrated that stress may impact migration or redistribution of lymphocytes between 
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blood and lymphoid organs (Stefanski, et al., 2003; reviewed by Dhabhar, 2002). In the 
current study, we further investigated the mechanism involved in restraint stress-induced 
alteration of the immune response and lesion development in both the CNS and 
peripheral lymphoid tissue following Theiler’s virus infection. This was accomplished by 
examining the alterations in chemokine expression in both the brain and spleen of 
restrained and non-restrained CBA mice. We demonstrate that restraint stress down 
regulates the expression of certain chemokines and diminishes immune cellular 
infiltration into the CNS.  
 
2. Materials and methods  
2.1 Mice  
Three-week-old male CBA mice (purchased from Harlan Labs, Indianapolis, IN) 
were housed in pathogen-free condition. The mice were housed 3-4 mice per cage, 
counterbalanced by weight upon arrival, and acclimated for one week prior to 
commencing the experiments.   
 
2.2 Virus 
The BeAn strain of Theiler’s virus was obtained from Dr. H. L. Lipton, Department 
of Neurology, University of Chicago, Evanston, IL and was propagated and amplified in 
L-2 cells. The culture supernatant containing infectious virus was aliquoted and stored at 
-80oC before use (Welsh et al., 1987). 
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2.3 Experimental design 
A 2 (infected vs. non-infected) by 2 (restraint vs. non-restraint) factorial design was 
employed. At four weeks of age, cages were randomly assigned to one of the following 
treatment conditions: (1) Non-infected/Non-restrained (NI/NR) mice remained 
undisturbed in their home cages; (2) Non-infected/Restrained (NI/R): each mouse was 
subjected to restraint stress in their home cages; (3) Infected/Non-restrained (I/NR): mice 
were infected intracerebrally with BeAn virus; or (4) Infected/Restrained (I/R): each 
mouse was intracerebrally infected with virus and  subjected to restraint stress. 
Three experiments were conducted in this study in order to evaluate chemokine 
alterations and CNS lesions. In each experiment, the mice were divided into four groups 
as described above. The specific procedure followed plus numbers of mice used per 
group (in parenthesis) were: 1) To determine chemokine alterations at day 2 p.i.: NI/NR 
(4), NI/R (4), I/NR (4), I/R (5);  2) To determine chemokine alterations at day 7 p.i.: 
NI/NR (8), NI/R (8), I/NR (7), I/R (14);  3) To determine microscopic lesions in CNS:  
NI/NR (3), NI/R (3), I/NR (3), I/R (6).   
 
2.4 Restraint stress protocol 
The restrained mice were placed in well-ventilated restraining tubes (2.7-cm internal 
diameter and 14-cm length) for 12 h (from 9pm-9am) each of 3 or 7 consecutive nights 
(Sheridan et al., 1991; Campbell et al., 2001). The tubes were perforated with small holes 
to allow adequate ventilation. Restraint stress was initiated 1 day prior to infection and 
continued for 2 or 6 subsequent sessions (for the mice sacrificed at day 2 p.i. and day 7 
p.i., respectively) as indicated above.  
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2.5 Infection of mice  
Mice were anesthetized with metofane and then either intracerebrally inoculated into 
the right cerebral hemisphere with a 5x104 plaque forming unit (PFU) of BeAn viral 
inoculum in a 20µl volume (infected mice) or sham-infected with 20µl of sterile 
phosphate-buffered saline (PBS) (non-infected group). 
 
2.6 Behavioral assessment 
All mice were weighed at the beginning of the experiment and daily 3 hours after the 
stressed mice were release from restraining tubes. Daily food intake per cage was also 
recorded. Mice were scored daily for clinical signs of disease according to the following 
criteria: 0=healthy, grooming complete, active; 0.5=fur slightly ruffled, grooming 
incomplete; 1=ruffled fur and/or slightly hunched posture; 2=hunched, slightly lethargic 
or irritable; 3=very lethargic, unresponsive, very hunched, sunken eyes; 4=dead. 
 
2.7 Spontaneous activity monitoring 
Spontaneous activity has been shown to be a sensitive measurement indicative of 
demyelination in Theiler’s virus infection (McGavern et al., 1999; Sieve et al., 2004; 
Yirmiya et al., 1994). To monitor the activity, individual mice were placed in each of four 
Digiscan monitors consisting of a 20 × 20-cm clear Plexiglas box with a grid of 
horizontal infrared beams mounted every 2.5 cm. Two tiers of beams were mounted 2 cm 
and 3 cm above the floor. The four monitors were connected to a Digiscan Analyzer 
(Omnitech Model DCM-8, Columbus, OH), as shown in an illustration (Figure 2-1), for 
translation of the activity data to a computer. 
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The number of beam interruptions was recorded and analyzed by Digiscan for 
assessment of activity in each 20 minute session. The following variables, either 
calculated directly by the Digiscan Analyzer or derived from the measured variables, 
were examined: 
1) Total distance (TD). The horizontal distance traveled by an animal in a session. 
2) Horizontal activity (HA). The number of separate horizontal movements executed 
by an animal with a minimum stop time of 1 s between movements. 
3) Vertical activity (VA). The number of separate vertical movements (rearing) in a 
session, separated by at least 1 s. 
4) Central time (CT). The total time a mouse spent in the movement at the central 
area in a session. 
5) Center distance (CD). The distance traveled by a mouse in the central area in a 
session. 
6) Marginal time (MT). The amount of time a mouse spent in the movement at the 
marginal area. 
7) Marginal distance (MD). The distance traveled by a mouse in the marginal area in 
a session. 
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Figure 2-1      An illustration showing one of the 4 digiscan monitors of an activity   
 monitoring box.  A representative tier of infared beam was shown. The highlighted  
 area indicate the central area, at which the activity and time a mouse spend during a  
 20 min monitoring session are recorded as central activity and central time. The rest  
 region indicates the marginal area for recording marginal activity and marginal time  
 of a mouse.  
 
 
 
 
 
 
 
2.8 Termination of mice 
Mice were sacrificed by pentobarbital injection i.p. at either day 2 p.i. or day 7 p.i. 
and then were perfused with diethyl pyrocarbonate (DEPC, Sigma)-treated PBS. The 
brains and spleens were removed, weighed, then were quick frozen in liquid nitrogen and 
stored at -80oC until used. 
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2.9 Ribonuclease protection assay  
Total RNA was extracted from the brain and spleen using TRIZOL Reagent (Life 
Technologies, Grand Island, NY) according to the manufacturer’s instructions. The mCK-
5c Multi-Probe Template Set (BD PharMingen, San Diego, CA) contains DNA templates 
for chemokines lymphotactin (Ltn), RANTES, MIP-1β, MIP-1α, MIP-2, IP-10, MCP-1, 
TCA-3 (T cell activation-3), Eotaxin, and two housekeeping genes L32 (ribosome RNA) 
and GAPDH (glyceraldehydes-3-phosphate dehydrogenase). The probe was labeled with 
32P –UTP (800 Ci/mmol, 10µCi/µl, PerkinElmer Life Sciences, Inc., Boston, MA). 
Ribonuclease protection assay (RPA) analyses were performed using RPA III and 
MAXIscript kit (Ambion, Austin, TX), according to manufacturer’s instructions.  
Briefly, 25µg RNA was hybridized overnight (16 h) with labeled probe and the 
reactions were subsequently digested with RNase A/T1 Mix, followed by precipitation 
with Inactivation/Precipitation III solution (Ambion, Austin, TX).  The protected RNA-
probe complexes were loaded and separated on 5% acrylamide/8M urea/1xTBE gel. Then 
the gel was dried for 2 h using a gel drier (Gel Drier, Model 583, Bio-Rad), and exposed 
to a Fujifilm Phosphor Imaging Plate in BAS cassette 2325 (Fuji Medical Systems USA, 
Inc.) for 16 h.  
The plate was scanned with a Fujifilm Bio-imaging Analyzer BAS-1800II 
(Kanagawa, Japan) and the photo-stimulated luminescence (PSL) was analyzed with the 
ImageGauge software (Version 3.12, Science lab, Fuji Photo Film Co.Ltd). The 
densitometry of each band was represented by the PSL reading and then normalized with 
a housekeeping gene (L32 or GAPDH).  
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2.10 Microscopic examination of brain tissue 
Brain samples were collected from mice in a second identical experiment at day 7 p.i. 
by terminal perfusion with 10% formalin.  The brains were removed, processed and 
embedded in paraffin.  Five-micron sections from each block were stained with 
hematoxylin and eosin (H&E) for microscopic examination.  
Brain sections were scored for perivascular cuffing, meningitis, and microgliosis by 
a trained experimenter blinded to the subject’s treatment condition.  A micrometer was 
used to determine the measurements of circumference, area, and diameter.  The score for 
perivascular cuffing was set by calculating the product of the average number of cell 
layers surrounding the vessels, the number of cuffs in the hippocampus, and the diameter 
of the cuff.  The scoring for meningitis was determined by calculating the number of 
inflammatory cell layers in the meninges, multiplied by the length of the meninges 
affected by inflammation and divided by the circumference of the meninges of the section. 
Microgliosis was evaluated by the cell number of microgliosis in the hippocampus 
divided by the area of the hippocampus. The score for each animal was derived from the 
average of 2-3 sections.  
 
2.11 Statistical analysis 
Analyses of variance (ANOVA) were used to evaluate between group differences 
across stress, infection, and time of sacrifice conditions. These analyses were followed by 
post hoc group mean comparisons using Duncan’s New Multiple Range Test. Results 
were considered significant if p < 0.05. 
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3. Results 
3.1  The effect of restraint stress on behavioral signs during the early phase of TVID 
3.1.1 Clinical score 
As depicted in Figure 2-2, clinical scores were elevated in both the infected and non-
infected restrained mice compared to the non-restrained infected and non-infected mice.  
The majority of the restrained mice (33/39) exhibited signs of ruffled fur and poor 
grooming on the second day of restraint stress (1 day p.i.) which became exacerbated 
with continued restraint. Some of the mice developed a hunched posture, but no signs of 
encephalitis in infected mice were seen at this early stage of disease.  An ANOVA 
conducted on the worst clinical score observed over the 7 day period confirmed that there 
was a significant main effect of restraint stress, F (1,64) = 154.41, p < 0.0001.  However, 
the main effect of infection, F (1,64) = 1.703, p > 0.05, and the interaction between 
restraint and infection were not significant, F (1,64) = 1.703 p > 0.05.  A similar pattern 
was observed in a previous study during the first 7 days post infection; however, when 
restraint was continued for an additional 2-3 weeks, the infected/restrained mice 
developed severe signs of encephalitis and high mortality (Campbell et al., 2001). Thus, 
one week of restraint stress is too early to observe an interaction between restraint and 
infection on clinical signs of acute infection.   
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Figure 2-2.  Clinical score following TMEV infection and restraint stress during the acute 
phase of TVID. Restraint stress exacerbates clinical scores in both infected and non-infected 
restrained mice during the first 7 days post infection. Non-restrained (both infected and non-
infected) mice displayed no apparent clinical signs at this time point.  Data are expressed as 
the mean + SEM. 
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3.1.2 Spontaneous activity 
The effect of restraint stress was also evidenced by spontaneous activity monitoring 
as depicted in Table 2-1 and Figure 2-3.  There was a main effect of stress on center time  
(CT), center distance (CD) and marginal time (MT), all Fs > 8.623, all ps < 0.0097. The 
data demonstrated that the vertical activity (VA) was reduced, and the overall 
spontaneous activity declined in the central area but increased in the marginal area 
following restraint stress.  A main effect of days post infection was found on total 
distance (TD) and center distance (CD), such that both total travel movement and the 
time spent in the central area in a session were reduced with time, all Fs > 6.237, all ps < 
0.0238.  No effect of infection on spontaneous activity was found.  The interaction of 
restraint by day p.i. on horizontal activity (HA), center time (CT) and marginal time (MT) 
were present, such that an increase in HA, CT and a decrement in MT were observed in 
nonrestrained animals over time (from day 1 p.i. to day 4 p.i.); whereas the opposite, a 
decrement in HA and CT and an increase in MT were noticed in restrained mice with 
time (from day 1 p.i. to day 4 p.i.), all Fs >  4.847, all ps < 0.0427. These results 
suggested that the spontaneous activities of restrained mice were significantly decreased, 
so that the restrained animals spent more time in the margin and less time in the center, 
indicative of sign of anxiety following stress; and that a further reduction of such an 
effect of stress was seen with extended restraint stress.  
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             Table 2 -1  The main effect of restraint stress and day postinfection on spontaneous activity variables
Measure                                   Stress                        Day post infection
Non-restrained Restrained day 1 p.i. day 4 p.i.
Total distance (TD) 611.43 + 27.63 555.92 + 38.81 639.40 + 33.58 * 516.85 + 35.00 *
Horizonal activity (HA) 2692.69 + 64.36 2704.67 + 102.01 2747.90 + 94.42 2651.85 + 92.61
Vertical activity (VA) 333.13 + 22.58 * 212.58 + 19.32 * 285.95 + 22.02 235.65 + 26.08
Central time (CT) 373.83 + 40.48 * 196.28 + 28.62 * 265.79 + 29.80 268.82 + 46.18
Central distance (CD) 262.63 + 20.34 * 187.63 + 16.16 * 262.63 + 20.34 * 187.63 + 16.16 *
Marginal time (MT) 826.17 + 40.48 * 1003.72 + 28.62 * 934.22 + 29.80 931.18 + 46.18
Marginal distance (MD) 348.56 + 16.88 368.67 + 26.35 390.00 + 25.08 331.25 + 21.89
*
 denotes significance between two conditions (restrained vs. non-restrained or day 1 p.i. vs.day 4 p.i.), when p  < .05. The data was
 represented by mean+S.E.M.
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Figure 2-3.  The effect of restraint stress by day post infection interaction on spontaneous 
activity variables. The effect of restraint stress on reducing horizontal activity (HA) was not 
shown until day 4 p.i.. Restraint stress diminished the time a mouse spend in the central area 
(CT), whereas increased the marginal time (MT). The change in time of movement at 
different area was more evident with extended restraint stress, as revealed by ANOVA, all 
Fs >  4.847, all ps < 0.0427.   
0
500
1000
1500
2000
2500
3000
3500
no n-restrained          restrained
H
o
riz
o
n
ta
l a
ct
iv
ity
day 1 p.i.
day 4 p.i.
0
100
200
300
400
500
600
no n-restra ined          restrained
Ce
n
tr
al
 
tim
e 
(s)
day 1 p.i.
day 4 p.i.
0
200
400
600
800
1000
1200
no n-restrained          restrained
m
ar
gi
n
al
 
tim
e 
(s)
day 1 p.i.
day 4 p.i.
 
 
  
45 
3.1.3 Body weight 
Body weight was dramatically reduced over time by restraint stress in both the 
infected and non-infected mice (Figure 2-4).  Again, an ANOVA confirmed a significant 
main effect of restraint, F (1,231) =76.143, p < 0.0001, and time of sacrifice, F (7,231) = 
5.251, p < 0.0001; however, neither the main effect of infection nor its interaction with 
restraint or time were significant, all Fs (1,76) <0.403, ps >0.53. It is noteworthy that we 
observed black feces in one non-infected/restrained and two infected/restrained mice at 
necropsy.  However, no evidence of hemorrhage or ulcers was evident in the stomach or 
intestine of these mice when examined histologically (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-4.  Effect of restraint stress on body weight. Restraint stress caused loss of body 
weight in both infected and non-infected mice.  Data are expressed as the mean + SEM. 
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3.2 Effects of stress on spleen and thymus weights 
The physiological impact of the restraint stress manipulation was also reflected by 
reductions in organ weights when mice were sacrificed at day 7 p.i. (Figure 2-5). 
Restraint significantly reduced spleen, F (1,31) = 26.89, p < 0.0001, and thymus weights, 
F (1,31) = 348, p <0.0001, in both the infected and non-infected groups. Although 
adrenal weights were also reduced, this effect failed to reach statistical significance, F 
(1,31) = 3.84, p = 0.07.  Also, neither the main effects of infection nor the interactions 
between infection and restraint were significant, all Fs (1,32) < 2.72, p > 0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-5.  Effect of restraint stress on organ weights. The weights of spleen and thymus 
were considerably decreased after stress, but not affected by infection.  Data are expressed as 
the mean + S.E.M. 
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3.3 Chemokine alterations in the brain following Theiler’s virus infection and restraint 
stress 
To determine whether Theiler’s virus infection and restraint stress alter the 
expression of chemokines involved in the recruitment of inflammatory cells, brains were 
collected at days 2 and 7 p.i. for RNase protection assay (Figure 2-6).  As depicted in 
Figure 2-6, infection tended to increase the levels of several chemokines in the brain at 
day 7 p.i., whereas restraint stress selectively attenuated infection-related increases in IP-
10, RANTES and Ltn.  For each time point, a series of ANOVAs were conducted for each 
chemokine entering infection and restraint as between subject variables.   
At day 2 p.i., infection and restraint did not alter chemokine expression, all Fs (1,11) 
< 3.044, ps > 0.05.  In contrast, at day 7 p.i. significant main effects for infection were 
observed for IP-10, RANTES, Ltn, MCP-1, and TCA-3, wherein infection elevated 
expression of these cytokines, all Fs (1,31) > 7.85, ps < 0.009.  Although eotaxin 
appeared to be elevated by infection, this difference failed to reach significance, F (1,31) 
= 1.95, p = 0.17.  These findings indicate that Theiler’s virus infection results in a 
selective pattern of chemokine expression and that these chemokines may be involved in 
the local virus-induced immune response that recruits inflammatory cells into CNS.  
Restraint stress appears to decrease the level of infection-related expression of IP-10, 
RANTES, and Ltn on day 7 p.i..  Supporting this, significant main effects of restraint 
stress were observed on IP-10, RANTES, and Ltn expression on day 7 p.i., all Fs (1,31) > 
3.96, ps < 0.05, but not day 2 p.i., all Fs (1,11) < 3.044, ps > 0.05.  Importantly, these 
main effects were qualified by significant restraint by infection interactions for IP-10, 
RANTES, and Ltn, all Fs (1,31) > 4.28, ps < 0.05, suggesting that the effect of restraint 
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stress depended on infection status.  Post hoc mean comparisons confirmed that the 
infection-related increases in these chemokines were decreased by restraint stress, all ps < 
0.05.  Other chemokines were not altered by restraint or infection at day 7 p.i., including 
MIP-1, MIP-1, and MIP-2, all Fs (1,31) < 1.698, ps > 0.05.  No other differences were 
significant.  Taken together, these results suggest that restraint stress decreases infection-
related increases for IP-10, RANTES, and Ltn expression, which would be expected to 
decrease the recruitment of inflammatory cells into the CNS.  
To characterize the temporal dynamics of the cytokine response in brain, a series of 
ANOVAs were conducted for each chemokine entering time of sacrifice, infection and 
restraint as between subject variables.  Main effects for time of sacrifice were found for 
the chemokines IP-10, RANTES, Ltn, MCP-1, TCA-3, and MIP-1, all Fs (1,42) > 3.84, 
ps < 0.05.  Transcripts of these chemokines were minimal at day 2 p.i., but elevated at 
day 7 p.i., indicating that the induction of these chemoattractants was enhanced over time.  
Importantly, significant two-way interactions were observed between infection and time 
of sacrifice for IP-10, RANTES, and Ltn, all Fs (1,42) > 4.08, ps < 0.05, indicating that 
the level of virus-induced chemokine expression increased over time.  There also 
appeared to be an interaction between infection and time for MCP-1 and TCA-3, but 
these interactions failed to reach significance, all Fs (1,42) > 3.134, ps = 0.08.  The two-
way interactions between time of sacrifice and restraint stress, all Fs (1,42) < 2.193, ps > 
0.146, and the three-way interactions between time, infection, and restraint were not 
significant for any of these chemokines, all Fs (1,42) < 2.674, ps > 0.11. 
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Figure 2-6.  Phosphor image of a representative RPA for the chemokine expression in the 
spleen (lane 3-6) and brain (lane 7-10) following restraint and/or BeAn infection at day 7 
post infection. Total RNA was isolated from the brains and spleens of CBA mice at day 7 
postinfection. 25µg RNA was hybridized with a 32P-labeled chemokine probe set as 
described in Materials and Methods. The housekeeping genes L32 and GAPDH were used 
for the normalization of sample loading and technique error. Lane 1, a chemokine probe; 
lane 2, the corresponding RNase-protected probes following hybridization with yeast tRNA 
to testify the assay performance.  Lane 3,4,5,6, and lane 7,8,9,10 are the spleen and brain 
samples respectively collected at day 7 postinfection. NI/NR (Non-infected/Non-restrainedl), 
NI/R (Non-infected/Restrained), I/NR (Infected/Non-restrained) and I/R 
(Infected/Restrained). 
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Figure 2-7.  The effect of restraint stress on chemokine expression in the brain at days 2 and 7 p.i. 
during acute TMEV infection.  The levels of chemokines were derived from the densitometric 
ratio of individual chemokines to the housekeeping gene GAPDH and multiplied by 1000. At day 
2 p.i., chemokine levels were not changed by stress nor infection.  At day 7 p.i., infection 
increased mRNA expressions of IP-10, RANTES, Ltn, MCP-1 and TCA-3.  Restraint stress 
decreased infection-related increases in the production of IP-10, RANTES, and Ltn at day 7 p.i. 
as compared to non-restrained mice.  The values are expressed as the mean + S.E.M. 
0
10
20
30
40
50
IP
-
10
 
Restrained
Nonrestrained
Th
e
 
D
e
n
si
to
m
e
tri
c 
R
a
tio
 
o
f  
Ch
e
m
o
ki
n
e
 
Ex
pr
e
ss
io
n
 
in
 
th
e
 
Br
a
in
Day 2 post Infection Day 7 post Infection
0
10
20
30
40
50
Restrained
Nonrestrained
0
10
20
30
40
50
60
70
R
AN
TE
S 
0
10
20
30
40
50
60
70
0
0.5
1
1.5
2
Lt
n
 
0
0.5
1
1.5
2
0
5
10
15
20
M
CP
-
1
0
5
10
15
20
0
5
10
15
20
TC
A-
3
Noninfected Infected
0
5
10
15
20
Noninfected Infected
  
51 
3.4 Chemokine alterations in the spleen after infection and restraint stress 
To explore the effect of stress on the peripheral immune response to TMEV, we 
examined the expression of chemokines in the spleen at days 2 and 7 p.i. (Figure 2-8).  In 
contrast to the brain, several chemokines were up-regulated in spleen as early as day 2 
p.i., and restraint stress attenuated this response.  A series of ANOVAs were conducted 
for each chemokine entering infection and restraint as between subject variables for each 
time point.   
Significant main effects of infection were found at day 2 p.i. for IP-10, Ltn, MCP-1, 
MIP-1β, and TCA-3, all Fs (1,13) > 5.516, ps < 0.04, indicating that infection alone 
increased expression of these splenic chemokines.  However, MIP-1α, eotaxin, MIP-2, 
and RANTES expression were not altered by infection at day 2 p.i., all Fs (1,13) < 1.11, 
ps > 0.05.  Because the chemokine response was detected earlier in spleen than in brain, 
suggests that the amplification of immune response to Theiler’s virus infection was 
generated peripherally.  At day 7 p.i., IP-10, Ltn, MIP-1β, TCA-3, RANTES, and MIP-2 
were significantly elevated by infection, all Fs (1,33) > 6.175, ps < 0.0182; but, there was 
no effect of on MCP-1 or TCA-3, all Fs (1,13) < 0.335, ps> 0.05.  
Restraint stress reduced levels of IP-10, Ltn, MCP-1, MIP-1β, RANTES, and TCA-3 
at day 2 p.i., all Fs (1,13) > 16.804, ps < 0.001, and at day 7 p.i. for RANTES only, F 
(1,33) = 4.272, p < 0.05.  Although restraint appeared to decrease levels of MIP-1, 
MCP-1, and MIP-1 at day 7 p.i., these differences were not statistically significant, all 
Fs (1,33)<2.93, ps > 0.10. These findings were qualified by significant restraint by 
infection interactions at day 2 p.i. on the expression of IP-10, MIP-1, MCP-1 and TCA-
3, all Fs (1,13) > 6.179, ps < 0.03, but not at day 7 p.i., all Fs (1,33) < 3.131, ps > 0.05,  
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Figure 2-8.  The impact of restraint stress on chemokine expression in the spleen at days 2 and 7 
p.i. during acute TMEV infection.  The levels of chemokines were derived from the 
densitometric ratio of individual chemokine to the housekeeping gene L32 and multiplied by 
1000. At day 2 p.i., infection increased IP-10, Ltn, MCP-1, MIP-1β, and TCA-3. At day 7p.i., IP-
10, Ltn, MIP-1β, TCA-3, RANTES, and MIP-2 were elevated by infection, but MCP-1 and 
TCA-3 subsided at this time point. The expression of virus-induced IP-10 was decreased over 
time, while MIP-1α and MIP-2 were upregulated over time.  Stress significantly suppressed the 
expression of IP-10, Ltn, MCP-1, MIP-1β, RANTES, and TCA-3 as early as day 2 p.i.; however, 
this effect was only seen in RANTES expression on day 7 p.i.  The values were represented by 
the mean + S.E.M. 
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Figure 2-8.  continued. 
suggesting that the suppressive effects of stress were attenuated over time.  Post hoc 
mean comparisons verified that the infection-related increases in these chemokines were 
suppressed by restraint at day 2 p.i., all ps < 0.05.  Similar to the early chemokine 
response to infection observed in spleen, the immunosuppressive effects of stress on 
chemokine expression occurred more rapidly in spleen (day 2 p.i.) than in brain (day 7 
p.i).  
To further explore how the cytokine response in spleen changed over time, a series of 
ANOVAs were conducted for each chemokine entering time of sacrifice, infection and 
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restraint as between subject variables.  Significant main effects for time of sacrifice were 
observed for IP-10, MIP-1, and MIP-2, indicating that IP-10 was down regulated, F 
(1,46) = 4,637, p < 0.04, and MIP-1 and MIP-2 were up regulated over time, all Fs (1,46) 
> 9.08, ps < 0.0004.  Significant interactions between restraint and time of sacrifice were 
found for IP-10, RANTES, Ltn, and TCA-3, all Fs (1,46) > 4.405, ps <.04.   
 In general, restraint suppressed the expression of these chemokines at day 2, but 
restraint either had no effect (IP-10, RANTES, lymphotaxin,) or increased (TCA-3) 
expression at day 7.  Although the interactions between infection and time sacrifice failed 
to reach significance, all Fs (1,46) > 3.059, ps > 0.09, a significant three-way interaction 
between infection, restraint, and time was observed for IP-10, F (1,46) = 9.563, p < 0.003.  
This interaction was attributable to a restraint-induced suppression of IP-10 in infected 
mice at day 2 p.i. followed by a reversal of this effect of restraint at day 7 p.i..   
 
3.5 Histopathology findings 
Previously we examined the effect of restraint stress on CNS inflammation in mice 
infected with TMEV at day 7 p.i. following five nights of RST and two nights without 
stress (Campbell et al., 2001). In the current experiments, the mice were subjected to 
restraint stress each night for a total of seven nights.  
A mild to moderate focal nonsupprative meningoencephalitis characterized by 
perivascular cuffing, microgliosis and meningitis occurred in the hippocampus of 
infected/non-restrained (I/NR) mice (see Figure 2-9C and Table 2-2. meningitis not 
shown). In contrast, there was a very mild pattern of inflammation, manifested by 
decrease in cuffings and microgliosis in the hippocampus and meninges of 
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infected/restrained (I/R) mice (Figure 2-9D), illustrating the marked effect of continuous 
restraint stress on the severity of encephalitis. Additionally, there was no obvious 
morphological change of neural cells and no inflammation in the hippocampus of the 
noninfected/restrained (NI/R) mice (Figure 2-9B).  
The pathology changes were also confirmed by a series of ANOVAs performed on 
perivascular cuffing, microgliosis and meningitis scores.  Across all measures, significant 
main effects were found for infection, all Fs (1,11) > 11.65, p < 0.06, and restraint, all Fs 
(1,11) > 11.65, p < 0.06.  More importantly, significant interactions between infection and 
restraint stress were also observed, all Fs (1,11) > 6.181, p < 0.03.  Post hoc mean 
comparisons confirmed that restraint stress strikingly reduced the number and severity in 
perivascular cuffings, microgliosis and meningitis in the infected mice, all ps < 0.003 
(Table 2-2).   
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 Figure 2-9.    H&E stained sections of hippocampus collected at day 7 post infection (50X).  
(A).Non-infected/Non-restrained. (B)Non-infected/Restrained. (C) Infected/Non-restrained 
hippocampus. Mild to moderate microgliosis (as shown in the box) and perivascular cuffing  
(indicated by arrow). (D) Infected/Restrained. Mild perivascular cuffing (indicated by arrow). 
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Table 2-2     Histological assessment of H&E stained brain section
non-infected/ non-infected/ infected/ infected/
Features non-restrained restrained non-restrained restrained
Perivascular cuffs 0+0 0+0 7.267 + 2.800 * 0.320 + 0.121 *
Meningitis 0+0 0+0 0.047 + 0.018 * 0.007 + 0.004 *
Microgliosis 0+0 0+0 0.427 + 0.137 * 0.035 + 0.035 *
Histological score was evaluated as described in the methods and materials. The scores are represented by mean + S.E.M.
Prominent pathological changes of perivascular cuffs, meningitis and microgliosis were observed in the infected/non-restrained 
barins, and these alterations were markedly reversed by stress. * indicates p < 0.001.
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4. Discussion 
 The current study represents part of a series of investigations into the effects of 
restraint stress on the neuropathogenesis of Theiler’s virus infection in mice.  We showed 
the profound effect of restraint stress as evidenced by worsened clinical signs, decreased 
body weight and reduced spontaneous activity during the acute infection. We have 
previously demonstrated the detrimental effects of restraint stress on this murine infection 
and have proposed that the mechanism involved is primarily mediated by a stress-induced 
immunosuppression resulting in a decreased inflammation of the CNS and consequently 
an impaired viral clearance (Campbell et al., 2001).  One of the possible mechanisms for 
decreased CNS inflammation is reduced chemokine expression during the early stages of 
Theiler’s virus infection, as chemokine expression in the CNS has been demonstrated to 
be involved in the recruitment of immune cells (Theil et al., 2000; Hoffman et al., 1999; 
Murray et al., 2000).  Therefore, the current study investigated the effects of restraint 
stress on chemokine expression in mice infected with Theiler’s virus.  
We will firstly focus on the effect of viral infection on mRNA chemokine levels in 
the brain (Table 2-3 and Table 2-4).  In this study, intracerebral inoculation of the BeAn 
strain of Theiler’s virus did not induce significant chemokine expression in the brain at 
day 2 p.i., but did selectively induce mRNA elevation of CXC chemokine: IP-
10/CXCL10; C chemokine: Ltn/XCL1; and three CC chemokines: TCA-3/CCL1, MCP-
1/CCL2 and RANTES/CCL5 in the brain of CBA mice at day 7 p.i..  A similar profile of 
chemokine increases during the early phase of TMEV infection has previously been 
reported (Murray et al., 2000; Theil et al., 2000) in other strains of mice.   
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Table 2-3  Summary of the chemokine changes in the brain and spleen at day 2 post infection  
 
Day2 p.i. BRAIN SPLEEN
Chemokines Infection Restraint Infection by Restraint Infection Restraint Infection by Restraint
Ltn (+) (---)
IP-10 (+++) (---) (-)
RANTES (---)
MCP-1 (+++) (---) (-)
MIP-1alpha
MIP-1 beta (++) (---) (---)
MIP-2
TCA-3 (+++) (---) (-)
Eotaxin
(+/-): p < 0.05; (++/--): p < 0.01; (+++/---): p < 0.001; blank:  unchanged
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Table 2-4  Summary of the chemokine changes in the brain and spleen at day 7 post infection 
Day7 p.i. BRAIN SPLEEN
Chemokines Infection Restraint Infection by Restraint Infection Restraint Infection by Restraint
Ltn (++) (-) (-) (+++)
IP-10 (+++) (-) (-) (+)
RANTES (+++) (-) (-) (+++) (-)
MCP-1 (+++)
MIP-1alpha
MIP-1 beta (+)
MIP-2 (+)
TCA-3 (+++)
Eotaxin
(+/-): p < 0.05 ; (++/--): p < 0.01 ; (+++/---): p < 0.001 ; blank:  unchanged
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There are various sources of chemokines for instance:  IP-10 is produced by 
astrocytes, oligodendrocytes, microglia, and endothelial cells and is a chemoattractant for 
activated T cells and monocytes (Salmaggi et al., 2002; Palma et al., 2001). IP-10 can 
also facilitate T cell adhesion to endothelial cells (Taub et al., 1993) and participate in T 
cell priming (Dufour et al., 2002). The cellular sources of RANTES include astrocytes, 
oligodendrocytes, microglia, and activated memory T cells (Hvas et al., 1997; Palma et 
al., 2001) and RANTES is also involved in the recruitment of memory T cells and 
monocytes.  In previous TMEV studies, it was reported that expression of CNS IP-10 and 
RANTES displayed similar kinetics, in which both chemokines were increased during the 
encephalitis phase and remained at a relatively high level throughout the disease 
(Hoffman et al., 1999; Murray et al., 2000; Theil et al., 2000). The parallel expressions of 
IP-10 and RANTES were seen in both acute and chronic stage of experimental allergic 
encephalomyelitis (EAE) model (reviewed in Elhofy et al., 2002), mouse hepatitis virus 
(MHV)-induced demyelinating disease (reviewed in Glass et al., 2002) and was also 
detected in the CSF of MS patients (Sorensen et al., 1999). These observations suggest 
that the elevation in the T cell chemoattractants, IP-10, and RANTES, coincide with the 
immune response to the viral infection and also with the development of demyelination. 
Furthermore, it indicates that these chemokines may be involved in the accumulation of T 
cells in the CNS and in maintaining the inflammatory response.  
MCP-1 is induced by both Theiler’s virus and MHV infection during the acute 
disease, and is also detected in the CNS of rats during acute EAE. During the remission 
of EAE, MCP-1 became undetectable and then resurged as the disease progressed into the 
relapsing phase, demonstrating that its level and kinetics correlated with the disease 
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development (see reviews by Karpus and Ranoshoff, 1998).  Macrophages, astrocytes, 
and T cells, which all possess the main MCP-1 receptor, CCR2, may accumulate in the 
CNS following attraction by MCP-1 in EAE (Jee et al., 2002). Conversely, in vitro, anti-
MCP-1 remarkably inhibited the migration rate of lymphocytes isolated from MS patients 
by 60% either with neutralizing antibody or translational arrest of MCP-1 mRNA.  
Inhibition of MCP-1 can also reduce monocyte adhesion (Maus et al., 2002), indicating 
that inflammatory cell migration through brain endothelium is MCP-1 dependent to some 
extent (Prat et al., 2002). In addition, MCP-1 can also enhance NK cell migration and NK 
cell-mediated cytolysis (Allavena et al., 1994).  NK cells are known to be important in 
early viral clearance of Theiler’s virus (Paya et al.,1989).  
TCA-3 was also elevated in the brains of mice infected with Theiler’s virus as 
determined by RPA.  TCA-3 expression was detected in EAE 1-2 days prior to the onset 
of clinical signs and was produced by activated encephalitogenic T cells (Godiska et al., 
1995). Interestingly, polymorphisms have been described in the chemokine genes TCA-3 
(Scya1), MCP-1 (Scya2) and MCP-5 (Scya12), which have also been suggested to be 
candidates for a locus (eae7) controlling susceptibility to monophasic 
remitting/nonrelapsing EAE in SJL mice, but not in EAE-resistant strains B10.S/DvTe 
and Balb/cJ mice (Teuscher et al., 1999).  The increased expression of TCA-3 in the 
current study might imply that the virus-induced TCA-3 plays a role in the susceptibility 
of CBA mice to Theiler’s virus infection and the later development of demyelination.  
Ltn mRNA levels were also increased as a result of Theiler’s virus infection. Ltn is a 
novel γ-chemokine, produced by activated T cells and NK cells, and is also a specific 
chemoattractant for T cells and NK cells (Giancarlo, et al., 1996; Hedrick et al., 1997; 
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Kelner et al., 1994). Moreover, when mice were infected with an adenovirus vector over 
expressing Ltn, the kinetics of Ltn production was closely correlated with the number of 
cellular infiltrates (CD4+, CD8+ and NK cells) in the lungs (Emtage et al., 2002). 
MIP-2, an important mouse neutrophil chemoattactant (Wolpe et al., 1989), was not 
significantly changed in the brain after infection in our study, which may account for the 
lack of neutrophils in the inflammatory infiltrate of CNS.  
Taken together, the increased expression of multiple chemokines induced by 
Theiler’s virus infection may account for the recruitment of inflammatory cells, observed 
in the meninges and hippocampus of the infected brain in this study. We speculate that 
the inflammatory cells consist of T cells, NK cells, macrophages and also resident 
microglia. Our results demonstrated that the time of sacrifice was correlated with the 
expression of virus-induced chemokines, which include Ltn, IP-10 and RANTES. The 
up-regulation of these chemokines implied that recruitment of immune cells was 
increased over time.  The source of the elevated chemokines is unknown, but could either 
be CNS resident glia or peripheral immune cells.  
We found an altered chemokine pattern in the spleen of virus-infected mice at day 2 
p.i., but no virus-induced chemokine expression in the brain at this same time point; the 
spectrum of chemokine expression in the spleen at day 2 p.i. was similar to that in the 
brain at day 7 p.i., which included increased Ltn, IP-10, TCA-3, MCP-1, MIP-1β, but not 
RANTES in the spleen. The similarity of the chemokine spectrum and the delayed 
reaction in the CNS again suggest that the immune response to Theiler’s virus is initiated 
in the periphery.  
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Secondly, considering the effects of restraint stress on chemokine expression in the 
brain (Table 2-3 and Table 2-4), we detected significantly decreased levels of the virus-
induced upregulation of brain IP-10, RANTES, and Ltn in the stressed mice. This may 
account for the reduced degree of inflammation in the brain (e.g. meninges and 
hippocampus) of infected/restrained animals, which would be compatible with a 
suppressed chemoattractive influence. Restraint also affected the induction of 
chemokines in the spleen as shown in our results. A broader spectrum of chemokines 
than seen in the brain, was considerably decreased by stress, which included IP-10, Ltn, 
RANTES, MIP-1β, MCP-1 and TCA-3 at day 2 p.i., and RANTES only at day 7 p.i.. 
Thus, stress profoundly impacts the peripheral immune system, resulting in the inhibition 
or suppression of the systemic immune response to pathogens.  The alterations of 
chemokine profile over time, as shown by statistical analysis, revealed that the levels and 
the variety of chemokine expression were notably reduced from day 2 p.i. to day 7 p.i., 
which suggested the suppressive effects of restraint were attenuated over time.  
Exposure to chronic stress has been shown to compromise the immune response to 
viral infection. It is well known that restraint stress induces an elevation of serum 
glucocorticoid (GC), which alters inflammatory cell trafficking to draining lymph nodes 
and inflamed sites; and an increase of catecholamines produced by sympathetic nervous 
system (SNS), which can suppress the activation of virus-specific T cells (Bonneau et al., 
1991 and 1993; Dobbs et al., 1993; Feng et al., 1991; Hermann et al., 1993, 1994a and b; 
Kusnecov et al., 1992; Padgett et al., 1998; Sheridan et al., 1998). GC is a stress hormone 
that confers multiple functions physiologically and pathologically. For example, cytokine 
synthesis and its actions are affected by GC following stress, which has been attributed to 
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altered immune cell redistribution and migration (e.g. Chung et al., 1986; Fingerle-
Rowson et al., 2003; Perretti, et al., 1994; Steer et al., 1998). This suppressive action is 
caused by inhibition of transcription, translation, secretion, and destabilization of 
cytokine mRNA (e.g. IL-1 and TNF-) (reviewed in Sapolsky et al., 2000), which alter 
leukocyte migration (Perretti, et al., 1994; Steer et al., 1998). Generally, the extravasation 
and chemotaxis of circulating leucocytes into tissues are governed by vascular adhesion 
molecules, such as ICAM, VCAM, selectin, and various chemokines, that enhance the 
movement of cells to inflammatory sites. Tailor et al. (1999) found that dexamethasone 
could inhibit the secretion of IL-1-induced ICAM-1 and chemokine KC, and 
consequently reduce leukocyte adhesion. GC’s have also been shown to inhibit RANTES 
mRNA in T cells and lung endothelial cells (Kwon et al., 1995; Wingett et al., 1996). 
Mizobe et al. (1997) documented that the down-regulation of MCP-1 and a reduced 
migration of macrophage and granulocytes to injured sites following acute restraint stress 
was mediated by GC.  
The underlying mechanism of GC’s interference with chemokine production is not 
fully understood. It is thought that the immunosuppressive actions of GC’s are primarily 
mediated through the binding of GC to glucocorticoid receptors (GR’s), forming a GR 
complex, which translocates to the nucleus, targeting the inflammatory mediator genes 
that regulates their expression (reviewed in Sapolsky et al., 2000; Marchetti et al., 2001) 
or affects NF-κ B activation (Ohtsuka et al., 1996). Smith et al. (1997) identified several 
chemokine genes (MCP-1, 3, IP-10) that were attenuated by GC following exposure to 
LPS stimuli, supporting the hypothesis that chemokine expression may be regulated by 
GC’s. 
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In addition to glucocorticoid, the products of the SNS have been considered to 
contribute to cell trafficking during restraint stress. For example, reduced cellularity of 
inflamed tissue can be restored in mice pretreated with 6-hydroxydopamine (6-OHDA), a 
neurotoxin which is readily taken up by adrenergic nerve terminals that blocks the 
binding of catecholamine (Hermann et al., 1994), illustrating the inhibitory role of 
catecholamine in inflammatory cell migration. The cross talk between the nervous and 
immune systems is based on the innervation of mononuclear cells within lymphoid 
organs by extensive efferent nerve endings of SNS. T cells and B cells carry -adrenergic 
receptors and macrophages bear  and  adrenergic receptors. Furthermore, it has been 
shown that MIP-1 generated by monocytes can be inhibited by adrenaline (Li et al., 
2003).  Therefore, SNS-mediated down-regulation of chemokines following stress may 
account for the results obtained in the spleens in the current study.  The spleen is one of 
the major lymphoid organs for T and B cells activation while the thymus is the location 
for T cell maturation. The significant weight loss of the spleen, as well as the prominent 
thymic atrophy observed in the current study could be explained by diminished cellularity 
that resulted from increased plasma glucocorticoid, which has direct toxic effect on 
immune cells, and/or from apoptosis (Tarcic et al., 1998; Yin et al., 2000), thus 
eventually leading to reduced production of chemokines. 
In conclusion, restraint stress applied to mice infected with Theiler’s virus resulted in 
decreased cellularity in the CNS.  We hypothesize that the decreased CNS inflammation 
occurs as a result of reduced expression of the chemokines Ltn, IP-10, RANTES and 
MCP-1, which are chemoattractants for CD4+, CD8+ T cells, macrophages and NK cells. 
It should be noted that the current study focused on the effect of stress and infection on 
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the expression of chemokines at transcriptional level and did not include determination of 
protein levels and their correlations with mRNA. Therefore, the alterations of certain 
chemokine transcripts may not be consistent with protein changes. Secondly, the specific 
functions of these chemokines in TVID and the phenotype of the cells within the lesions 
require further investigation.  However, this study delineated possible mechanisms by 
which stress impacts the local and systemic immune response to a neurotropic viral 
infection. In this model, stress has profound effects on the early events during infection 
with Theiler’s virus which has important implications in our understanding of how stress 
may play a role in the establishment of autoimmune disease.   
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III   THE EFFECT OF RESTRAINT STRESS ON CYTOKINE 
EXPRESSION IN THE CNS AND SPLEEN DURING THE ACUTE 
TMEV INFECTION 
1. Introduction 
The etiology of multiple sclerosis (MS) remains uncertain and multiple factors, such 
as genetic predisposition and external environmental factors, such as infectious pathogens, 
psychological stressors and climates, have been reported to be linked to the pathogenesis 
of MS.  Infectious agents, such as viruses have been associated with neurological 
disorder (Gilden, 2005).  Theiler’s murine encephalomyelitis virus-induced 
demyelination (TVID) has served as an animal model to investigate infectious 
mechanisms mediating central nervous system (CNS) demyelination in human MS. 
Intracerebral inoculation of Theiler’s virus, a natural murine pathogen, produces a 
biphasic CNS disease in susceptible mice. The acute phase of disease involves a mild 
encephalomyelitis with predominant neuronal infection, whereas the chronic phase is 
characterized by inflammatory demyelination in white matter with glial and microglial 
infection (Lipton et al., 1975).  Unlike the resistant strains of mice, which are able to 
clear the virus during acute infection and do not develop demyelination, the susceptible 
strains of mice fail to clear virus and a persistent CNS infection is established that is 
essential for the induction of demyelination in the spinal cord (Lipton et al., 1984; 
Rodriguez et al., 1983). Although it is evident that the susceptibility to Theiler’s virus 
infection and demyelination is genetically regulated (Brahic and Bureau, 1998), the 
immune response also plays a critical role in determining the viral load and the degree of 
  
69 
viral persistence, thus effecting the progression and severity of demyelinating disease 
(Aubagnac et al., 1999; Rodriguez et al., 1996).     
The acute encephalomyelitis is primarily mediated by both innate and adaptive 
antiviral immunity via infiltrating CD4+, CD8+ T cells (reviewed in Oleszak et al., 2004) 
and NK cells (Paya et al., 1989), while the adaptive immunity contributes to the late 
demyelination, by delayed-type hypersensitivity (DTH) responses to viral antigens via 
CD4+ T cells (Borrow et al., 1993; Gerety et al., 1994).   
In response to Theiler’s virus infection, immune cells produce a variety of 
inflammatory mediators, such as cytokines, chemokines and enzymes. Cytokines play a 
crucial role in the regulation of the immune response in clearing the virus from the CNS 
and mediating demyelination. It has been shown that a panel of dominant pro-
inflammatory (Th1) cytokines, such as interferon- (IFN-), tumor necrosis factor (TNF)-
α, interleukin (IL)-6, interleukin (IL)-12, etc, was induced during acute 
encephalomyelitis in all strains of mice, but at a higher level in susceptible mice than 
resistant mice (Chang et al., 2000; Sato et al., 1997; Theil et al., 2000).  Some Th1 
cytokines, for example, IFN-, exhibit antiviral activity as observed in knockout mice 
(Rodriguez et al., 2003). In addition, Th1 cytokines may further activate and regulate 
other immune cells, such as antigen presenting cells and microglia, thus promoting 
protection against viral infection (reviewed by Oleszak et al., 2004).  
After the first two weeks of infection, Th1 cytokine levels decline in resistant mice, 
which correlates with the clearance of virus from the CNS; whereas in susceptible strains 
of mice, Th1 cytokines remain at relatively high levels and are partly responsible for the 
progression of demyelination (Begolka et al., 1998; Chang et al., 2000; Murray et al., 
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2002; Sato et al., 1997; Trottier et al., 2004). It has been shown that anti-inflammatory 
(Th2) cytokines may alleviate demyelination in TVID (Drescher et al., 2000), and this is 
also seen in the remission of experimental allergic encephalomyelitis (Begolka et al., 
1998).  
The specific Th1/Th2 cytokine paradigm found in animal models has not always 
been seen in MS patients and the correlation between the Th1/Th2 cytokine paradigm and 
clinical variables may not always be consistent. The fluctuations of MS seem to be 
related with the upregulation of both Th1 and Th2 cytokines (Balashov et al., 2000; Link, 
1998).  In contrast, the opposite observation was also reported that a reduction in Th1 and 
Th2 T cell phenotypes in active disease (Matsui et al., 2004). These results suggest 
dysregulation of Th1/Th2 cytokine paradigm in MS. However, the association of 
Th1/Th2 balance with clinical manifestations of MS is supported by the effectiveness of 
several therapeutic agents, such as ibudilast and glatiramer acetate, which can ameliorate 
the disease by diminishing the Th1 response and generating Th2 dominance (Feng et al., 
2004; Vieira et al., 2003). The mechanism of triggering or exacerbating MS is unknown, 
but it has been proposed that stressful life events may contribute to, or have an effect on 
the flare-ups of MS (Mohr et al., 2004).  
The stress response involves a complex interaction between the neuroendocrine and 
the immune systems, resulting in alterations in both innate and adaptive immunity to 
various pathogens and stimuli, thus enhancing the risk or vulnerability to inflammatory 
and autoimmune diseases, as well as infectious disease. The mechanisms by which stress 
modulates the pathogenesis or progression of these diseases are not fully understood. Two 
major pathways, the hypothalamic-pituitary-adrenal (HPA) axis and the 
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systemic/adrenomedullary sympathetic nervous system (SNS) are activated in response to 
stress, resulting in the production of glucocorticoids (GC) and catecholamines (CA) from 
the two systems. GC, CA as well as other stress hormones, opioids, growth hormones and 
prolactin, impact the function of immune system (Pruett, 2003). Among these stress 
hormones, the role of glucocorticoids in the immune response has been extensively 
studied. It has been widely used as an immunosuppressor or anti-inflammatory agent in 
the therapy of many autoimmune diseases, including MS.  
On the other hand, the effectors of immune cells, such as cytokines, secreted in 
response to stress stimulation, can influence the neuroendocrine system via cytokine 
receptors, thus providing links between the two systems (reviewed in Haddad et al., 
2002).  Therefore, cytokines appear to be pivotal factors in the pathogenesis of MS and 
the stress response.   
We employed a restraint stress model, to mimic both the psychological and 
physiological effects of stress in the Theiler’s virus model in order to investigate the 
underlying mechanism by which stress affects MS. Previous studies from our laboratory 
have shown that stress increased serum corticosterone (Campbell et al., 2001), decreased 
NK cell activity (Welsh et al., 2004), reduced chemokine expression and CNS 
inflammation (Mi, et al., 2004) during the acute infection. In this study, we further 
examine the cytokine expression following restraint stress and Theiler’s virus infection 
and the stress-induced Th/Th2 cytokine shift. These studies should enable us to gain 
some insight of the role of environmental factors, stressor and virus, on the pathogenesis 
of MS.   
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2. Materials and methods 
2.1 Subjects and grouping 
3-week-old male CBA mice were obtained from Halan Laboratories (Indianapolis, 
IN) and were maintained on a 12 h light/dark cycle. The animals were counterbalanced 
by weight and then were allowed to habituate for one week before the initiation of the 
any experimental procedures.  
The mice and were randomly assigned into one of the following four groups using an 
A 2 (infected vs. non-infected) by 2 (restraint vs. non-restraint) by 2 (2 days of infection 
vs. 7 days of infection) factorial design: (1) Non-infected/Non-restrained (NI/NR) mice 
remained undisturbed in their home cages; (2) Non-infected/Restrained (NI/R): each 
mouse was subjected to restraint stress for 3 consecutive nights (for the mice terminated 
at day 2 p.i.) or 8 consecutive nights (for the mice terminated at day 7 p.i.) in their home 
cages; (3) Infected/Non-restrained (I/NR): mice were inoculated intracranially with BeAn 
virus; or (4) Infected/Restrained (I/R): each mouse was subjected to one-night of restraint 
stress one day prior to viral inoculation and then was subjected to subsequent stress 
sessions of  2 or 7 nights (for the mice sacrificed at day 2 p.i. and day 7 p.i., respectively), 
as described in Mi et al. (2004). 
 
2.2 Restraint stress paradigm 
Restraint was applied by placing the mice into well-ventilated restraining tubes (2.7-
cm internal diameter and 14-cm length) for 12 h (from 9pm-9am) each for 3 or 8 
consecutive nights (Campbell et al., 2001; Mi et al., 2004; Sheridan et al., 1991). The 
tubes were drilled with small holes to allow adequate ventilation. Restraint stress was 
initiated 1 day prior to infection and continued for 2 or 7 subsequent sessions.  
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2.3 Virus and viral inoculation 
The BeAn strain of Theiler’s virus was obtained from Dr. H. L. Lipton, Department 
of Neurology, University of Chicago, Evanston, IL and was propagated and amplified in 
L2 cells as previously described (Welsh et al., 1987). 
Following isoflurane anesthesia, 5x104 plaque forming unit (PFU) of the BeAn strain 
of Theiler’s virus in a 20µl volume was inoculated into the right cerebral hemispheres of 
the mice in the infected groups, or a 20µl of sterile phosphate-buffered saline (PBS) was 
infected into the non-infected mice.  
 
2.4 Termination of mice 
Mice were sacrificed by the i.p. injection of pentobarbital at either day 2 p.i. or day 7 
p.i.. Mice were perfused with diethyl pyrocarbonate (DEPC, Sigma)-treated PBS into the 
right ventricle of the heart. The brains and spleens were aseptically removed, weighed, 
then were flash frozen in liquid nitrogen and stored at -80oC until used. 
 
2.5 Ribonuclease protection assay (RPA) 
      Total RNA was extracted from the brain and spleen using TRIzol (Invitrogen, 
Carlsbad, CA) according to the manufacturer’s instructions. Two Multi-Probe Template 
Sets, mCK-2b (IL-12p35, IL-12p40, IL-10, IL-1, IL-1, IL-1 Receptor antagonist (IL-
1Ra), IL-18/ interferon-gamma-inducing-factor (IGIF), IL-6, IFN-γ, migration inhibitory 
factor (MIF), and two housekeeping genes L32 (ribosome RNA) and GAPDH 
(glyceraldehydes-3-phosphate dehydrogenase) and mCK-3b (TNF-, lymphotoxin- (LT-
beta), IL-6, IFN-, IFN-, transforming growth factor beta 1, 2, 3 (TGF-β1, 2, 3) and 
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housekeeping genes, L32 and GAPDH) (BD PharMingen, San Diego, CA) were used to 
examine cytokine expression in the tissues.  The probe was labeled with 32P –UTP (800 
Ci/mmol, 10µCi/µl, PerkinElmer Life Sciences, Inc., Boston, MA). RPA were conducted 
using RPA III and MAXIscript kit (Ambion, Austin, TX), according to the manufacturer’s 
instructions.  
Briefly, 25µg RNA was hybridized overnight (16 h) with labeled probe and the 
reactions were subsequently digested with RNase A/T1 Mix, followed by precipitation 
with Inactivation/Precipitation III solution (Ambion, Austin, TX).  The protected RNA-
probe complexes were resolved on 5% acrylamide/8M urea/1xTBE gel. Then the gel was 
dried for 2 h on a gel drier (Gel Drier, Model 583, Bio-Rad), and exposed to a Fujifilm 
Phosphor Imaging Plate in BAS cassette 2325 (Fuji Medical Systems USA, Inc.) for 14-
16 h.  
        The plate was scanned with a Fujifilm Bio-imaging Analyzer BAS-1800II 
(Kanagawa, Japan) and the photo-stimulated luminescence (PSL) was analyzed with an 
ImageGauge software (Version 3.12, Science lab, Fuji Photo Film Co.Ltd). The 
densitometry of each band was represented by the PSL reading and then normalized with 
a housekeeping gene (L32 or GAPDH).  
 
2.6 Western blot analysis 
        While isolating the RNA from the aqueous phase of homogenates using TRIzol, the 
remaining organic phase was used for further protein isolation as described in the 
manufacturer’s instructions (Invitrogen, Carlsbad, CA).  Western blot analyses for TNF-α 
were conducted in 4-20% Tris-HCl Ready Gels (BioRad, Laboratories, Hercules, CA).  
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25 µg of protein was loaded into each lane for western blotting.  Following 
electrophoresis, proteins were transferred to a nitrocellulose membrane (Hybond-C super, 
Amersham, Illinois, USA) on a Trans-Blot SD  Semi-dry Transfer Cell and the non-
specific binding sites were blocked with 5% Non-fat dry milk in Tween-Tris Buffered 
Saline (TTBS, 0.1% Tween-20 in 100 mM Tris-CL [pH 7.5], 0.9% NaCl). The membrane 
was then incubated for 2 h at room temperature with rabbit anti-mouse TNF- polyclonal 
antibody (CHEMICON International, Inc.) 0.15 µg/mL in TTBS or rabbit anti-GAPDH 
monoclonal antibody (Advanced ImmunoChemical Inc, Long Beach, CA, 1:300 in TTBS) 
for loading control. After three washes with TTBS, the membrane was incubated for 30 
min at room temperature with biotinalated donkey anti-rabbit IgG secondary antibody 
(CHEMICON International, Inc., 1:10000 dilution in TTBS) followed by three TTBS 
washes. Next, the membrane was incubated with streptavidin-horseradish peroxidase 
conjugate (Amersham Biosciences, UK, 1:1000 in TTBS).  The protein-antibody 
compounds were revealed with a SuperSignal West Pico Chemiluminescent Substrate kit 
(PIERCE, Rockford, IL) after four washes with TTBS before exposing to X-OMAT film 
(Kodak, Rochester, NY). Molecular weights were determined using MultiMark 
(Invitrogen, Carlsbad, CA).  Western blots were scanned for quantification with Image J 
1.33U (NIH, USA). The expression of TNF-α was normalized with GAPDH.  
 
2.7 Plaque assay 
To correlate the cytokine expression with the viral load in the brains of infected mice, 
the brains of some of the infected animals were dissected and cut longitudinally along the 
brain, the left and right hemispheres were alternatively collected for either RPA or viral 
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titration by a plaque assay. Briefly, the brain was aseptically removed, weighed, and 
homogenized in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen Carlsbad, CA). 
Cellular debris was removed by centrifugation and the titer of virus in the supernatant 
was determined by standard plaque assays on L2 cells.   
 
2.8 Real-time RT-PCR 
We analyzed cytokine expression in a subset of the RNA samples by real-time RT-
PCR.  Total RNA (1g) was reverse-transcribed into cDNA using SuperScript II Reverse 
Transcriptase (Invitrogen, Carlsbad, CA) according to manufacturers instructions using 
oligo(dT) or random hexamer primers. Real-time RT-PCR was performed with a 
GeneAmp 5700 Sequence Detection System (Perkin-Elmer, Norwalk, CT) and SYBR 
Green PCR Master Mix (Applied Biosystems, Foster City, CA). Reactions were 
performed in MicroAmp Optical 96-Well Plates (Applied Biosystems, Foster City, CA) in 
a volume of 25L. Data was analyzed using GeneAmp 5700 SDS Software (Perkin-
Elmer, Norwalk, CT). For each sample, the cytokine cycle threshold (Ct) values were 
normalized against -actin Ct values. Amplification specificity was determined using 
dissociation curve analysis and, in some cases, by direct sequencing of the PCR product. 
The following primers were used: 5’-actin: GCA ACG AGC GGT TCC G; 3’-actin: 
TCC AGC CTT CCT TCT TGG G; 5’IL-1: AGG CAG GCA GTA TCA CTC ATT GT; 
3’IL-1: GGA AGG TCC ACG GGA AAG AC; 5’IL-6: CCA GAA ACC GCT ATG AAG 
TTC CT; 3’IL-6: CAC CAG CAT CAG TCC CAA GA; 5’ IL-10: CAG CCG GGA AGA 
CAA TAA CTG; 3’IL-10: CCG CAG CTC TAG GAG CAT GT; 5’IL-12p40: AGA CCC 
TGC CCA TTG AAC TG; 3’ IL-12p40: GAA GCT GGT GCT GTA GTT CTC ATA TT; 
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5’IFN-: CAG CAA CAG CAA GGC GAA A; 3’IFN-: CTG GAC CTG TGG GTT GTT 
GAC; 5’LT-: GAG AGG GTC TAC GTT AAC ATC AGT CA; 3’ LT-: CGC CCC GAA 
GAA GGT CTT; 5’TNF-: TGA TCC GCG ACG TGG AA; 3’TNF-: CCG CCT GGA 
GTT CTG GAA. 
 
2.9 Statistical analysis 
     Two-way ANOVA was conducted on the data for the two variables restraint and 
infection. Duncan’s multiple range tests and means comparisons were used for post hoc 
analyses. A p value of 0.05 or less was considered significant in all cases. 
 
3. Results 
3.1 Cytokine expression in the brain following Theiler’s virus infection and restraint 
stress 
To assess the potential effect of restraint stress on the immune response in the CNS 
following Theiler’s virus infection, brains were collected at day 2 and 7 p.i. and the 
cytokine levels were determined by RNase protection assay (Figure 3-1).  The main 
effect of infection, restraint and the interaction between the two variables for each 
cytokine were conducted by a series ANOVA at the time points of day 2 and 7 p.i. 
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        A.                                                                     B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1.  Phosphor image of a representative RPA for cytokine expression in the brain 
following restraint or/and BeAn infection at day 7 post infection using (A) mCK-2b and (B) 
mCK-3b kits. Total RNA was isolated from the brains and spleens of CBA mice at day 7 p.i. 
25µg RNA was hybridized with a 32P-labeled chemokine probe set as described in Materials 
and methods. The housekeeping genes GAPDH was used for the normalization of sample 
loading and technique error. Lane 1,2,3,4 represents the brain samples of NI/NR (Non-
infected / Non-restrained), NI/R (Non-infected / Restrained), I/NR (Infected / Non-restrained) 
and I/R (Infected / Restrained), respectively, collected at day 7 post infection.  
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 As summarized in Table 3-1, at day 2 p.i., infection induced a cytokine elevation of 
LT-, TNF-, IFN-γ, IFN- and IL-6 all Fs (1,27) > 4.201, ps < 0.05.  IL-12p40 and MIF 
were also expressed at a higher level in the brains of infected/non-restrained mice than 
the normal controls, as confirmed by post hoc mean comparisons, all ps < 0.05.  At day 7 
p.i., a main effect of infection was observed for LT-, TNF-, IFN-γ, IFN-, IL-1, IL-6 
and IL-12p40, all Fs (1,58) > 3.993, ps < 0.05 (Table 3-1).  
      A panel of fewer cytokines appeared to be affected by restraint stress than infection, 
wherein restraint increased TNF-, but decreased LT- in the brain at day 2 and 7 p.i., all 
Fs (1,28) > 6.196, ps < 0.02 for day 2 p.i. and all Fs (1,58) > 6.913, ps <  0.01 for day 7 
p.i. (Table 3-1).  
      As depicted in Figure 3-2 and Table 3-1, an interaction between infection and restraint 
was observed in cytokine expression, wherein restraint significantly decreased the 
infection-induced IFN- at day 2 p.i. [F (1,28) =4.664, p = 0.04] and LT- at day 7 p.i. [F 
(1,58) = 8.978, p = 0.004].  Post hoc mean comparison also showed a lower cytokine 
production in infected/restrained than infected/non-restrained animals in the cytokines 
LT- and IL-12p40 at day 2 p.i. and cytokines IFN- and IL-6 at day 7 p.i., all ps < 0.05, 
suggesting a suppressive effect on pro-inflammatory cytokine production by stress. 
Interestingly, INF- was detected at a higher level in the I/R mice than I/NR mice at day 
7 p.i., p < 0.01.  
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 Table 3-1  Summary for alterations in cytokine expression in the brain following TMEV infection and  restraint stress 
restraint and Theiler’s virus infection 
 
 
 
 
 
 
 
                  
 
 
 
       
    A summary for alterations in cytokine expression in the brain following  
    TMEV infection and restraint stress. The results are shown as the main effect of either  
    infection (INF) or restraint stress (RS), and the interactions between the two variables,  
    which are revealed by ANOVA and post hoc mean comparison. (+) / (-) represent  
    significant increase or decrease (all ps < 0.05) in cytokine expression in the brain, respectively.  
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                                   Day 2 post infection                                   Day 7 post infection       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2.  The effect of restraint stress on the cytokine expression in the brain during acute 
TMEV infection.  The levels of cytokine expression were derived from the densitometric 
ratio of the individual cytokine to the housekeeping gene GAPDH and multiplied by 1000. 
At day 2 p.i., IFN-, LT-β, IL-12p40, IL-6 and IFN-β were increased by TMEV infection, 
and the expression of IFN-, LT-β, IL-12p40 were decreased following restraint stress. The 
cytokines remained at an elevated level at day 7 p.i., and restraint stress reduced the 
expressions of IFN-, LT-β, IL-12p40 and IL-6, however, IFN-β was increased by stress. The 
values were represented by mean + S.E.M.                  
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                          Day 2 post infection                                   Day 7 post infection       
 
 
 
 
Figure 3-2. continued. 
 
 
3.2 Cytokine expression in the spleen following Theiler’s virus infection and restraint 
stress 
      To further examine the effect of restraint stress on the peripheral immune response 
following infection, we evaluated the cytokine levels in the spleen using RPA at day 2 
and 7 p.i. (Figure 3-3). 
      As summarized in Table 3-2, ANOVA analyses revealed a main effect of infection on 
cytokine production, wherein Theiler’s virus induced increases in TNF-, TNF-, IFN-, 
IFN- and IL-12p40 at day 2 p.i., all Fs (1,28) > 4.214, ps < 0.05 and LT-, IL-6, IL-1 
and IL-12p40 at day 7 p.i., all Fs (1,58) > 5.033,  ps < 0.03 (Table 3-2).  
      A notable effect of stress on the cytokine expression in the spleen was noticed at day 
2 p.i., demonstrating that restraint resulted in reductions in TNF-, TNF-, LT-, IFN-γ 
and IFN-, all Fs (1,28) > 7.252, ps < 0.01. In contrast, restraint produced a less 
remarkable suppressive effect of stress on cytokine expression at day 7 p.i. At this time 
point, only a down-regulation of IFN- by stress was detected.  In addition, stress also 
elevated a Th2 cytokine, IL-10, in the spleen at day 2 p.i., F (1, 28) 5.091, ps < 0.03, but 
this increase did not reach significance at day 7 p.i., F (1, 28) = 2.688, p = 0.1 (Figure 3-
4).   
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          A.                                                 B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3.  Phosphor image of a representative RPA for cytokine expression in the spleen 
following restraint and/or BeAn infection at day 7 post infection using (A) mCK-2b and (B) 
mCK-3b kits. Total RNA was isolated from the brains and spleens of CBA mice at day 7 p.i. 
25µg RNA was hybridized with a 32P-labeled chemokine probe set as described in Materials and 
methods. The housekeeping gene L32 was used for the normalization of sample loading and 
technique error. Lanes 1,2,3,4 represent the brain samples of NI/NR (Non-infected / Non-
restrained), NI/R (Non-infected / Restrained), I/NR (Infected / Non-restrained) and I/R (Infected 
/ Restrained), respectively, collected at day 7 p.i..  
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                                                               Day 2 post infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4.  The effect of restraint stress on the cytokine expression in the spleen during 
acute TMEV infection.  The levels of cytokine expression were derived from the 
densitometric ratio of the individual cytokine to the housekeeping gene L32 and multiplied 
by 1000. At day 2 p.i., restraint stress significantly decreased TMEV-induced expression of 
proinflammatory cytokines TNF-, TNF-, LT-, IFN-, IFN-, IL-6 and IL-12p40; however, 
an anti-inflammatory cytokine, IL-10 declined following restraint stress. The values were 
represented by mean + S.E.M.                  
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Table 3-2  Summary for alterations in cytokine expression in the spleen following TMEV infection and  restraint stress  
     A summary of alterations in cytokine expression in the spleen during acute  
     TMEV infection and restraint stress. The results are shown as the main effect of either  
     infection (INF) or restraint stress (RS), and the interactions between the two variables,  
     which are revealed by ANOVA and post hoc mean comparison. (+) / (-) represent significant increase  
     or decrease, all p<0.05, in cytokine expression in the brain, respectively. 
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Restraint decreased the virus-induced cytokine expression of TNF- at day 2 p.i. and 
not at day 7 p.i., post hoc mean comparison confirmed significant declines in TNF-, LT-
, IL-6, IFN- and IFN- in the spleen of I/R mice as compared to I/NR mice at day 2 p.i., 
all ps < 0.05 (Figure 3-3). However, this effect was not observed at day 7 p.i. These 
results suggest that stress exerts a greater effect on the peripheral immune function by 
down-regulating pro-inflammatory cytokines during the earlier stage rather than the later 
stage in restraint animals (Table 3-2).    
 
3.4 The expression of cytokines determined by real time RT-PCR 
To confirm the RPA results of cytokine expression, a subset of RNA samples from 
the brain and spleen at day 7 p.i. was further examined using real time RT-PCR.  As 
summarized in Table 3-3, we confirmed a main effect of infection for TNF-, LT-, IL-1, 
IFN- and IL-12p40 in the brain, and TNF-, IL-12p40 in the spleen; and a main effect of 
stress for IFN- in the spleen, all Fs (1,11) > 18.258, ps < 0.005. PCR revealed the main 
effect of infection for IFN-γ in the brain that was not seen in the subset of RPA data but 
was found in the overall RPA data.  In general, the PCR data agreed with the subset RPA 
data, except for IL-1 and IL-10 in the brain and TNF- and IFN- in the spleen. This 
discrepancy was also seen when we compared the subset PCR with the overall RPA data, 
and possibly due to a smaller size (n=11) of samples assayed using PCR than RPA (n=78), 
resulting a greater variability.  Overall, it appeared that a greater agreement of the results 
was found in the spleen than the brain. Therefore, both methods are sensitive for cytokine 
detection and the results using either method generally demonstrate a good accordance 
with each other.  
  
87
 
                
Table 3-3.  Comparisons of PCR and RPA on the examination of cytokine expression 
Brain (day 7 p.i.) PCR Brain (day 7 p.i.) RPA
Cytokines INF RS INF and RS Cytokines INF RS INF and RS
TNF- (+) TNF- (+)
Lt- (+)  NI:R>NR; I:R<NR Lt- (+) *
IFN- (+) IFN-
IL-1 (+) (+) (+) IL-1 (+)
IL-12p40 (+) IL-12p40 (+) *
IL-10 (+) NI:R>NR; I:R<NR IL-10 (-)
Spleen (day 7 p.i.) PCR Spleen (day 7 p.i.) RPA
Cytokines INF RS INF and RS Cytokines INF RS INF and RS
TNF- (+) NI:R<NR; I:R>NR TNF- *
Lt-  (-) Lt- * * *
IFN- (+) (-) NI:R<NR; I:R>NR IFN- * *
IL-1  (-) IL-1 * * *
IL-12p40 (+) IL-12p40 (+)
IL-10 * IL-10 *
(+)/(-) represents an increase or decrease in the levels of expression
 * indicates non-statistically significant trends, or patterns of agreement.
Highlighted area indicates the difference between PCR and RPA in a subset of samples
                                                                                                indicates the difference in the results between PCR and overall RPA
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3.3 The expression of TNF-α  protein level in the brain and serum 
TNF- is an essential cytokine involved in the innate antiviral response, and our 
previous study showed the serum TNF- was elevated in all restrained animals at day 1 
and 2 p.i., irrespective of whether they were infected or not (Welsh et al., 2004). In the 
current study, we further examined the CNS TNF- using western blotting and serum 
TNF- using ELISA.   
A main effect of infection was observed on the TNF- level in the brain, F (1,12) = 
5.958, p < 0.04. An interaction between infection and restraint did not reach significance; 
however, restraint stress significantly decreased the TNF- in the brain of infected mice, 
as confirmed by post hoc mean comparison (Figure 3-5A).  The serum TNF- level was 
determined by ELISA showing that TMEV infection induced an increase of TNF- at day 
7 p.i., F (1,21) = 9.018, p = 0.0068; however, RST did not change the TNF- level in the 
serum (Figure 3-5B). The result indicated a difference in TNF- response in the 
circulation (systemic) and the CNS (local) following Theiler’s virus infection and 
restraint stress. 
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Figure 3-5.  The TNF- protein level in (A) the brain using western blot and in (B) the 
serum using ELISA at day 7 p.i.  (A) The TNF- protein expression in the brain was 
increased by TMEV infection, and decreased by restraint stress. The TNF- level was 
derived from the densitometric ratio of TNF- and GAPDH. The value was represented by 
mean + S.E.M.  (B)  TMEV infection increased serum TNF- level at day 7 p.i.; however, 
the level was not affected by restraint stress.   
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3.4 The correlation between pro-inflammatory cytokine production and viral clearance in 
the brain 
      Pro-inflammatory cytokines play an important role in viral clearance and further 
activation of immune cells in innate immunity to viral infection. To determine whether 
the level of cytokines correlates with the ability to clear virus, we set up a separate 
experiment, which consisted of two groups: infected/non-restrained and 
infected/restrained mice. This allowed us to examine the cytokine expression and the 
viral titers in the brain from the same animal.  At day 7 p.i., the mice were terminated and 
the brain was dissected out. Then we alternatively took the left or right hemispheres for 
cytokine assays by RPA and the remaining half for determination of viral titers by plaque 
assays.   
Restraint appeared to impair the viral clearance in the brain at day 7 p.i., resulting in 
higher viral titers in the restraint mice (p = 0.001) as depicted in Figure 3-6. Individual 
cytokine levels were correlated with viral titers by simple regression. The pro-
inflammatory cytokines LT-, TNF- and IFN- were negatively correlated with viral 
titers in the brain, wherein higher viral level consistently correlated with lower cytokine 
expression, all ps < 0.05. In addition, a marginal correlation between the TNF- protein 
levels and the viral titers in the brain, wherein an increase in TNF- was associated with a 
lower viral titers in the brain, p = 0.056, R = 0.694 (Figure 3-7). These results indicate the 
potential role of pro-inflammatory cytokines in viral clearance.  
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Figure 3-6.  The impact of restraint stress on viral titers in the brain at day 7 p.i. by plaque 
assay.  The viral titer was calculated by the logarithm of plaque forming assay (PFU) per 
gram of brain tissue. The values were represented by mean + S.E.M. (*) indicates p < 0.0001.   
 
 
4. Discussion 
The current study is a continuation of our investigation of the effects of restraint, as a 
model for stress, on both the central and peripheral immune response to Theiler’s virus 
infection.  Experimental infection of Theiler’s virus in the brain elicits both innate 
immunity and adaptive immunity, which are characterized by CNS mononuclear 
infiltration consisting of NK cells, macrophages, virus-specific CD4+ and CD8+ T cells, 
as well as activation of the CNS residential microglia and astrocytes.   
 
4.1 The reduction in cytokine expression suggests suppressed function of immune cells 
and decreased cellularity following restraint stress 
A dominant panel of pro-inflammatory cytokines TNF-, LT-, IFN-, IFN-, IL-6 
and IL-12p40 was induced in the brain as early as day 2 p.i. and continued to be detected  
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Figure 3-7. The correlation between viral titers and cytokine expression in the brain at day 7 
p.i. The viral titers from the left or right hemisphere and the mRNA expression of IFN-, LT-
β and both the messenger and protein of TNF- were analyzed by simple regression, R value 
was indicated in each box, and all the ps < 0.05.      
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up to day 7 p.i., indicative of cellular immunity produced by those potential cellular 
resources mentioned above.  For the first time, we reported a similar profile of pro-
inflammatory cytokines TNF-, TNF-, IFN-, IFN-, IL-12p40 and IL-6 in the spleen 
following inoculation of Theiler’s virus in the brain, although the profile differed at day 2 
p.i. and day 7 p.i.  A reduction in the expression of LT-, IFN-, IL-12p40 and IL-6 by 
restraint was documented in the brain. As compared to the brain, a greater number of 
cytokines in the spleen, TNF-, TNF-, IFN-, IFN-, IL-12p40, IL-6 and LT-, were 
profoundly reduced by restraint at day 2 p.i. However, no such effects were observed at 
day 7 p.i. These results suggest a remarkably suppressive effect of restraint stress on 
systemic cellular immunity in this model.  
IFN-, TNF- and IL-12 are the crucial pro-inflammatory cytokines in the activation 
of both the innate and adaptive immune components (reviewd in Elenkov and Chrousos, 
2002). For example, NK cell activation is critical in the early defense against Theiler’s 
virus infection (Paya et al., 1989). NK cells are regulated by IL-12 and they secrete IFN- 
as one of their immunological effector molecules.  Activation of macrophages/microglia 
to become competent APC is dependent on viral infection, as well as the further 
stimulation by pro-inflammatory cytokines, such as IFN-. IFN-, a type II interferon, 
which has been shown to induce MHC class II expression and various costimulatory 
molecules, such as B7-1, B7-2, CD40 and ICAM-1 (Olson et al., 2001; Peng et al., 1998), 
which are required for a functional APC.  IL-12 and TNF- produced by activated APCs 
promote the cytotoxicity of both NK cells and cytotoxic T cells (CTLs) (Elenkov and 
Chrousos, 2002; Shaw-Jackson and Michiels, 1997; Watford et al., 2004).   The reduced 
production of these cytokines may reflect a decline in the innate immune functions by 
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either NK cells, APCs or CTLs following restraint. The down-regulation of NK cell 
activity and CTL in restraint stress models using a variety of different viruses has been 
documented by ours and other laboratories (Bonneau et al., 1991; Dobbs et al., 1993; 
Tseng et al., 2005; Welsh et al., 2004).   
The T cell function of the adaptive immune component is regulated by IL-12, a 
monocyte-derived immunoregulatory cytokine that promotes cellular immunity, 
particularly in the polarization toward Th1 cytokine production. As a heterodimeric 
cytokine for IL-12, one of its subunits, IL-12p35, which is constitutively expressed in a 
variety of cell types, was detected at comparable levels in either the brain or spleen under 
all the conditions (NI/NR, NI/R, I/NR, I/R); whereas the other biologically active subunit, 
IL-12p40 was up-regulated at day 2 and 7 p.i., indicating a Th1 cytokine response 
induced by viral infection. IL-12 and IL-12-induced IFN- produced by monocytes may 
contribute to the Th1 cell differentiation and production of IFN- and TNF-, as well as 
antagonizing Th2 cell differentiation and the secretion of Th2 cytokines, such as IL-10 
(Elenkov and Chrousos, 2002; Watford et al., 2004). We observed a decreased expression 
of IL-12p40, IFN- and TNF-, as well as an enhancement of IL-10 in the restrained 
mice at day 2 p.i., indicative of a shift from Th1 toward the Th2 profile and decreased 
cellular immunity as result of stress.  
An increase of IFN-, a type I IFN, was observed in the brain and spleen following 
TMEV infection. IFN- is a potential antiviral cytokine and an inducer of NK cell-
mediated cytolysis (Biron, 1999). However, it has also been used as a therapeutic agent 
for MS and an animal model of MS, EAE, by suppressing both IL-12 production and 
downstream Th1 cytokines (Klimstra et al., 2000). Unlike other pro-inflammatory 
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cytokines, IFN- level was elevated in the brain of I/R mice. Restraint-induced increase 
in type I IFNs has also been documented in other viral infections, such as influenza virus 
(Hunzeker et al., 2004). The rise of IFN- was correlated with impaired viral clearance 
brought upon by stress at day 7 p.i., which can possibly be explained by a compensatory 
response to decreased levels of antiviral IFN-γ and other pro-inflammatory cytokines.   
In addition to the diminished immune cell activity, which may account for the 
reduction of cytokine expression, the drop in cellularity of immune cells may also 
contribute to the change in cytokine levels. It has been shown that stress may alter the 
cellular composition in circulation and redistribution of immune cells in lymphoid organs 
using various experimental stressors, such as restraint, immobilization and social stress 
(Dhabhar et al., 1995; Fleshner et al., 1995; Stefanski et al., 2003). This effect was also 
observed in the Theiler’s virus restraint model by our laboratory, demonstrating that 
restraint leads to a decreased number of circulating lymphocytes (Welsh et al., 2004). 
Additionally, we previously showed that stress results in decreased expression of the 
chemokines, Ltn, IP-10 and RANTES, which are potential chemoattractants for NK cell 
and T cells (Mi et al., 2004). Therefore, the reduction in cellularity, as well as the decline 
in recruitment to the inflamed sites following restraint stress, may be additional reasons 
for reductions in cytokine expression in the brain or spleen. 
 
4.2 The decreased cytokine production is responsible for the impaired viral clearance 
following restraint stress 
Decreased immune function by stress results in impaired viral clearance, as shown 
by alterations in cytokine expression and the corresponding increase of viral titers in the 
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CNS of restrained mice. Our results demonstrate a significantly negative correlation 
between the pro-inflammatory cytokines IFN-, lymphotoxin- (LT-) and TNF- and 
viral load, suggesting a critical role of these cytokines in the containment of TMEV.  
IFN-γ is an important immune mediator for viral clearance in the CNS which 
functions by inducing type II nitric oxide synthase (iNOS) from glia and type I nitric 
oxide synthase (nNOS) from neurons. IFN- has been shown to be critically important in 
the pathogenesis of several different viral infections, such as measles and herpes simplex 
virus (Reviewed in Chesler and Reiss, 2002). The crucial role of IFN-γ in Theiler’s virus 
infection has been demonstrated previously, whereby the administration of monoclonal 
antibody to IFN-γ increases viral persistence and demyelination in both susceptible SJL/J 
and resistant C57BL/10NJ strains of mice (Rodriguez et al., 1995). Persistent viral 
infection and demyelination has been also recorded in C57BL/6 IFN-γ-/- knockout mice, 
but not in wild type mice (Murray et al., 2002).  In addition, IFN- was found to inhibit 
the in vitro replication of TMEV in cerebral vascular endothelial cell (Welsh et al., 1995).  
TNF- confers antiviral activity, especially when synergized with other cytokines, 
such as IFNs (Ito and O’Malley, 1987; Wong and Goeddel, 1986). The effect of TNF- in 
viral infection of the CNS may be mediated by the upregulation of TNF- receptor, as 
reported in an in vitro study using mouse hepatitis virus (MHV)-JHM strain (Rempel et 
al., 2005). The antiviral function of TNF- has also been demonstrated in cerebral 
vascular endothelial cell in in vitro TMEV infection (Welsh et al., 1995). In the Theiler’s 
virus model, TNF- has been shown to play a major role as a toxic effector to 
oligodendrocytes and consequently demyelination (Selmaj and Raine, 1988). In the acute 
infection, TNF-, as well as IFN-, is produced by CTL, which mediate the non-cytotoxic 
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mechanisms, suggesting a potential role for TNF- in the elimination of virus (Lyman et 
al., 2004).   
LT-, a membrane form of lymphotoxin expressed on activated T, B and NK cells, 
plays a critical role in the resistance to intracellular pathogens, including viruses 
(Benedict et al., 2001; Lin et al., 2003; Marshall et al., 1999; Soderberg et al., 2004), 
bacteria (Ehlers et al., 2003) and prions (Mabbott et al., 2003; Oldstone, et al., 2002). LT-
 induces antiviral activity to Theiler’s virus infection by mounting an effective CTL 
activity enabling viral clearance during the early stage, thus diminishing demyelination at 
the later stage. Compared to the soluble LT-, LT- plays a minor role in demyelination 
(Lin et al., 2003).  
Cytokines alone are not sufficient for complete clearance of virus. However, they are 
among the core factors that regulate or coordinate the immune cells, and changes in their 
level may be indicative of the degree of activation of immune system.   
 
4.3 Alteration in cytokines expression is mediated by both humoral and neuronal 
mechnisms  
It is well recognized that glucocorticoid regulates the Th1/Th2 balance by suppressing 
IL-12, thus removing its inhibitory effect on the production of Th2 cytokines, such as IL-
10 (Elenkov and Chrousos, 2002). This is supported by the finding that in the restrained 
animals, IL-12p40 expression was significant lower, and IL-10 was elevated as compared 
to that in the non-restrained animals. The turnover of IL-12/IL-10 could be explained by 
restraint-induced elevation of circulating corticostrone as reported previously (Campbell 
et al., 2001).  In vitro studies revealed that the suppressive effect on IL-12 by 
  
98 
dexamethasone is mediated by inhibition of mitogen-activated protein kinase (MAPK) 
and transcription factor NF-κB (Ma et al., 2004) or by decreased expression of IL-12 
receptors β1, β2 and IL-12 binding ability (Wu et al., 1998). It has also been reported that 
glucocorticoid induces IL-10 production, as well as other Th2 cytokines, IL-4 and IL-13 
in rat CD4+ T cells (Ramierz et al., 1996). Recently, another type of IL-10 producing T 
cell, known as T regulatory cell (TR 1 cell), was shown as a potential source of IL-10 
following glucocorticoid exposure, which is mediated by upregulation of a different 
transcription factor, FOXP3 (Karagiannidis et al., 2004). Moreover, glucocorticoid can 
promote IL-10 production by both macrophages and dendritic cells (Franchimont, 2004); 
thus, together with the TR 1 cell, these cells may be the major source of IL-10 in the 
restraint response. 
An IL-10 increase, which is a Th2 response, was only observed in the spleen, not in 
the brain in our model. We speculate that restraint-induced catacholamines (CAs) may be 
involved in this Th1/Th2 regulation, in addition to the hypothesis of peripheral-derived 
immune regulation. Because the spleen is predominantly innervated by sympathetic nerve 
fibers, activation of the SNS results in the release of norepinepherine in either a synaptic 
or a nonsynaptic manner in the spleen (Elenkov et al., 2000), for example, during 
restraint stress. Catecholamines inhibit IL-12 and subsequent Th1 cytokine productions 
but stimulate IL-10 production via β2-adrenergic receptors, thus providing additional 
machinery for the Th1/Th2 transition (Elenkov and Chrousos, 2002). The Th2 skew was 
observed at day 2 p.i. but not day 7 p.i., which was in parallel with the finding that a 
greater number of Th1 cytokines were reduced by restraint stress. It is possible that the 
repeated restraint of eight sessions may produce an adaptation to the stressor after the 
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first two or three sessions of restraint, as evidenced by behavioral observations (data not 
shown), so that a blunted SNS response or glucocorticoid resistance in the spleen might 
occur due to the extended stress exposure. However, the corticosterone which was 
sustained at elevated levels over the entire session of restraint (unpublished data) may 
contribute to the major suppressive effect of stress. By contrast, another study showed 
that neither splenic nerve transection nor adrenalectomies (ADX) can abrogate the 
increase in foot shock-induced cytokine production in the spleen (Meltzer et al., 2004). 
Therefore, it is conceivable that both the neural and hormonal mechanisms are necessary 
for induction of the stress effect.    
 
4.4 Differential immunoregulatory mechanisms may be involved in the CNS and 
peripheral immune organs during stress  
Generally, our data indicate similar but distinct cytokine profiles in the brain and the 
spleen following infection, with a greater number of Th1 cytokines detected in the brain. 
This could be due to several mechanisms, including either more potential cellular sources 
for cytokine production in the brain, such as astrocytes, microglia and infiltrating 
inflammatory cells; or a higher viral load in the CNS than in the spleen (manuscript 
submitted).   
The discrepancy between immune response in the brain and spleen is further 
demonstrated by the differential expression of IL-10 in the two organs. The increase in 
IL-10 caused by stress was only found in the spleen at day 2 p.i., and not at day 7 p.i.. 
The elevation of IL-10 appears to be associated with the decline in Th1 cytokines and IL-
12 production in the spleen. The IL-10 response was never detected in the brain. However, 
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the down-regulation of IL-12p40 and Th1 cytokines were present up to day 7 p.i. in the 
brain. It is plausible that two mechanisms may account for the reduced Th1 response 
following stress: either by reducing the expression of the upstream cytokine, IL-12p40; or 
by producing the Th1-inhibitory cytokine, IL-10.  However, the skew in Th2 response was 
only noticed in the spleen at day 2 p.i., suggesting the inhibitive role of Th2 cytokine on 
Th1 cytokine production was transient in this restraint model. The absence of Th2 
response in the brain at either time point examined, may suggest an additional mechanism, 
that a direct down-regulation of Th1 cytokines, rather than inhibition by Th2 cytokines, 
plays a major role in the stress-induced immune response to Theiler’s virus infection. We 
speculate that a regulatory effect by Th2 cytokines during restraint stress may occur in the 
periphery.  
IL-1 is a pleiotropic pro-inflammatory cytokine that is produced in response to 
various stimuli, such as infection and stress. IL-1 was expressed following infection, but 
not induced by stress, in the brain in this restraint model. Indeed, Deak et al. (2004) 
reported that the hypothalamic IL-1 production, which is the major CNS source for IL-
1 during stress response, is induced by hypoglycemia, but not by restraint. Therefore, 
this may indicate that the IL-1 production in the CNS is dependent on the type of stressor 
used at exposure.  Several other cytokines were found differentially expressed in the 
brain and spleen following stress and/or infection, such as TNF- and IFN-, a further 
indication of the difference in the immune response between the CNS and peripheral 
lymphoid organ. 
 In summary, restraint stress of mice infected with Theiler’s virus, produced 
decreased pro-inflammatory cytokine expression in the brain and spleen, as compared to 
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the non-restrained mice, and caused impaired viral clearance and subsequent prolonged 
or persistent viral infection. The stress-induced regulatory mechanisms in viral infection 
and the cell type involved in the process warrant further investigation.   
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IV   THE EFFECT OF RESTRAINT STRESS ON THE 
SYSTEMIC TMEV INFECTION  
1. Introduction 
Psychological or physiological stress has been associated with compromised immune 
function and is implicated in the onset, reactivation or exacerbation of a number of 
infectious and autoimmune diseases.  The response to a stressor, defined as a challenge 
that could alter or disturb the stability of the internal milieu, is characterized by the 
release of stress hormones (e.g. glucocorticoids) and neurotransmitters (e.g. 
catecholamines) due to the activation of the hypothalamic-pituitary-adrenal (HPA) axis 
and the systemic/adrenomedullary sympathetic nervous system (SNS) (Chrousos & 
Elenkov, 2002; Stratakis & Chrousos, 1995). Glucocorticoids have long been known to 
be anti-inflammatory and immunosuppressive (Barnes & Adcock, 1993), and play a vital 
role in the stress-induced immune response.     
Restraint stress (RST), induced by restricting the animal’s movement, has served as a 
common procedure for studying stress effects in laboratory animals (Pare & Glavin, 
1986).  The stress-induced immunosuppression in viral infections has been extensively 
investigated. Studies have demonstrated that stress suppresses infiltration of mononuclear 
cells (Sheridan et al., 1991); production of virus specific cytokines (Bonneau, 1996; 
Sheridan et al., 1991); and CTL responses (Bonneau et al., 1991; Bonneau et al., 1993; 
Wonnacott & Bonneau, 2002).  Consequently, viruses may establish persistent infections  
as a result of the impaired immunological surveillance. 
         Theiler’s murine encephalomyelitis virus (TMEV) is a member of the cardiovirus 
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genus of the family Picornaviridae.  It is a naturally occurring, murine enteric pathogen 
causing asymptomatic infection of mice, and occasionally, it penetrates into the central 
nervous system (CNS) resulting in a CNS disease (Theiler, 1934).  Experimental 
intracranial inoculation of the BeAn or DA strains of TMEV into susceptible mice 
induces a biphasic disease - an acute encephalomyelitis in the gray matter and a chronic 
progressive demyelination involving the white matter of the spinal cord (Lipton, 1975).  
The chronic disease, both clinically and microscopically resembling human multiple 
sclerosis (MS), has been used as an important experimental model for MS.  
         Upon initial infection, TMEV predominantly replicates in neurons (Brahic, et al., 
1981), and then spreads to macrophages and glial cells in the CNS (Clatch et al., 1990; 
Dal Canto & Lipton, 1982; Lipton et al., 1995; O’Shea et al., 1997).  For mice susceptible 
to demyelination, the viral RNA can be detected within the CNS as late as one year p.i..  
Furthermore, TMEV results in systemic infection as evidenced by viral RNA detection in 
the heart, intestine and lymph nodes of infected mice, but can be eliminated by four 
months p.i. (Trottier et al., 2002).  In contrast, resistant mice clear the virus from CNS in 
the acute phase and do not develop demyelination (Dal Canto & Lipton, 1975; Lipton, 
1975), which emphasizes the necessity for TMEV to establish a persistent infection 
during the early phase in order to induce demyelination at the late stage of disease. 
         The establishment of viral persistence is determined by the genetic characteristics of 
the mice.  For susceptibility to TMEV persistence and demyelination, the major genetic 
basis was mapped on H-2Dd locus, whereas the resistance was linked to H-2Db locus 
(Brahic & Bureau, 1998); although other genes, such as Tmevp2, Tmevp3, have also been 
implicated (Bihl et al., 1999).  In addition, a timely, strong immune response by the host 
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is critical for clearing the virus from CNS.  During the early disease, NK cells, 
macrophages, and virus-specific CD4+ and CD8+ CTL are recruited into the CNS and 
contribute to the elimination of TMEV from the CNS (Kang, et al., 2002; Murray, et al., 
2002; Oleszak et al., 2004; Paya, et al., 1989).  In addition, CNS CD4+ T infiltrates 
participate in clearing the virus by generating Th1 cytokines, rendering help for the CD8+ 
response, as well as promoting the humoral immune response (Karls et al., 2002; Sato, et 
al., 1997, Welsh et al., 1987).  
        However, the effectiveness of viral clearance can be undermined by an impaired 
immune response.  For example, resistant BALB/cByJ mice became susceptible to 
TMEV following depletion of T cells by experimental exposure to low-dose irradiation 
(Nicholson et al., 1996).  Also, an administration of immunosuppressive 
cyclophosphamide and rabbit anti-mouse thymocyte serum to TMEV-susceptible SJL/J 
mice (Lipton et al., 1977) and anti-CD4 monoclonal antibody to CBA mice (Welsh et al., 
1987) resulted in higher mortality, a prolonged high level of virus, and an increase in the 
severity of CNS injury.  
        We previously reported that the RST in CBA mice resulted in impaired viral 
clearance and attenuated inflammation in the CNS, as well as worsening clinical 
symptoms and higher mortality during the acute phase, in part, by elevating circulating 
corticosterone (Campbell et al., 2001), decreasing NK cell activity (Welsh et al., 2004), 
and down-regulating chemokine expression (Mi et al., 2004).  In the current series of 
experiments, we investigated the effect of stress on the viral clearance of TMEV and the 
pathology in systemic organs.  We hypothesized that immunosuppression by RS could 
exacerbate systemic TMEV infection, thus facilitate the establishment of viral persistence.  
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Additionally, since TMEV displayed preference for myocardium and skeletal muscle 
(Gomez et al., 1996), we further examined whether restraint stress resulted in any change 
in pathogenecity of TMEV to particular organs. 
 
2. Materials and methods 
2.1 Experimental design 
Three experiments were conducted in this study using separate groups of mice.  
1) Experiment 1. Determination of viral titers in the CNS and extraneural organs.  
All the mice were infected with BeAn. A 2 (restraint vs. non-restraint) by 3 
(time of sacrifice days 1, 3 and 7 p.i.) factorial design, 3-10 mice per cell, 
were used to determine the impact of RS on viral titers in organs throughout 
the body.  
2) Experiment 2. The pathology in systemic organs following infection and RS. 
A 2 (infected vs. non-infected) by 2 (restraint vs. non-restraint) factorial 
design, 3-6 mice per cell, was applied to examine the microscopic pathology 
in systemic organs.  All the mice in this experiment were sacrificed at day 7 
p.i.   
3) Experiment 3. TMEV pathogenecity following stress.  To investigate whether 
RST can alter the pathogenecity of TMEV, we isolated the virus from the 
heart of infected/restraint mice from experiment 1, and intracranially 
inoculated the isolates to a third group of mice.  A 3 (virus isolates from the 
hearts of 3 infected/restraint mice) by 3 (time of sacrifice days 1, 3 and 7 p.i.) 
factorial design, 3-4 mice per cell, but no restraint was applied.  
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2.2 Mice  
Male CBA mice at three weeks of age were obtained from Harlan Labs, Indianapolis, 
IN.  Mice were maintained under a pathogen-free environment in a 12:12 light/dark cycle 
(lights on from 6:00AM to 6:00PM).  Mice were counterbalanced by weight upon arrival, 
and housed 3-4 mice per cage.  Mice were allowed to acclimate to such conditions for 
one week prior to any experimental manipulations.  
        At four weeks of age, cages of mice were randomly allocated to one of the following 
experimental conditions, if applied, dependent on the experimental design: (1) NI/NR: 
mice remained undisturbed in their home cages; (2) NI/R: each mouse was subjected to 
RST in their home cages; (3) I/NR: mice were infected intracerebrally with BeAn virus; 
or (4) I/R: each mouse was intracerebrally infected with BeAn virus and subjected to RST. 
 
2.3 Virus 
The BeAn strain of TMEV was kindly provided by Dr. H. L. Lipton, Department of 
Neurology, University of Chicago, Evanston, IL.  The virus was propagated and titrated 
on L2 cells by standard plaque assay and stored at -80oC (Welsh et al., 1987).  
 
2.4 Restraint stress protocol 
  Mice were physically restrained in a 60 ml polypropylene syringe, which was 
perforated with ventilation holes of 0.4 cm diameter.  Mice were restraint stressed for 12 
h (9pm-9am) daily.  Restraint stress was initiated one day prior to infection, and 
continued for seven more consecutive nights (Campbell et al., 2001; Sheridan et al., 
1991). 
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2.5 Infection of mice 
  Mice were anesthetized with isoflurane (Rhoda Organique Fine Ltd., Avonmouth, 
Bristol, UK) and 5.5X104 PFU BeAn virus in 20 l inoculum was injected intracranially 
into the right cerebral hemisphere.  Animals in non-infected groups were sham-infected 
with 20 l sterile phosphate-buffered saline (PBS).   
 
2.6 Determination of viral titers  
The brain, spinal cord, thymus, spleen, superficial cervical lymph nodes (SCLN), 
deep cervical lymph nodes (DCLN), lumbar lymph nodes (LLN), mesenteric lymph 
nodes (MLN), heart, lungs, liver, intestine, kidneys and testes were aseptically removed, 
weighed, and homogenized in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen 
Corporation, USA).  Cellular debris was centrifuged and the titer of virus in the 
supernatant was determined by standard plaque assays on L2 cells.   
 
2.7 Collection of tissue for microscopic examination  
In experiment 2, the mice were sacrificed at day 7 p.i.  The organs, as described 
above, were removed, fixed in 10% formalin, embedded, sectioned and stained with 
hematoxylin & eosin (H&E) for microscopic examination.  
 
2.8 Recovery and amplification of heart-adapted TMEV  
A previous study showed that TMEV exhibited a predilection for the heart and 
skeletal muscle when injected intraperitoneally, causing myocarditis and myositis in 
susceptible strains of mice and immunodeficient SCID mice (Gomez, 1996).  To 
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investigate if stress alters the pathogenecity of Theiler’s virus to myocardiocytes, 
resulting in increased viral replication and lesions in the heart and the other organs, 3 
infected/restrained mice, which were terminated at day 7 p.i., were randomly selected for 
this study.  
Virus from the heart homogenates of the 3 mice was amplified in L2 cells.  Briefly, 
the monolayer of L2 cells in a T-25 flask were incubated with the virus-containing 
supernatant in the presence of DMEM and 0.5% BSA at room temperature for 1h.  Then 
the medium was removed and the cells were cultured with DMEM-0.5% BSA at 370C 
and 3% CO2 for 2 –3 days until a cytopathic effect (CPE) was seen microscopically.  The 
monolayers were then removed with a scraper and transferred with the medium to a 
centrifuge tube.  After centrifuging at 2000 rpm, 40C, the supernatant was incubated on 
L2 monolayers in a T-75 flask at the same condition as described above.  The virus was 
further amplified in a T-125 flask following the same procedures as above when CPE was 
observed. The virus-containing supernatant was collected and the titer of the virus was 
determined by plaque assay.  
Three isolates of virus (5.5X104 PFU/g) propagated from the hearts were 
intracranially injected into three groups of non-restrained CBA mice.  The mice were 
sacrificed at days 1, 3, 7 p.i.  The brain, heart, thymus, spleen, gastracnemius muscle 
were aseptically removed.  In order to determine whether there was a correlation of viral 
load with the histopathological changes, half of the tissues were processed for viral 
titration by plaque assays, and the other half of the tissues were processed for 
histopathology.  Additionally, the sciatic nerves were also dissected for histopathological 
examination.   
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2.9. Validation of recovered virus as Theiler’s virus by radioimmunoassay (RIA) 
       In order to determine that the viruses isolated from the heart were indeed Theiler’s 
virus, their identity was confirmed using an RIA as previously described (Sieve et al., 
2004).  Briefly, a flexible u-shaped, 96-well polyvinyl chloride plate (Costar, Cambridge, 
MA) was initially washed with PBS/Tween-20 (0.05% v/v) and rinsed by reverse osmosis 
(RO H2O).  The plate was coated with 100 µL of supernatant from each sample (1.0 x 107 
pfu/100 µL) and incubated at 4°C for 24 hours.  Following the incubation, the plate was 
washed as described above.  The plate was blocked with 3.0% non-fat dry milk (NFDM) 
in PBS (pH 9.0) for one hour at 37°C.  After washing, either a positive control serum 
from rabbit (generated by 3 serial injections of UV inactivated BeAn strain of Theiler’s 
virus into a rabbit), or an anti-goat negative control serum from rabbit (Sigma, Saint 
Louis Missouri, USA) was diluted 1/20 in assay buffer (made up from two parts:  495 mL 
of part A:  0.08M Trizma HCl, 0.03M Trizma base and 0.15M NaCl at a final pH of 7.2, 
and 5 mL of part B:  1.0% NFDM and 0.5% Tween-20 in RO H2O) and added to the 
wells (100 µL total volume) . Serial two fold dilutions of antiserum were diluted to 1/640 
of the original concentration.  Following the serial dilutions, the plate was then incubated 
for one hour at 37°C.  Next, the plate was washed and rinsed again (as previously 
described) before adding 100 µl polyclonal goat anti-rabbit (Sigma, Saint Louis, Missouri, 
USA) antibody diluted 1/500 in assay buffer to every well.  After incubating at 37°C for 
one hour and a subsequent washing, 100 µl of 125I-Protein A (1 x 105 cpm/100 µl assay 
buffer) was added to each well, and the plate was incubated at room temperature for one 
hour.  The plate was then washed and rinsed with PBS/Tween-20 and RO water (as 
described above).  Once the plate was dry, every well was cut out, put into tubes and 
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counts were determined by using a gamma counter (Beckman gamma 5500 counting 
system). 
 
3. Results 
3.1 Effects of stress on viral titers in organs 
3.1.1  The stress effects on the viral titers in the CNS 
          During the first seven days p.i., stress resulted in a significant increase in the 
overall viral titers in the brain F (1,23) = 4.407, p < 0.05, but not in the spinal cord, F 
(1,23) = 1.172, p > 0.05. The viral titers in both the brain and the spinal cord increased 
with the day p.i., all Fs (1,23) > 7.331, ps < 0.003.  The main effect of stress on viral 
replication was not seen until day 7 p.i, when the stressed mice were developed 
significantly higher titers in the brain and the spinal cord than the non-restrained mice, all 
Fs (1,15) > 8.376,  ps < 0.01 (Figure 4-1). 
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Figure 4-1.  The effects of restraint stress on TMEV replication in the brain (A) and the 
spinal cord (B) during early infection. The viral titers are represented by logarithmic plaque 
forming unit per gram of tissue examined.   and  indicate non-restraint and restraint mice, 
respectively. The number of mice used with each experimental condition ranged from 3-10 
animals. * indicates a significant difference in viral titers between restrained and non-
restrained mice, p < 0.05. 
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3.1.2  The effect of stress on the viral titers in extraneural organs 
Although TMEV is mainly used in the study of neurological disease, it was 
originally identified as an enteric pathogen, and there is also evidence that this virus may 
systemically infect other organs (Gomez et al., 1996).  In this experiment, extraneural 
organs were also removed from the animals to determine whether stress altered viral 
dissemination.  
Our results showed that stress increased viral titers in the heart [F (1,15) > 13.17, p 
< 0.01], and a timing effect of enhanced replication of virus over time [F (1,15) > 13.71, 
p < 0.001].  The infectious virus was only detected in the heart in 1 out of 3 (33.3%) non-
restrained mice as late as day 7 p.i.  However, in the restrained mice, the replication of 
TMEV was observed in 2 out of 3 (66.7%) at day 3 p.i. and all 6 mice (100%) at day 7 
p.i.; moreover, the titers were increased in the restrained mice at day 7 p.i. [F (1,7) > 
12.82, p < 0.01] (Figure 4-2A).  
The virus was occasionally found in the lungs, liver and intestine of restrained mice 
but not in none of the non-restrained mice during the first 7 days p.i., suggesting that 
restraint tended to facilitate the propagation of virus in these organs, although difference 
were not statistically significant due to insufficient animals (data not shown).  The virus 
was never detected in the kidneys or testes in either restrained nor non-restrained mice. 
Lymphoid organs are particularly important tissues to examine during viral infection. 
Consequently, three groups of local lymph nodes (LNs), including cervical LNs, 
mesenteric LNs and lumbar LNs, spleen as well as thymus were examined.  It appeared 
that restraint increased the overall viral titers in cervical LNs and mesenteric LNs during  
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Figure 4-2. (A) The effects of restraint stress on parental TMEV replication in the heart 
during early infection.  The data was derived from 3-6 animals per group (B) The effects of 
restraint stress on the pathogenecity of TMEV to the heart. The data was obtained from 9-12 
mice per group, which were infected with heart-adapted TMEV. The viral titers are 
represented by logarithmic plaque forming unit per gram of tissue examined.   and  
indicate non-restrained and restrained mice respectively. * indicates a significant difference 
in viral titers between restrained and non-restrained mice, p < 0.05. 
 
 
 
 
  
114 
the 7 days post infection, all Fs (1,14) > 5.897, all ps < 0.05.  Compared to the cervical 
LNs (104 PFU/g), lower viral loads (103 PFU/g) were exclusively identified in restrained 
mice, from which the virus was detected in the mesenteric LNs of 3 out of 3 mice at day 
3 p.i. and 3 out of 6 mice at day 7 p.i., and in the lumbar LNs of 4 out of 6 mice at day 7 
p.i. (Figure 4-3).  However, these stress effects were not significant [Fs (1,7) < 4.264, p > 
0.07] except in the mesenteric LN at day 3 p.i with F (1,4) = 56.58, p = 0.002.    
  Stress appears to enhance the overall viral replication in the spleen during the first 
7 days p.i., [F(1,15) > 16.96, p < 0.001].  Restraint resulted in an increase in viral load in 
the spleen as early as days 1 p.i., as well as at day 3 p.i. [Fs(1,4) >11.604, ps < 0.05]; 
however, a longer stressor of 8 nights did not impact the viral clearance in the spleen, F 
(1,7) = 0.21, p = 0.65.  This finding was further confirmed by ANOVA showing an 
interaction between stress and the duration of stress on viral replication, which indicated 
a suppressive effect of stress on viral amplification at days 1 and 3 p.i. [F(1.15) = 7.119, p 
= 0.0067],  but not day 7 p.i. (Figure 4-3).  
 Although the thymus appeared not to be a preferential site for TMEV replication 
under non-restrained condition, our results showed a potention that infection could be 
enhanced by a longer duration of stress of 8 nights, in 2 of 6 restrained mice, with a viral 
titer of 103~104 PFU/g.  However, this did not reach significance (Figure 4-3).   
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Figure 4-3.  The differential effects of restraint stress on TMEV replication in lymph nodes 
(LN): (A) cervical LN, (B) mesenteric LN, (C) lumbar LN and lymphoid organs: (D) spleen 
and (E) thymus during early infection. The viral titers are represented by logarithmic plaque 
forming unit per gram of tissue examined.   and  indicate non-restraint and restraint mice 
respectively. The number of mice used in each experimental condition ranged from 3-6 
animals per group. * indicates a significant difference in viral titers between restrained and 
non-restrained mice, p < 0.05. 
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Figure 4-3.  continued. 
 
 
 
 
 
3.2  Histopathology 
3.2.1  CNS changes following stress and infection 
At day 7 p.i. with TMEV virus, a non-suppurative inflammation characterized by 
perivascular cuffing, microgliosis and meningitis, was present in I/NR mice; whereas a 
reduced pattern of inflammation was observed in the brain of I/R animals, that was 
consistent with our previous findings (Campbell et al., 2001; Mi et al., 2004).  
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Inflammation, evidenced by cuffings and microgliosis, not as remarkable as seen in 
the brain, primarily involved the gray matter of the cervical, thoracic and lumbar spinal 
cord at day 7 p.i. in I/NR mice (Figure 4-4A).  A mild meningitis, cuffs and microgliosis 
also occurred in the preceding areas of the spinal cord (Figure 4-4A, A1,A2,A3,A4).  No 
lesions were detected in the sacral spinal cord. In contrast with the observations in I/NR 
mice, I/R mice had little evidence of inflammation in the spinal cord (not shown).  
 
3.2.2  The response of lymphoid organs to stress and infection 
The thymuses of both I/R and NI/R mice were markedly reduced in volume with 
depletion of T lymphocytes that caused a pronounced alteration of lobular architecture 
and a loss of corticomedullary distinction.  Although the medulla remained identifiable, it 
contained few T lymphocytes but an increase in adipose tissue (Figure 4-4B, C).  No 
lesions such as inflammation, indicating viral infection, were detected in infected mice.   
Restraint stress also greatly reduced the size of the spleen in either infected or non-
infected animals. However, no lesions were detected in the spleen or lymph nodes 
microscopically.   
 
 
 
 
 
 
 
 
 
 
  
118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-4.  The effects of restraint stress on the histopathological changes of systemic organs by 
H&E. (A) A section of spinal cord of an infected/non-restrained mouse demonstrated a mild 
inflammation (20X) represented by meningitis (shown as white arrows in A and A1 at 40X 
magnification), peripheral vascular cuffings (indicated by black arrow in A and A2 (40X)), and 
microgliosis (MG) as indicated by white arrow heads in the box at left (L) of A and A3 (40X). 
The counterpart area at the right (R) in the spinal cord showed no microgliosis as seen in A4.   
(B) The thymus from a normal mouse (4X) showed cortex (c) and medulla (m). (C) The thymus 
from a restrained mouse. (4X).    
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Figure 4-4. continued. (D) A representative liver section of restraint mice showed severe hemorrhagic 
hepatic necrosis (10X).   (E) Restraint stress on the pathogenecity in the heart of Theiler’s virus. A 
mild inflammation as indicated by white arrow in myocardium was observed in a mouse 
intracerebrally injected with heart-adapted TMEV.  
 
3.2.3 The pathology in systemic organs after infection and stress 
A focal subcapsular hepatic necrosis occurred in restrained (both infected and non-
infected) mice, as seen in Figure 4-4D.  The lesion was characterized by coagulation 
necrosis with various degrees of hepatocellular degeneration and fragmentation, scattered 
accumulation of neutrophils and presence of mild hemorrhage. A mild focal 
hepatocellular vacuolation adjacent to the necrosis area was also present.  A Gram 
staining indicated no bacterial infection of the liver was identified due to RST.  
No lesions were detected in the kidneys, testes, intestines, heart or lungs of either I/R 
or I/NR mice, despite the identification of virus in the latter two organs of I/R animals.  
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3.3  The effect of stress on viral pathogenecity  
3.3.1 The viral replication of heart-adapted virus in the brain, spleen, thymus, heart and 
skeletal muscle 
We have shown that stress altered the susceptibility of a variety of tissues or organs 
to TMEV infection.  In order to further confirm that the pathogenicity of TMEV could be 
altered by stress, the virus isolated from heart homogenates, designated as heart-adapted 
virus (HAV), of three restrained mice was propagated (as described in Materials and 
methods), collected and injected intracranially into three groups of CBA mice, 
respectively.  The mice were killed at day 1, 3 and 7 p.i., and the organs removed as in the 
previous experiment.  
The three heart-adapted viruses proved to be more infectious to myocardium than 
the original virus.  In other words, they replicated to a higher titer in the heart than 
parental TMEV [F (1,39) = 11.25, p = 0.002].  Furthermore, the percentage of mice with 
evidence of infectious virus in the heart was also increased compared to parental TMEV, 
from 1/14 (7%) to 20/32 (62.5%) overall, as well as at each time point examined, as 
depicted in Figure 4-2A, B and Table 4-1.  The virus was detected as early as day 1 p.i., 
in HAV-infected mice, while not seen until day 7 p.i. in the mice infected with parental 
TMEV.  
 The HAV propagated from 3 mice, noted as HAV-1, 2 and 3, also showed a diverse 
infectivity in myocardium (Table 4-2).  HAV-3 caused heart infection as early as day 1 p.i. 
and this strain of virus was consistently detected at day 3 and 7 p.i., as well as with the 
highest percentage among the three HAV strains.  The other two strains HAV-1 and 2  
were first found at day 3 p.i., and were detectable in only 50% (2/4) of mice at day 7 p.i.   
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Table 4-1  The viral titers in the heart of non-restrained CBA mice infected with 
parental and heart-adapted TMEV 
 
 Heart-adapted TMEV includes 3 strains of virus recovered from three animals, respectively.  Average titer refers 
to the mean titers of all the identified heart-infected mice, and those without detectable virus are not included.  
 
Day 1 p.i. Day 3 p.i. Day 7 p.i.
Parental TMEV Percentage of infected mice 0%  (0/3) 0%  (0/3) 33.3% (1/3)
Average titers (log 10PFU/g) 0 0 3.13
Adapted TMEV Percentage of infected mice 22.2%  (2/9) 100% (9/9) 64.3% (9/14)
Average titers (log 10PFU/g) 0.25 1.78 1.98
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Day 1 p.i. Day 3 p.i. Day 7 p.i.
HAV-1 Percentage of infected mice 0%  (0/3) 100% (3/3) 50% (2/4)
Average titers (log 10PFU/g) 0 1.71 2.07
HAV-2 Percentage of infected mice 0%  (0/3) 100% (3/3) 50% (2/4)
Average titers (log 10PFU/g) 0 1.7 2.01
HAV-3 Percentage of infected mice 66.6% (2/3) 100% (3/3) 83.3% (5/6)
Average titers (log 10PFU/g) 1.13 1.94 1.87
Table 4-2   The comparison of viral titers in the heart of CBA mice infected with  
different strains of heart-adapted virus 
 
HAV-1, 2 and 3 denotes the three strains of virus recovered from the hearts of three infected/restrained mice infected 
with parental TMEV and sacrificed at day 7 post infection.  Average titers are represented by the mean viral titers 
from the mice in which virus was detected in the heart.  
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This finding implied a variation in biological characteristics of HAVs, which may result 
from the stress process and result in the differences in viral clearance in the heart. 
Because of the embryonic and histological homogeneity of skeletal muscle with 
myocardial muscle, we additionally removed the gastrocnemius muscle in order to 
determine if TMEV also displayed infectivity in this muscle.  Interestingly, a very low 
replication of TMEV was seen in gastrocnemius muscle at day 7 p.i. in 6/14 mice, 
confirming the tropism of TMEV also towards skeletal muscle (data not shown).  
 The heart-adapted virus showed no difference in viral titers in the brain, spinal cord, 
spleen and thymus as compared to the parental TMEV strain (data not shown).  To further 
verify that the heart-infected virus was Theiler’s virus, rather than another potential 
cardiovirus, the virus was replicated in L2 cells and proved to be Theiler’s virus by 
radioimmunoassay using anti-Theiler’s antibody (data not shown). 
 
3.3.2 The pathological alterations in the mice infected with heart-adapted TMEV 
We observed no difference in the histopathological changes of the CNS and spleen 
between the HAV-infected and parental TMEV-infected animals.  However, a focal, mild 
inflammation was observed in the heart of HAV infected mice (Figure 4-4E).     
 
4. Discussion 
In the present study, we investigated the effects of RST on TMEV infection in the 
CNS and systemic dissemination throughout the body.  Furthermore, we also examined 
the change in pathogenecity of TMEV that develops following restraint stress. 
 Our data demonstrated the profound effect stress on the dissemination of TMEV.  
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The finding that higher titers of virus were detected in the brain and spinal cord of 
restrained mice suggests that stress impaired and/or delayed the viral clearance from the 
CNS.  However, the delay was not evident until day 7 p.i., presumably because the virus 
replicated in both restrained and non-restrained mice during the first few days of 
infection in the absence of an effective immune response.  However, at 7 days p.i. the 
immune response to TMEV takes effect and begins to reduce viral titers in the non-
restrained mice.  In the restrained mice, the delay in the development of an effective 
immune response, as evidenced by reduction of inflammatory infiltrates into the CNS of 
infected/restraint mice at day 7 p.i., allowing for continued viral replication. These 
findings temporarily correlated with the decreased chemokine expression at day 7 p.i. in 
the CNS resulting from RST (Mi et al., 2004).  
Viral replication occurred in certain lymphoid organs and stressed mice generally 
developed higher viral titers in these tissues. The thymus did not appear to be a 
preferential tissue for replication of TMEV, since virus was not detected in the thymus of 
the non-restrained mice and the majority of the restrained mice (only 2 I/R mice had 
detectable virus in the thymus).  In contrast, the spleen was greatly affected by RST, such 
that increased viral titers were noticed as early as day 3 p.i., which occurred earlier than 
the CNS; but the suppressive effect was attenuated with time, so that most of the 
restrained mice cleared the virus from the spleen by day 7 p.i.  We have previously 
reported that restraint stress resulted in reduced chemokine expression in the spleen 
following at day 2 p.i., which resolved with time (Mi et al., 2004).  Nonetheless, it might 
imply that the glucocorticoid resistance of splenocytes plays a role in restraint stress-
induced immune responses, as seen in social disruption stress (Johnson et al., 2004; Stark 
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et al., 2001; Quan et al., 2003).   
  Morphologically, the thymus responded by a prominent reduction in size while the 
size of the spleen was moderately altered. These results could be explained, at least in 
part, by the fact that the thymus has greater glucocorticoid receptor expression than the 
spleen (Miller et al., 1998), which would result in a greater degree of apoptosis induced 
by glucocorticoids in the thymus (Ahmed and Sriranganathan, 1994; Goya et al., 2003). 
Additionally, thymocytes are primarily immature T cells (CD4+ CD8+ T cells), which are 
more sensitive to glucocorticoid induced by stress (Tarcic et al., 1998); whereas the 
spleen contains fewer immature T cells when compared to the thymus.    
Generally, RST tends to increase viral titers in cervical LN over the seven days of 
infection, despite the fact that comparable virus loads were detected in the cervical LNs 
of both the restrained and non-restrained mice from the individual time point examined; 
while TMEV was found primarily in the mesenteric LNs and lumbar LNs of the 
restrained mice at later times (day 3 and 7 p.i.).  The differential effect of restraint on the 
viral clearance among cervical LNs, mesenteric LNs and lumbar LNs may be associated 
with the route of infection.  Since the virus was first introduced into the brain, TMEV in 
the parenchyma and meninges would drain to the cervical LNs (Bradbury et al., 1981), 
possibly for priming T cells (Weller et al., 1997).  The detection of virus in the lumbar 
and mesenteric LNs at a later time may suggest the dissemination of TMEV from the 
brain to the spinal cord and abdominal organs following stress, which resulted in 
infection of these organs and drainage by lumbar and mesenteric LNs.  
 RST had little effect on the morphology of LNs.  The underlying mechanisms of 
stress on the LNs were not investigated in this study.  It has shown that glucocorticoids 
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influence tissue-specific endothelial cells to interact with immune cells (Chung et al., 
1986) and the expression of lymphocyte adhesion molecules for the entry into LNs, such 
as L selectin (Sackstein and Borenstein, 1995), thereby inhibiting the homing of 
lymphocytes to LNs and subsequent effects on local immunity. 
In addition to the CNS and lymphoid organs, the fact that the widespread 
dissemination of TMEV occurs following stress demonstrates that repeated restraint 
stress increases the susceptibility to systemic viral infection.  
Interestingly, we discovered focal hepatic coagulative necrosis exclusively in 
stressed mice, regardless of infection status.  The pathogenic mechanisms responsible for 
this tissue injury remain unclear.  It was reported that stress, trauma and sleep deprivation 
may enhance translocation of gastrointestinal bacteria to the liver and spleen (Ando et al., 
2000; Ding et al., 2004; Everson and Toth, 2000; Wang et al., 2004).  However, we were 
unable to detect bacteria in the liver of restrained mice using Gram staining and therefore 
other mechanisms may account for the liver lesions. We speculate that the elevation of 
circulating glucocorticoids or tumor-necrosis factor (TNF-), as detected in previous 
studies (Welsh et al., 2004) could result in hepatotoxicity. Additionally, stress-induced 
immunosuppression may impair the barrier which the liver serves for preventing the entry 
of intestinal endotoxin, consequently causing overburden of the liver function.  In support 
of this hypothesis a recent study demonstrated that stress interferes with hepatic lipid 
peroxidation resulting an increase of γ-glutamil transferase (γ-GT) (Correa et al., 2004), a 
marker for liver injury. 
 In terms of infectivity, our data showed that restraint significantly increased parental 
TMEV replication without inducing remarkable lesions in the myocardium.  The absence 
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of lesions may be due to a short time after infection at which the tissues were examined, 
decreased viral virulence and/or different strains of mice used in this study.  Roos et al. 
(1996) found that various degrees of myocardial lesions were detected in different strains 
of mice when intraperitoneally infected with DA virus.  Supporting evidence showed that 
a conspicuous lesion and higher viral load in the myocardium were observed when mice 
were infected with more virulent GDVII or DA derivatives compared to original DA and 
BeAn strains (Rames et al., 1994; Rames, 1995).  
        In the final experiment of the current study, heart-adapted virus isolated from 
stressed mice, when injected via the same route, with the same dosage but without 
restraint, produced an altered pathogenecity that was manifested by an early (day 1 p.i.) 
and higher myocardial infectivity, as compared to those animals infected with the 
parental TMEV.  This alteration in infectivity was accompanied by a mild inflammation 
in the myocardium.       
        The reason for the altered pathogenecity was not examined in the current study, but 
it is believed that multiple factors may contribute to this change.  First, the higher level of 
virus in stressed mice allows the generation of increased numbers of mutant viruses with 
altered pathogenecity. For example, TMEV may be readily mutated on VP1 and VP2 
loops of capsid, resulting in alteration in sialic acid (the receptor for entry of persistent 
Theiler’s virus) binding ability and virulence (Jnaoui et al., 2002; McCright et al., 1999).  
Second, the endocytosis of TMEV is thought to be a receptor-mediated process.  It was 
shown previously that the sialic acid binding receptors on rat macrophage (Gessl et al., 
1989) and sialic acid in HeLa cells (Sinha and Melnykovych, 1972) may be up-regulated 
in response to glucocorticoids.  Thus, the increase in sialic acid expression on the cell 
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surface may facilitate the entry of virus into the cells, and account for the increased 
infectivity following the exposure to elevated glucocorticoids.  Third, Huber et al. (1990) 
discovered that viral receptors expressed in vascular endothelial cells of different organs 
vary in binding activity for the virus.  They documented that Coxackievirus isolated from 
a certain organ of systemically infected animals exhibited preferential infectivity for the 
same type of organ, i.e. the virus recovered from the heart proved to be more infectious to 
the heart than any other organ, suggesting the crucial role of VEC in mediating the virus 
tropism.  These findings could explain that the infectivity in the CNS by either parental or 
adapted TMEV showed no difference.  
  Our results provide evidence for various possible pathways for the dissemination of 
TMEV following intracerebral inoculation.  The nature of progression of viral replication 
in the spinal cord suggests that the dissemination of virus from the inoculated brain to the 
adjacent spinal cord.  This process may help explain the development of TMEV-induced 
disease in which the virus is cleared from the brain and persists in the spinal cord during 
the chronic phase.  Even though the viral load of both tissues were very similar at day 7 
p.i., less severe inflammatory lesions were observed in the spinal cord than in the brain, 
which suggest that the severity of lesion may correlate with not only the viral load, but 
also the duration of exposure to a certain viral load.  The mode of TMEV dissemination 
from the brain to the spinal cord remains uncertain; however, it is most likely via direct 
spread of viral progeny to neighboring neurons (Ha-Lee et al., 1995), and/or astrocytes 
(Aubert and Brahic, 1995) or by via axonal and dendritic transportation (Dal Canto and 
Lipton, 1982; Rodriguez et al., 1983; Stroop et al., 1981).  
  The detection of virus in such vascularized organs as the spleen and the liver, 
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indicate that the hematogenous spread could be another route for the dissemination of 
TMEV which may occur immediately following the intracerebral infection.  It has shown 
that the TMEV can infect and replicate in cerebrovascular endothelial cells (Welsh et al., 
1995; Zurbriggen and Fujinami, 1988), supporting this as a possible mechanism for entry 
into the circulation. In addition, the hematogenous spread of TMEV has been confirmed 
by the isolation of the virus from blood (Borrow, 1989).  Such a viremia may be 
responsible for systemic infection of other organs that include the lungs, heart and 
gastrointestinal tract, as shown in our data.  
        Another potential pathway for viral dissemination is via the lymphatic circulation as 
evidenced by detection of the virus in the lymph nodes.  Viral infection of cervical LNs 
was observed as early as day 1 p.i. (104 PFU/g) suggesting that early infection of 
inflammatory cells from the brain were drained to the local LNs and thereby circulated 
throughout the body via the lymphatic system.  Although the specific manner by which 
virus spreads from and to LNs could not be determined, macrophages have been 
implicated to be a reservoir for TMEV in the late stage of TVID (Clatch et al., 1990; 
Lipton et al., 1995; Rossi et al., 1997).  In spite of these possible pathways of virus spread, 
the dissemination of TMEV may also vary depending on the route of infection (Ha-Lee et 
al., 1995; Gomez et al., 1996). 
 In the present studies, we report that the repeated restraint stress profoundly impacts 
the viral clearance from the CNS and systemic organs during TMEV infection, and alters 
the pathogenicity of this virus.  These profound effects, including the liver injury induced 
by restraint, may explain the exacerbated clinical symptoms and higher mortality in 
stressed and infected animals, which are not common in non-stressed animals.  However, 
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the viral distribution within the diverse tissues and the mechanisms by which the virus 
enters these cells require further investigation.  The fact that stress alters the pathogenesis 
of TMEV infection may have important implications for other disease processes.  Stress 
may render a virus pathogenic for diverse organs and result in novel diseases.  
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V   THE EFFECT OF DURATION OF RESTRAINT STRESS ON THE 
LATE DEMYELINATING DISEASE 
1. Introduction 
Multiple sclerosis (MS) is the most common demyelinating disease of the central 
nervous system (CNS) in humans with a higher incidence in females than in males. The 
causative agents of the MS are unclear; however, several environmental agents, such as 
viruses and stress, have been suggested in the pathogenesis of MS.  The disease is 
characterized by multiple plaques found in the white matter of the CNS, accompanied by 
inflammatory infiltrates in the lesions, an indication of immune-mediated involvement. 
Psychological stress has been reported to influence the clinical course of MS, in 
which the stressors may result in exacerbation of MS symptoms (Ackerman et al., 2002; 
Mohr et al., 2004; Strenge et al., 2001). It appears that the association between stress and 
aggravation of MS is not always consistent in that certain stressors may ameliorate the 
disease. This suggests that the impact of stress on MS may depend upon the type and 
intensity of the stressor (Mohr and Cox, 2001; Nisipeanu and Korczyn; 1993).  The 
underlying mechanism of the effects of different stressors on MS remains unclear. The 
dual role of stress on disease course has been extensively studied in animal models for 
MS, such as Experimental Allergic Encephalitis (EAE).  
EAE is induced by the injection of myelin components or CNS homogenates in 
complete Freund’s adjuvant into mice or rats to produce demyelination. If the animals are 
then subjected to repeated or prolonged restraint stress prior to challenge of myelin basic 
protein (MBP), it has been demonstrated that a decreased incidence and severity of the 
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disease in rats and mice (Levine et al., 1962; Whitacre et al., 1998). Whitacre et al. (1998) 
also reported that one hour of restraint per day exacerbated the clinical symptoms of EAE, 
rather than suppression as observed by nine hours of restraint stress.  Acute pre-stressed 
mice displayed an early onset of EAE (Chandler et al., 2002). The bidirectional 
regulation of stress was also documented in experimental arthritis, in which chronic 
intermittent noise suppressed the severity of bradykinin-induced adjuvant-arthritis 
(Strausbaugh et al., 2003), whereas a one-hour noise stress per day prior to type II 
collagen immunization aggravated arthritis (Rogers et al., 1983).  
The differential immune and neuroendocrine responses following various stress 
exposures have been studied and well-defined by Dhabhar and McEwen (1997). They 
proposed a bidirectional effect on the immune system by a differential type of stressor, 
which is based on the duration, intensity of stressor and perception of the stress by the 
subject. An acute stressor, which is short-term lasting for minutes to hours, allows for the 
adjustment and adaptation of the organism to a changed situation, known as “eustress” 
and results in immune-enhancement; whereas chronic stressor, which is long-term and 
lasts for days to months, ultimately leads to maladaptive and pathological processes, 
know as distress and is thought to be immunosuppressive. They also demonstrated an 
enhanced skin delayed type hypersensitivity (DTH) following acute stress and a reduced 
cutaneous DTH in response to chronic stress. The enhancement of DTH response 
following acute stress was due to an alteration in leukocyte trafficking to the skin (Bilbo 
et al., 2002; Dhabhar and McEwen, 1997).  Other authors have reported that an acute 
stress increased the immunoglobulin (Ig) response following immunization of sheep red 
blood cell, while a prolonged stress suppressed the antibody response (Millan et al., 1996; 
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Silberman et al., 2003; Zalcman and Anisman, 1993).  Furthermore, mitogen-induced T 
cell proliferation was increased by acute stress (Bauer et al., 2001) but decreased by 
chronic stress (Silberman et al., 2002).  
It appears that the duration of stress is an important index in defining acute and 
chronic stress. It is well established that activation of the hypothalamus-pituitary-adrenal 
(HPA) axis and sympathetic nervous system (SNS) mediates the stress-induced immune 
response through the release of glucocorticoids (GC), epinephrine and norepinephrine 
from the two axes. Other stress hormones, such as corticotropin releasing hormones 
(CRH), adrenocorticotropic hormone (ACTH), opiates and prolactin, are secreted in a 
sequential, ordered pattern in response to stress. Each hormone has its own kinetics, thus 
indicating that differential effects of acute and chronic stress may reflect a temporally 
combined effect of all the stress hormones (Sapolsky et al., 2000). In addition, GC 
display a dual action: a modulating action, to produce a stress response; and a preparative 
action, to set up a response to the subsequent stressor and develop an adaptation (for 
review, see Sapolsky et al., 2000). Furthermore, the role in pharmacological manipulation 
of GC for immunosuppressive therapy differs from the physiological function of 
endogenous GC, which suggests the complexity of the function of GC.  It is also 
proposed that an animal mounts a rapid response (immunostimulating) to an acute 
stressor; however, if this response is not shut-off in a timely manner, for example, 
following exposure to a chronic stressor, a high “allostatic load” will eventually “wear 
and tear” the system, resulting in immunosuppression (Dhabhar, 2003).  The underlying 
mechanisms mediating the acute and chronic stress remain to be elucidated.  
Epidemiological data revealed a gender effect in MS, in which MS affects females 
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more frequently than males. It is conceivable that sex hormones such as estrogen and 
progesterone may play a role in this disease. Pregnancy, especially in the third trimester, 
appears to be associated with a lower disease rate and less severe relapses. Such a 
protective effect on MS course during pregnancy is thought to be related to high estrogen 
levels; whereas the exacerbation of MS is observed during postpartum and the menstrual 
cycle when estrogen levels are low (Pozzilli et al., 1999; Salemi et al., 2004).  The gender 
difference was also documented in the mouse EAE model, in which females exhibit a 
greater susceptibility to CNS lesions (Teuscher et al., 2004). The therapeutic effect of 
estrogen through estrogen receptors in male EAE (Palaszynski et al., 2004a), as well as 
the protective role of androgens in EAE (Palaszynski et al., 2004b) implies the 
relationship between sex hormones and the immune system. However, the gender effect 
in the induction of demyelination is dependent on both the antigens used for 
immunization and the genetics of mouse (Okuda et al., 2002). The association of a stress 
and a gender effect in EAE has been reported previously. For example, female rats are 
protected from the acute and stress-induced exacerbation of EAE, which was not seen in 
male rats; the disease was further suppressed in female rats than males following chronic 
stress (Whitacre et al., 1998).  
The present series of experiments were designed to investigate the role of acute or 
chronic stress on the pathogenesis of MS using a Theiler’s virus induced demyelination 
model for MS. Intracerebral inoculation of Theiler’s virus in susceptible strain of mice 
causes an acute encephalitis during the first two week p.i., and a chronic progressive 
demyelination detected about four weeks p.i. (Lipton, 1975). The persistent viral 
infection in the CNS is critical for the development of demyelination, which is mediated 
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by myelin-specific autoreactive CD4+ T cells via epitope spreading (Miller et al., 1997; 
Welsh et al., 1989). We have previously shown that a chronic restraint stress markedly 
suppresses natural killer cell activity (Welsh et al., 2004), chemokine (Mi et al., 2004) 
and specifically pro-inflammatory cytokine expression (Mi et al., manuscript in 
preparation), resulting in impaired viral clearance in the CNS (Mi et al., submitted) and 
exacerbation of subsequent demyelination (Sieve et al., 2004).  Due to the potential 
immunoenhancing role of acute stress, we hypothesize that the exposure of mice to a 2 
hour session of acute restraint prior to the viral inoculation will augment the antiviral 
immunity in the early infection, thus causing an enhanced viral clearance. Consequently 
following acute restraint stress, there should be an improvement in the late demyelination 
as compared to either non-restrained or chronically restrained mice. Additionally, the 
effects of stress were examined in both female and male mice, so as to determine the 
effects of both gender and stress in Theiler’s virus-induced demyelination (TVID).   
 
2. Materials and methods 
2.1 Subjects 
SJL/J mice were bred in the animal facility at Texas A&M University using breeding 
pairs obtained from Charles River laboratory (Boston, Massachusetts). Mice were 
maintained under a pathogen-free environment in a 12:12 light/dark cycle (lights on from 
6:00 am to 6:00 pm). At three weeks of age, male pups and female pups were housed in 
separate rooms.  Mice were allowed to acclimate to such conditions for one week prior to 
any experimental manipulations.  
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2.2 Infection 
The BeAn strain of TMEV (kindly provided by Dr. H. L. Lipton, Department of 
Neurology, University of Chicago, Evanston, IL) was propagated and titrated on L2 cells 
by a standard plaque assay and stored at -80oC (Welsh et al., 1987).  7x104 PFU BeAn 
virus in 20l inoculum was injected intracranially into the right cerebral hemisphere of 
mice at 4-weeks of age.  Mice in non-infected groups were sham-infected with 20l 
sterile phosphate-buffered saline (PBS).   
 
2.3 Restraint stress paradigm 
Mice were physically restrained in a 60 ml polypropylene syringe with perforated 
ventilation holes of 0.4 cm diameter.  Mice were either acutely restrained for a single 
session of 2 h (5am-7am) or chronically restrained for 8 h (12:00 am-8:00 am), for five 
consecutive nights per week, with two nights off in between weeks, for a total duration of 
four weeks.  The viral inoculation occurred 15 minutes following release from the 
restraint tube for the acute restrained mice or 2 h after the first session of chronic restraint 
for the chronically stressed mice (Campbell et al., 2001; Dhabhar and McEwen, 1997; 
Sheridan et al., 1991). 
 
2.4 Clinical scoring 
Clinical symptoms were evaluated according to a numerical score for signs of 
demyelination and paralysis as described previously (Borrow et al., 1998; Sieve et al., 
2004): 0 = no behavioral impairment, 1 = weakness in hind limbs, 2 = slightly wobbly 
gait, 3 = definitely wobbly gait, 4 = very wobbly gait, hunched posture, and loss of 
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righting reflex, 5 = all of the signs mentioned above, and incontinence, 6 = moribund.    
 
2.5 Footprint analysis 
Footprint stride and spread has been reported as a sensitive indicator of neurological 
deficits caused by demyelination or axonal loss in mice (Johnson et al., 2004; McGavern 
et al., 1999; McGavern et al., 2000).   Briefly, the forelimb and hindlimb paws of mice 
were painted with red and blue nontoxic paint and the mice walked along a 2.5 by 3.6 
inch runway lined with white paper. A minimum of eight forelimb and eight hindlimb 
paw prints per mouse were used for the three spreads and three strides measurement.  
 
2.6 Corticosterone assay  
Mice were bled from the saphaneous vein between 7:30am- 9:30 am, immediately 
after releasing from the restraint tubes at various times throughout the course of the 
experiment.  The bleeding procedure has been described elsewhere (Johnson et al., 2004, 
Sieve et al., 2004).  Plasma samples were obtained by centrifugation and separation, and 
then were stored at –800C until assayed. Plasma corticosterone (CORT) level was 
determined by radioimmunoassay (RIA) using a 125I-RIA kit (ICN Biomedicals, Costa 
Mesa, CA).  
 
2.7 The determination of antibody to Theiler’s virus and myelin proteins  
The plasma antibodies against Theiler’s virus, myelin basic protein (MBP), myelin 
oligodendrocyte glycoprotein peptide (MOG33-35) and proteolipid protein peptide (PLP139-
151) were measured using a RIA, as described previously (Dolimbek et al., 2002; Sieve et 
  
138
al., 2004; Young et al., 1983). The assay was developed using radiolabeled protein-A 
which binds to the Fc portion of immunoglobulin.  
Briefly, a flexible u-shaped, 96-well polyvinyl chloride plate (Costar, Cambridge, 
MA) was initially washed with PBS/Tween-20 (0.05% v/v) and water purified by reverse 
osmosis (RO H2O).  The plate was coated with 100 µl of carbonate buffer (pH 9.6) 
containing Theiler's virus (1.0×107 p.f.u./100 l) for anti-TMEV antibody determination. 
For assessment of MBP, MOG and PLP peptides, 100 l assay buffer (made up from two 
parts: 495 ml of part A:  0.08M Trizma HCl, 0.03M Trizma base and 0.15M NaCl at a 
final pH of 7.2,  and 5 ml of part B:  1.0% NFDM and 0.5% Tween-20 in RO H2O) 
containing 1.0 g of either MBP (from bovine; Sigma, Saint Louis, MO 63103 USA), 
MOG 33-55 (Sigma), or PLP 139-151 (AnaSpec, California) was added to the wells.  The 
plates were incubated at 4°C for 24 hours and then washed as described above.  The plate 
was blocked with 3.0% non-fat dry milk (NFDM) in PBS (pH 9.0) for one hour at 37°C.  
After washing, either a positive control rabbit serum (generated by 3 serial injections of 
UV inactivated BeAn strain of Theiler’s virus into a rabbit), or goat polyclonal IgG anti-
MBP and goat polyclonal IgG anti-MOG antiserum (Santa Cruz Biotechnology, 
California) or an anti-goat negative control serum from rabbit (Sigma, Saint Louis 
Missouri, USA) were diluted 1/20 in assay buffer and added to the wells (100 µL total 
volume). Doubling dilutions of antiserum were carried out until a final dilution of 1/640 
was achieved.   
Following the serial dilutions, the plate was then incubated for one hour at 37°C 
before washing the plate and rinsing again (as previously described).  Then, a polyclonal 
goat anti-rabbit (Sigma, Saint Louis, Missouri, USA) antibody was diluted 1/500 in assay 
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buffer, and 100 µl was added to every well.  After incubating at 37°C for one hour and a 
subsequent washing, 100 µl of 125I-Protein A (1 x 105 cpm/100 µl assay buffer) was 
added to each well, and the plate was incubated at room temperature for one hour.  The 
plate was then washed and rinsed with PBS/Tween-20 and RO water (as described above).  
Once the plate was dry, every well was cut out, put into tubes and counts were 
determined by using a gamma counter (Beckman gamma 5500 counting system). 
 
2.8 Histological examination 
Mice were sacrificed by the i.p. injection of pentobarbital at day 220 p.i. and 
perfused with PBS into the right ventricle of the heart. Left or right hemisphere of the 
brain, and coronal sections of the spinal cord were alternatively collected for either viral 
titration or microscopic examination. The thymus, spleen, heart, liver, adrenals, sciatic 
nerve and gastrocnemius muscle were aseptically removed for histological analysis.  
The tissues for histological examination were fixed in 10% formalin, embedded, 
sectioned and stained with hematoxylin & eosin (H&E) for microscopic examination of 
lesions. For further evaluation of demyelination and inflammation, spinal cords were 
stained with Weil’s myelin staining and Holmes staining respectively. B cells, T cells, 
macrophages and astrocytes were stained for analysis of the cellular phenotype during 
demyelination using an immunochemistry.  
The loss myelin sheath was demonstrated by Weil’s staining.  Briefly, a 10-15m 
paraffin section of spinal cord was deparaffinized and immersed in 5% celloidin for 
immobilization of the section on slides. After washing the section with distilled water, the 
stained with 4% iron aluminum (ferric ammonium sulfate, FeNH4(SO4)2-12H2O) and 1% 
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hematoxylin at 50-600C, for 40 min, followed by rinses with tap water.  Then the section 
was placed in 4% iron aluminum until the gray matter or degenerated area can be 
differentiated and was washed well in several changes of water.  For complete 
differentiation, the section was stained with Weigert’s borax ferricyanide solution [2g 
sodium borate (Na2B4O7-10H2O) and 2.5 g potassium ferricyanide (K3Fe(CNO6) in 200 
ml distilled water] for 3 min, followed by washes with distilled water and tap water.  Next, 
the slide was placed in 0.5% lithium carbonate for 1 min. After several rinses with water 
and dehydrated, the slides was ready for microscopic examination.   
 
2.9 Determination of viral titers  
The remaining brain and spinal cord were weighed and homogenized in Dulbecco’s 
Modified Eagle Medium (DMEM, Invitrogen Corporation, USA).  Cellular debris was 
removed by centrifugation and the titer of virus in the supernatant was determined by 
standard plaque assays on L2 cells.   
 
2.10 Experimental design 
A 2 (infected vs. non-infected) by 3 (acute restraint, chronic restraint and non-
restraint) by 2 (male vs. female) factorial design, 5-15 mice per cell, was applied in this 
study. Baseline footprint and plasma corticosterone were measured. To monitor the 
alteration in clinical manifestation following TMEV infection and restraint stress, clinical 
scoring was assessed weekly, and footprint measurement was performed every 10 days in 
the first month postinfection, twice in the second month and monthly thereafter during 
chronic disease. Mice were sacrificed at day 220 p.i. when most infected animals 
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developed clinically marked paralysis.  
 
2.11 Statistical analysis 
Analyses of variance (ANOVA) were conducted on the data for the three variables 
restraint, infection and gender. Duncan’s multiple range tests and means comparisons 
were used for post hoc analyses. A p value of 0.05 or less was considered significant in 
all cases. 
 
3. Results 
3.1 Clinical scoring of signs of neurological impairment  
As depicted in Figure 5-1, the main effects of infection, RST and day p.i. on clinical 
signs were observed, all Fs > 15.714, ps < 0.0001. There were also interactions of 
infection and stress, day post infection and infection, day post infection and stress, as 
well as interactions among day post infection, infection and stress, all Fs > 4.36, ps < 
0.0001, wherein restraint stress exacerbated clinical symptoms in infected mice; 
furthermore, the degree of exacerbation was increased over time. Clinical symptoms 
appeared earlier in chronically stressed mice as compared to non-stressed animals; 
whereas the onset was delayed in the 2-hours acutely stressed mice. However, the 
progression in severity of clinical sign appeared to be converging during the later stage of 
disease.  No gender difference in clinical signs by stress was observed.  Additionally, 
there was a progressive, wavelike trend in the clinical signs, particularly in the 
infected/non-restrained mice, which may suggest a relapsing-remitting disease process.  
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Figure 5-1.  Clinical score following infection and various duration of restraint stress 
during the course of TVID. 
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3.2 Stride length 
As shown in Figure 5-2, using baseline as a covariate, there was a main effect of 
infection, (F = 29.29, p = 0.0001) and restraint stress (F = 6.822, p = 0.0023) on stride 
length. The interaction of day p.i. by infection on stride length was qualified by ANOVA 
(F = 3.973, p = 0.002), such that the stride length was reduced with time in infected mice.  
The effects of the variables, infection, restraint and gender on stride length at 
individual time points by ANOVA showed that a reduction in stride length in all infected, 
as compared to non-infected, mice was first detected at day 45 p.i., F (1, 50) = 4.735, p = 
0.03, and that this reduction was not further observed until at day 120 p.i. and remained 
up to day 220 p.i. at the time of sacrifice, all Fs (1, 39) > 3.965, ps < 0.05.  A main effect 
of stress was found at day 20 p.i., wherein chronic stressed mice, independent of infection, 
displayed a decreased stride length, F (2,46) = 17.339, p = 0.0001. This may be due to 
that, at day 20 p.i., the mice were in the last session of chronic stress period, which 
started from day –1 p.i. up to day 24 p.i., suggesting that long and repeated stress may 
impact motor function. However, this effect may disappear with the termination of stress 
session, so that the stress effect was not observed at day 30 p.i., which was the sixth day 
after the end of stress.  At day 45 p.i., all stressed mice showed a decreased stride length 
as compared to the nonstressed mice, F (2,50) = 11.548, p = 0.0001.  
ANOVA also revealed an infection by restraint stress interaction on stride at day 195 
and 220 p.i., all Fs > 4.322, ps < 0.04.  Post hoc analysis confirmed the varying effect of 
acute and chronic restraint stress on stride length in infected animals, such that a 
descending order in hind limb stride length was seen in non-restrained, acute restrained 
and chronic restrained mice, respectively, indicating an impact of various duration of 
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restraint stress on the impairment of motor function.  This trend was also noted as early 
as day 30 and 60 p.i., but failed to reach significance. No gender effect and other 
interactions of these variables were identified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2.  Footprint of hind limb stride length following infection and restraint stress. 
The data was derived from 8 footprints per mouse, and are represented by mean + S.E.M. 
n=10-16 mice for each experimental condition. BL: baseline, was measured 2-3 days 
prior to infection or restraint was applied. 
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3.3 Plasma CORT levels 
A “main effect” of infection and stress on the baseline level of plasma CORT 
collected from the mice at 3 days prior to infection.  This could be a sample error, since 
neither infection nor stress was applied to the animals at the time of bleeding.  The 
plasma CORT after the first session, either acute (2 h) or chronic stress (8 h), and before 
infection, was assayed to examine the impact of the various restraint stress sessions on its 
secretion. ANOVA showed a main effect of stress on CORT level, wherein 8 hr restraint 
resulted in significantly higher plasma CORT (13-fold increase) than 2 h restraint (2.5-
fold increase) (Figure 5-3A).  As depicted in Figure 5-3B, a main effect of gender was 
found on CORT level, such that females always produce a higher CORT than males (F = 
6.916, p = 0.015), but the difference was not significant at baseline, F (1,16) = 2.753, p = 
0.1.  An interaction of restraint by gender revealed by ANOVA suggested that females 
had a higher CORT response to restraint than males, all Fs (1,16) >6.816, ps < 0.019 
(Figure 5-3B).  In addition, the CORT level was also measured at day 7 p.i. (acute 
restraint had ended 7 days previously), and it declined to the  baseline level as compared 
to controls (F = 2.651, p = 0.11) (data not shown). No effect of infection on CORT was 
found.   
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Figure 5-3.   The effects of various duration of restraint stress and gender on plasma 
CORT response.  (A) Plasma CORT level in response to acute (2 h) or chronic restrained 
(8h) in female and male mice (B). BL, baseline CORT was measured 3 days prior 
restraint was applied. The blood was sampled after the 2 h restraint or the first 8 h session 
and the level was determined using RIA assay. * indicated p<0.01. 
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3.4 Antibody measurement 
In all the infected groups (I/NR, I/AR, I/CR), there was a main effect of stress on 
anti-TMEV antibody production, such that a higher antibody level was detected in non-
restrained than either acute or chronic restrained mice. The differences in antibody 
production were observed at days 28 and 220 p.i., all Fs > 3.438, ps < 0.046. Post hoc 
analysis found no difference in antibody level between acutely and chronically restrained 
mice throughout the course of disease (Figure 5-4). Considering that the bleeding 
procedure might be a further stressor to the chronic restrained mice, the I/CR mice were 
bled biweekly, rather than weekly during the first month post infection, so that the data at 
day 7 and day 21 p.i. included only I/NR and I/AR mice. ANOVA confirmed the same 
effect of stress in that the 2 h restraint suppressed the anti-TMEV production, all Fs > 
7.136, ps < 0.032 (data not shown).  No gender effect was seen in the TMEV antibody 
response.  
Terminal bleeds were assayed for antibody against myelin components. A very low 
level of antibodies against MBP, MOG33-35 or PLP139-151 peptides was detected at day 220 
p.i. in any groups of animals and no effect of stress was found, all ps > 0.05.  However, a 
main effect of gender on MBP antibody production was revealed by ANOVA such that 
females had a higher MBP antibody than males, F (1,28) = 7.393, p = 0.011. Furthermore, 
a decrease of MBP antibody was noticed in female chronic restrained (I/CR) mice as 
compared to non-restrained (I/NR) using Duncan’s new multiple range test, p < 0.05 
(data not shown).  Very interestingly, a main effect of infection on PLP139-151 antibody 
was discovered with a surprisingly elevated PLP139-151 antibody in non-infected mice [F 
(91,46) = 7.013, p = 0.011], which was markedly increased in chronically restrained 
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(NI/CR) mice.  No other effects on the MBP, MOG33-35 or PLP139-151 antibody response 
was observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-4. Anti-TMEV antibody response during the course of TVID. The data were 
derived from 10-15 mice per experimental condition. The values were 1/40 dilution and 
represented by mean + S.E.M.  
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3.5. Microscopic examination 
The spinal cord lesions were first examined by H&E staining. As seen in Table 5-1, 
there was a higher incidence of demyelination in chronically restrained mice (37.5%) 
than acutely restrained (20%) or non-restrained mice (12.5%). The lesions primarily 
involved the white matter in the thoracic spinal cord, and cervical spinal cord to a lesser 
extent, but rarely detected in the lower lumbar section. As shown in Figure 5-5 A, B, C, 
demyelination occurred mainly in lateral column, ventral lateral column and ventral area; 
however, dorsal area (gracile fasciculus and cuneate fasciculus) was not involved.  The 
chronic restrained mice demonstrated the maximum percentage of demyelination, 
followed by acutely restrained, and the non-restrained mice displayed the minimum 
percentage of demyelination among the three groups (Table 5-1)  The lesion in non-
restrained and acutely restrained mice is characterized by loss of myelin sheaths in the 
white matter of spinal cord, as revealed by Weil’s staining (Figure 5-5B). A prominent 
inflammation manifested by meningitis, cuffs, and increased inflammatory cellularity in 
the demyelinating areas (Figure 5-5A). Axons in these areas are usually preserved. The 
chronically restrained mice exhibited minimal inflammation, accompanied by axonal loss 
in some animals (Figure 5-5D and E), suggesting more severe myelin damage by chronic 
restraint; whereas the lack of inflammatory cells in these mice may indicate a later stage 
of demyelination observed at sacrifice in this study. (NOTE: more slides of Holmes stain 
and immunochemistry for cell phenotype in demyelination are pending). 
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Figure 5-5.   Histopathology of demyelination in the spinal cord of SJL/J mice at the late 
TVID (day 220 p.i.).  (A) A representative section by H&E staining showed demyelination 
(marked by black line), meningitis (black arrow), perivascular cuffings (opened arrow), and 
inflammation in the demyelination area (*) (4X).   (B)  A serial section from the same mouse 
above confirmed demyelination, as indicated in the red line marked area, using Weil’s myelin 
staining (4X). The demyelinated area should stain black as is illustrated in the normal white 
matter in the opposite side of the section.  (C) A serial section of spinal cord by Holmes 
staining showing preserved axon (4X).  
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Figure 5-5. Continued.  (D) A representative section of spinal cord of a chronically restrained 
mouse displays axonal loss, as indicated in the boxed area, but with few inflammatory 
infiltrates (4X).  (E) A magnification (20X) showed loss of axon (blue arrow) in the spinal 
cord.  (F) A section from the same mouse as E illustrated showing intact axon (blue arrow) 
(20X).   
 
 
 
 
 
 
 
                    Table 5-1   Histological assessment of spinal cord during chronic demyelination
Non-restrained Acute restrained Chronic restrained
Incidence of demyelination 12.5% (1/8) 20% (4/20) 37.5% (3/8)
Percentage of demyelination 17.70% 27.30% 46.50%
Axonal loss (-) (-) (+)
Note: percentage of demyelination was caculated by the ratio of the area of demyelination against 
the area of white matter in the same section. The value was derived from the average of the sections in which 
demyelination was observed.  
D E 
F 
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4. Discussion 
The present investigation was designed to study the impact of the duration of stress 
on demyelination in Theiler’s virus infection in mice as an animal model for human MS.  
We showed that RST applied during early infection appeared to exacerbate the clinical 
neurological impairment in the chronic disease, as indicated by clinical scores, walking 
stride length and incidence of demyelination. Repeat chronic restraint (4 weeks of 8 h 
session) exhibited the most profound impact on the clinical signs, which replicated our 
previous findings (Sieve et al., 2004); whereas 2 h acute restraint displayed an 
intermediate effect in worsening the symptoms.   
The influence of stress on MS has been studied in another model for MS, namely the 
EAE model.  It has been reported that the disease course may be altered by various 
stressors, and the outcome of disease is determined by the timing of the stress exposure. 
For example, restraint stress prior to immunization delayed the onset and severity of EAE 
in B10.PL mice (Dowdell et al., 1999), and in Lewis rats (Griffin et al., 1993). A 
combination of various stressors (swim, odor, crowding, restraint stress, etc) in rats prior 
to EAE induction attenuated the disease, but no such a protection was seen if given after 
the immune induction of disease (Correa et al., 1998).   
In EAE, it has been shown that chronic pre-stress resulted in inhibition of antigen 
processing (Griffin et. al., 1993), decrease in proliferation of lymphocytes (Correa et al., 
1998) and interleukin-2, which may be responsible for or be an indication of limited 
clonal expansion of autoreactive T cells (Griffin et. al., 1993). It has also been 
demonstrated that the protective effect of RST is more profound when restraint stress was 
imposed on animals during the expansion period of autoreactive T cells. Yet no 
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suppression was noted if RST was administrated after the relapse of EAE, when the T 
cells were already expanded (Whitacre et al., 1998). The net effect of stress on immune 
function is largely determined by the timing at which the stress was introduced and the 
stage at which the immune response has developed against the antigen.  
An aggravation, not an attenuation as seen in EAE, in the disease severity was found 
in the Theiler’s virus model when RST was applied during early infection.  The induction 
of EAE (as indicated by paralysis) takes much a shorter time (about 10 days) than 
demyelination induced in the TVID model, which usually requires months and occurs in 
the chronic stage of disease. In TVID, the first phase of the immune response targets 
TMEV, which produces virus-specific T cell against viral peptides (VP) and lasts 
throughout the course of disease.  The second immune response, epitope spreading, 
occurs possibly due to bystander damage of TMEV-infected oligodendrocytes and results 
in releasing of endogenous autoneuroantigen and generation of myelin-specific T cells, 
which are responsible for the propagation of demyelination. The antimyelin T cells are 
generated after the second month post infection in a sequential order (Tompkins et al., 
2002).  We previously reported that RST produces a profound immunosuppression and 
consequently an impaired viral clearance (Campbell et al., 2001; Mi et al., 2004, Welsh et 
al., 2004). In the present chronic stress paradigm, 4 week RST appeared to temporally 
suppress the immune response to virus infection and may not impact the antimyelin 
response which usually initiated 2 months p.i. However, increased viral load by chronic 
restraint stress may hasten the subsequent epitope spreading and lead to an earlier onset, 
higher incidence of demyelination and more severe disease in this study.   
The results demonstrated that acute RST (2 h) initially delayed the onset, and then 
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the disease progressed as a similar rate as the non-restrained mice (after week 18 p.i.), but 
exhibited a similar degree of disease severity with all the other two groups. (Figure 5-1 
and 5-2).  The higher incidence of demyelination (Table 5-1) further suggested that the 2 
h RST exerted an exacerbating effect on the disease, but at a lesser degree than that of the 
chronic RST.  The data were at variance with others which reported an immunoenhancing 
effect of acute stress (Bilbo et al., 2002; Dhabhar and McEwen, 1997), which would be 
expected to result in a more efficient viral clearance and consequently an attenuated 
demyelination.  Acute stress has been reported to result in leukocyte redistribution from 
the circulation to the skin, lymph nodes, lungs, liver and bone marrow, so as to establish 
local immunity, for example, an enhanced DTH response (Dhabhar, 2002, 2003; Dhabhar 
and McEwen, 1997).  The increase in cell trafficking to those organs may lead to a 
reduction of leukocytes entering the CNS.  It may also be argued that acute stress 
increases the permeability of blood-brain-barrier (BBB) by mast cell degranulation 
(Esposito et al., 2001), resulting in an influx of leukocytes into the brain.  However, due 
to the distribution of mast cells in the brain, those areas, such as the diencephalons, 
cerebellum and brain stem, which have a greater number of mast cells, showed an 
increased permeability following stress; whereas the cortex, the site for virus injection, 
only showed a minimal change (Esposito et al., 2001).  We speculate that the 2 h session 
RST may have an overall suppressive effect similarly as with chronic RST, but to a lesser 
degree.  This interpretation of our results is indeed supported by other studies showing 
that either acute 15-min RST (Goujon et al., 1995), 15 min swim stress (Connor et al., 
2005) or foot shock (Meltzer et al., 2004) inhibit lipopolysaccharide (LPS)-induced 
proinflammatory cytokines production. These results taken together indicate that the 
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intensity, duration, and the experimental animals are key factors in determining the 
effects of stress.   
The stress hormones are believed to contribute to the bidirectional effect of stress. In 
this study, we measured the CORT level immediately after the cessation of 2 h restraint 
stress of acute restraint and the first 8 h of chronic restraint sessions. 8 h restraint stress 
results in a greater elevation (13 fold) than 2 h RST (2.5 fold) over baseline CORT level. 
We have shown that the CORT level remained elevated until the cessations of RST, 
indicating that the chronically restrained mice were repeatedly exposed to high CORT 
levels, even though there was a decrease in CORT during last two weeks of the 4-week 
periods of RST (Sieve et al., 2004).  The immunosuppression as a result of long-term 
elevated CORT exposure can be explained by the inhibitive functions of glucocorticoid, 
including antigen presentation, T and B cell activation, proliferation, cell trafficking and 
proinflammatory cytokine production (Sapolsky et al., 2000).  Brief and low-doses of 
CORT treatment, rather than long or high-doses of CORT can enhance skin DTH 
response (Dhabhar and McEwen, 1999), suggesting the duration and dosage of CORT 
determines its effect.  It has been reported that plasma CORT levels peaked at 30 minutes 
following RST and deceased but remained at levels greater than the baseline when the 2 h 
RST ended.  Subsequently, within 3 hours after the cessation of restraint stress, CORT 
levels returned to baseline or below baseline, and were accompanied by a reversal of the 
decrease in number of blood leukocytes (Dhabhar et al., 1994).  In our model, was the 
CORT level during acute RST in the range that caused immunoenhancement? Or was the 
duration of exposure to the elevated CORT levels (before it dropped below baseline) 
appropriate for promoting the immune function?  The questions remain to be answered. 
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Other groups have reported that plasma catecholamines (epinephrine and norepinephrine) 
were increased by the end of 2 h RST, and were reduced to baseline within 2 hours 
(Kanemi et al., 2005). This elevation was also observed in the first 2 weeks of chronic 
stress (Silberman et al., 2003), which lasted for a shorter time frame than the CORT 
response, indicating that the SNS axis contributes more to the immune regulation in the 
acute stress than in chronic stress response. This concept is supported by the finding that 
an increased susceptibility to Listeria monocytogenes was observed following a 
combination of acute cold and restraint stress, which was mediated by β1-adrenaergic 
receptors (Cao et al., 2003).  Meltzer et al. (2004) found that stress-induced 
immunosuppression seemed to be mediated by both HPA and SNS axes.  Moreover, other 
stress hormones, ACTH (Conti et al., 2000), CRH (Elenkov et al., 1999) and prolactin 
(Matalka, 2003) are additionally implicated in this complicated stress response. 
The histopathology confirmed the finding that the maximal aggravating effect of 
chronic restraint stress on the demyelination, such that axonal loss was observed, and a 
notable demyelination with prominent inflammation in acutely stressed mice, and 
minimal lesions were noted in the non-restrained mice. The scarcity of inflammatory cells 
in chronic restrained mice suggest a later stage of demyelination at day 220 p.i., at which 
time the inflammatory cells may have damaged the myelin and axon and exit the spinal 
cord.  In fact, our laboratory recorded an increased cellularity and inflammation in the 
chronically restrained mice at day 127 p.i. as compared to non-restrained mice (Sieve et 
al., 2004). Taken together with the current study, we observed a dynamic progression of 
demyelination. However, a lower incidence of demyelination was noted in this study, 
which is possibly due to the fact that the mice used were bred in our animal facility and 
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had not been subjected to transport stress. 
The suppressive effects of both the acute and chronic stress on the humoral response 
were demonstrated by a strikingly decreased anti-TMEV antibody production throughout 
the course of disease.  The serum antibody was detected as early at day 7 p.i. (data not 
shown), and remained at a relatively high level throughout the disease. Whilst the 
restrained animals only displayed baseline levels of TMEV antibody.  A significantly 
higher anti-TMEV IgG was noted at day 28 and day 220 p.i., indicating stress impacted 
the humoral response in both the phases of acute and chronic disease.  We observed a 
minimal level of serum antibody against MBP at day 220 p.i., with a slightly but not 
statisticall higher level, in non-restrained/infected than either acute or chronic 
restrained/infected mice.  At this time point, no PLP139-151 or MOG33-35 antibody was 
detected in the serum of any mice.  The detection of serum autoantibody to MBP and the 
myelin membrane during the chronic phase was previously reported (Rauch et al., 1987; 
Sieve et al., 2004; Welsh et al., 1987).  However, the humoral immune response plays a 
major role in viral clearance during the acute disease (Rossi et al., 1991), and only a 
minor role during the chronic demyelination, but an ameliorating effect was suggested 
(Rodriguez et al., 1988).   
Very interestingly, two chronic restrained, uninfected and one acute restrained, 
uninfected mice developed increased anti-MBP antibody in the serum at day 220 p.i..  A 
recent study described a possible scenario for the pathogenesis of autoimmune disease in 
the NOD model of diabetes. It has been shown that mice present with lymphopenia and 
the remaining T cells undergo vigorous compensatory proliferation of autoreactive T cells 
to islet cells (King et al., 2004). Our previous study recorded lymphopenia in stressed 
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mice (Campbell et al., 2001); therefore we speculate that restraint stress-induced 
lymphopenia provides the environment necessary for the homeostatic expansion of 
autoreactive T cells.  Autoantibodies to myelin have also been detected in normal human 
subjects (Johnson et al., 1986).  However, the fact that these animals in our study did not 
develop demyelinating disease may suggest a more complex explanation for this 
phenomena which would include the underlying increase in autoreactivity that occurs as a 
result of the homeostatic expansion of autoreactive T cells, but the fact that they have 
pre-existing autoantibodies may render them more susceptible to autoimmune disease.   
Like the gender effect in MS, there is a gender preference in female mice for 
developing Theiler’s virus induced demyelination but a rapid deterioration in disease 
severity is noted in males (Alley et al., 2003; Hill et al., 1998). We found a higher 
incidence of demyelination in males than females in this study.  However, the overall 
incidence of demyelination is low in this study, the gender effect on demyelination may 
be biased by the small number of animals.  The gender variance can also be attributed to 
genetic predisposition (Butterfield et al., 2003). Estrogen has been shown to have a 
protective effect in EAE (reviewed by Offner, 2004), but the role of estrogens in TVID 
and stress require further investigation. 
In conclusion, acute or chronic restraint stress of mice during early infection, 
resulted in an exacerbation of demyelination and clinical signs. Glucocorticoid, at least in 
part, may be responsible for the alteration in disease process through suppression of 
immune function.  This study offers experimental evidence demonstrating how stress 
may influence the pathogenesis of MS.  However, due to the nature of TVID, which 
consists of an acute infectious disease and a chronic autoimmune disease, as well as the 
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dual role of stress – enhancing susceptibility to infection and ameliorating autoimmune 
disease, makes it a complicated model for MS and stress.  Further study will be focused 
on the underlying mechanisms for acute stress-induced immune responses.   
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VI  DISCUSSION AND CONCLUSIONS 
 
The series of studies reported herein were aimed at revealing the effect of stress on 
the pathogenesis of MS using Theiler’s virus induced-demyelination (TVID) as a model 
for MS and restraint stress as an experimental stress model.  The main conclusion from 
this research is that RST applied prior to infection profoundly impacts the progression of 
both the acute encephalitis and the chronic demyelination.  
Restraint stress was shown to suppress the immune function as evidenced by reduced 
expression of chemokine and proinflammatory cytokines in the brain and spleen, 
decreased antibody production, and morphological alterations of immune organs - 
atrophy of spleen and thymus.  The reduction in chemokine expression may account for 
the decreased inflammatory cell infiltrates in the brain. The decreased pro-inflammatory 
cytokines may contribute, in part, to increased levels of virus within the CNS.  The 
impaired viral clearance alters the course of chronic demyelinating disease as 
demonstrated by an early onset, increased incidence and exacerbation of demyelination.  
The increased circulating corticosterone plays a pivotal role in the restraint stress-induced 
immunosuppression.  Additionally, restraint stress facilitates the systemic dissemination 
of TMEV resulting in increased viral replication in the heart and the development of a 
cardiotropic variant of TMEV that induces pathology in the heart.   
 
1. Cytokine and chemokine expression in Theiler’s virus infection 
Chemokines are chemoattractants that serve as signals in recruiting inflammatory 
cells into inflamed sites.  It was shown recently that the binding of a chemokine to the 
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receptors on the leukocytes attaching to the endothelial cell causes a rapid rearrangement 
of cytoskeleton and change of cell shape, thus facilitating the migration through the tight 
junction of vascular endothelium to the infectious sites (Hordijk et al., 2003; Walzer et al., 
2005). Previous studies from other laboratories showed a similar pattern of chemokine 
expression using different strains of Theiler’s virus (DA, BeAn, GDVII, H101) and mice 
(resistant or susceptible).  RANTES, IP-10 and MCP-1 were consistently detected in the 
CNS (brain and spinal cord) of DA-infected B10.M (susceptible, H-2f) and B10 (resistant, 
H-2b) mice, as well as in BeAn-infected SJL/J mice during early infection (Hoffman et al., 
1999; Murray et al., 2000), Another group also recorded that the same chemokine panel 
containing a greater number of cytokines, RANTES, MCP-1, IP-10, MIP-1, MIP-1 and 
, was observed in SJL/J mice infected with DA, or a more virulent GDVII virus and a 
less-virulent virus H101 (Theil et. al., 2000).  We first reported the chemokine expression 
of CBA mice that are of intermediate susceptibility to TVID and showed an increase of 
Ltn, RANTES, IP-10, MCP-1 and TCA-3 in the brain.  The differences reported by 
various laboratories may be due to different techniques used for measuring chemokines. 
The first two groups used RT-PCR, and Theil’s and ours used RPA, which included a 
greater number of chemokines in the commercial kit. The finding that a common panel of 
IP-10, RANTES and MCP-1 was found in all the stains of mice infected with various 
strains of virus suggests that the initial chemokine response to Theiler’s virus infection is 
independent of virulence of the virus and the genetic susceptibility of mice during acute 
infection.  However, the chemokines remained elevated in the spinal cord of susceptible 
B10.M, but returned to the baseline in resistant B10 at day 21 p.i., the time when virus is 
cleared from the resistant mice (Murray et al., 2000), indicating the chemokine 
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expression is correlated with virus levels or the degree of inflammatory infiltrates; 
whereas a resurgence was observed in the spinal cord of B10.M during the chronic phase 
(Murray et al., 2000) thus reflecting the degree of chemokine-governed infiltrates which 
is responsible for demyelination or persistent virus infection in susceptible mice.  The 
chemokine measurements enable us to look into the extent of inflammatory migration 
both temporally and spatially in this Theiler’s virus model.  Indeed, we also noted 
chemokine expressions in the spleen, suggesting an early viremia occurs and the systemic 
spread of virus in the lymphoid organs. The existence of virus in the spleen was 
confirmed by plaque assays (see chapter IV). 
Cytokines, effector molecules produced by immune cells, play an important role in 
numerous aspects of the immune response involving stimulation, activation, proliferation 
of immune cells, and direct antiviral activity.  Cytokine changes following Theiler’s virus 
infection have been documented using various strains of virus and mice. It has been 
shown that both susceptible and resistant mice displayed an increased expression of the 
panel of pro-inflammatory cytokines, including TNF-, IFN-, IL-1, IL-12, IL-6 in the 
brain during the acute phase, which is in accordance with our findings in the CBA mice.  
The difference in cytokine expression was seen in the chronic phase at which higher pro-
inflammatory Th1 cytokines, especially TNF-, IFN- and IL-6 were observed in the 
spinal cord of susceptible SJL/J mice (DA or BeAn infected) than resistant B6 mice 
(Chang et al., 2000; Sato et al., 1997; Troitter et al., 2004).  A study comparing the 
cytokine levels in BeAn-infected SJL/J and PLP immunized EAE suggested that TNF- 
and IFN- were correlated with infiltration CD4+ T cell and F4/80+ macrophages as well 
as clinical signs. (Begolka et al., 1998). Greater viral load was shown to be associated 
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with elevated cytokine expression in the CNS (Sato et al., 1997; Troitter et al., 2004). The 
virulence of virus seems not to be related to the pattern of cytokine in the CNS (Theil et 
al., 2000). It is suggested that the level of cytokines, but not the type, is responsible for 
the major difference in viral clearance between susceptible or resistant strains of mice.  
Anti-inflammatory Th2 cytokines were expressed in susceptible mice (Sato et al., 1997; 
Begolka et al., 1997), but did not correlate with susceptibility or resistance. We found no 
virus induced-Th2 cytokines in CBA mice; this could be due to different strain of mice 
used in our study. The variance of cytokine expression was also noticed in certain mice 
(Troitter et al., 2004). In addition, cytokine expression was shown to parallel with 
chemokine expression (Troitter et al, 2004), thereby, cytokine assessment may reflect the 
degree of activation of the immune response, and the chemokine level as well.  The 
determination of cytokine or chemokine level can be indicative of both innate and 
adaptive immune response to Theiler’s virus infection, and suggestive of viral clearance 
in the CNS, which further determines the progression of demyelination, due to the close 
association of their expression with viral load in this model.  
 
2. Restraint stress suppresses the immune response and increases the susceptibility 
    to infectious diseases  
The present study demonstrated a profound suppression by restraint stress on the 
immune response to the early Theiler’s infection.  The reduction in chemokine expression 
of Ltn, IP-10 and RANTES, which were demonstrated as chemoattractant for activated T 
cells, monocytes and NK cells (Giancarlo et al., 1996; Hedrick et al., 1997; Kelnel et al., 
1994; Salmaggi et al., 2002) may be responsible for the decreased inflammation in the 
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CNS following restraint stress.  The decrease in pro-inflammatory Th1 cytokines by 
restraint stress may be interpreted as diminished cellular sources of cytokines resulting 
from decreased cell trafficking in the CNS or glucocorticoid-induced reduction in 
lymphadenopathy of spleen, thymus and draining lymphoid nodes (Tarcic et al., 1998; 
Hermann et al., 1995).  Expression of IL-12 p40, a key cytokine driving Th1 response in 
Theiler’s virus infection, declined in the restrained mice, which may contribute further to 
reduced Th1 cytokine production.  The decreased Th1 cytokines, TNF-, IFN-γ and IL-6 
were shown to be correlated with increased viral load within the brain. Together with our 
previous results, which showed a decreased NK cell activity by restraint stress (Welsh et. 
al., 2004), the current study reinforces the strikingly suppressive effect of stress on the 
exacerbation of early Theiler’s virus infection, as evidenced by increased mortality 
(Campbell et al., 2001), and increased CNS viral replication (Campbell et. al., 2001 and 
this study).  
The stress-induced negative effect on immune function was also verified using other 
virus models. Sheridan and colleagues employing influenza virus showed that RST 
impaired both chemokine expressions of MCP-1 and MIP-1 (Hunzeker et al., 2004) and 
cytokine production of IL-1, TNF- and IL-6 in the lung (Konstantinos and Sheridan, 
2001; Sheridan et al., 1991; Sheridan et al., 2000). A delayed infiltration in the lung and 
decreased NK cell activity were also noted in the lung (Hunzeker et al., 2004; Tseng et al., 
2004).  Consistent with their findings (Hunzeker et al., 2004), we observed an increase of 
type I interferon  induced by RST, which may be explained by a compensatory response 
and/or adaptive response to restraint stress.  The level of IL-1 was not significantly 
changed by RST in the brain in Theiler’s virus infection, which is in contrast to influenza 
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infections in the lung.  Unlike the lung, in which inflammatory cells primarily contribute 
to IL-1 production, the hypothalamus is the main source for CNS IL-1, the production of 
which was not impacted by restraint stress (Deak et al., 2004).  Since cytokines are 
produced by the CNS, immune system and endocrine organs, as well as the extensive 
distribution of cytokine receptors between these systems, cytokines are considered as a 
common mediator for communication within the systems.  The stress response involves 
all the three systems so that cytokines induced by stress may interact with the infection-
cytokines within the CNS, thus making the cytokine response in the CNS more intricate 
than other systems.  
Previous research has shown that TMEV infection upregulates toll-like receptor 
(TLR) expression on microglia and subsequent production of proinflammatory cytokine 
and chemokine expression, and that stimulation of TLR also increased MHC class II and 
costimulatory molecules, thus inducing APC function of CNS microglia (Olson and 
Miller, 2004).  Accordingly, during restraint stress, increased viral load may have 
promoted APC function and viral clearance. However, the predominately 
immunosuppression of stress was evidenced by the findings in this study. The 
contradiction can be explained by the increased release of GC induced by stress, which 
have been found to bi-directionally regulate TLR expression,  such that TLR-4 and TLR-
2 were up-regulated and TLR-3, down-regulated by GC (Galon et al., 2002). TLR-3 has 
shown to recognize viral dsRNA and the engagement of TLR-3 resulted in activation of 
NF-B pathway (Alexopoulou et al., 2001), suggesting a decreased stimulation of TLR 
during stress and thus inhibiting antigen presentation.  GC-mediated regulation in antigen 
presentation has been extensively studied in dentritic cells (DC). For example, 
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dexamethosone inhibit maturation of DC by down-regulating costimulatory molecules 
and antigen presenting molecules (Matasic et al., 1999; Ruemmele et al., 1999; Pan et al., 
2001), and clonal expansion of DC (Matsue et al., 2002). Yet the endocytoxicity of DC 
was not affected by dexmethesone (Pan et al., 2001).  It was recently reported that CORT 
inhibited the formation of viral peptide-MHC I class complex in DC, and further 
decreased activation of T cells (Tryckenmiller et al., 2005).  Literature concerning the 
effects ofGC on microgila is sparse; however, the findings from DC implicated that 
TMEV infection-induced activation of microglia may be partially counteracted by CORT 
during restraint stress, and may further contribute to the decreased proinflammatory 
cytokines through inhibition of TLR mediated NF-B pathway.  In fact, GC was also 
reported to directly inhibit iNOS, NO and TNF- production of microglia (Chang and Liu, 
2000; Drew and Chavis, 2000).  
The down-regulation of immune response in lymphoid organ by restraint stress was 
additionally substantiated in herpes simplex virus (HSV-6) infection. Cellular immunity, 
NK cell and HSV-specific CTL, virus-specific memory CTL (CTLm) were suppressed by 
restraint stress (Bonneau et al., 1991a; Bonneau et al., 1993). Restraint-induced decrease 
in IL-2 production results in a slowdown in the proliferation of CTLm in the lymph nodes 
(Bonneau et al., 1991b).  The reduction in cytokine production was noted in the spleen, 
which accounted for the decreased splenic HSV-specific CTLm (Bonneau, 1996).  It is 
noted that this HSV model demonstrated stress-induced immunoregulation using a 
neurotropic virus infection, which is in accordance with our report, that restraint stress 
exacerbated HSV-induced encephalitis and increased mortality, with decreased CNS 
cellularity (DeLano and Mallery, 1998) and a delayed HSV-specific CD8+ response in the 
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CNS (Anglen et al., 2003).   
Further investigation of infection in extraneural organs in our study revealed an 
enhanced viral replication in the heart, spleen and cervical lymph nodes after stress, 
suggesting a facilitated systemic infection of Theiler’s virus possibly by elevated 
corticosterone following restraint stress.  Since the viral antigen can be detected in 
systemic organs up to 4 month in non-stressed mice (Trottier et al., 2002), we speculated 
that the increased viral replication in the stressed mice may prolong the persistence of 
virus in these organs and therefore these sites may become additional sources of virus for 
repeated CNS infection.   
The present study substantiated the fact that restraint stress compromises antiviral 
immunity, resulting in impaired viral clearance in the CNS, and also contributed 
additional experimental evidence to the notion that stress increases the susceptibility to 
infectious disease, including any candidate virus for MS.  Additionally, the altered 
tropism of Theiler’s virus to the heart following stress, implies a novel infectious disease 
could develop as result of stress-induced immunosuppression in the organs that are not 
normally affected.  
 
3. Restraint stress exacerbates chronic demyelination in Theiler’s virus infection  
To our knowledge, we are the first laboratory ever to study the stress and 
demyelination in a virus model.  The present study provides laboratory data 
demonstrating that stress can aggravate demyelination which is in agreement with clinical 
observations and epidemiological evidence that stressful life events are associated with 
exacerbation of MS (Ackerman et al., 2002; Mohr et al., 2004; Strenge et al., 2001).  
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Therefore we conclude that the impaired antiviral immunity caused by RST allow the 
establishment of viral persistence and increase viral load in the CNS, which produces 
exacerbation of demyelination. The change can be attributed, at least in part, to the 
sustained elevation of corticosterone over the stress period (Campbell et al., 2001; Sieve 
et al., 2004).  The magnitude of increase in corticosterone can decline with exposure time, 
which is due to blunted HPA axis activity resulting from habituation or adaptation of 
animals to repeated chronic stress (Bauer, et al., 2001; Pecoraro et al., 2004).  The stress 
effect can remain as long as 10 days after the cessation of stress (Whitacre et al., 1998).  
Therefore, the chronic stress may profoundly impair the immune function for a 
considerable length of time.    
The observations of the association between MS and stress do not always agree. For 
example, a study reported an attenuation of MS after stress exposure (Nisipeanu and 
Korczyn; 1993). Some MS patients have psychological symptoms, which might be the 
result but not the cause of exacerbation (Mohr and Cox, 2001).  The inconsistency 
between studies suggests that complex and differential mechanisms of stress, as well as 
various categories of MS patients, relapsing-remitting MS (RRMS) or primary 
progressive MS (PPMS), may determine the outcome of the course and progression of 
demyelinating disease. For example, autopsy studies revealed that MS patients have more 
CRH/AVP neurons and higher CRH mRNA in the hypothalamus than healthy controls 
(Erkut et al., 1995; Huitinga et al., 2004), indicating activation of these neurons in MS 
patients. However, the severity of disease was related to the reduction in the number and 
activity of CRH/AVP neurons (Huitinga et al., 2004).  These findings implicate the role 
of HPA axis (not related to stress) in MS and possibly an altered HPA axis responsiveness 
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at the stress exposure.  It has been found that the different HPA responsiveness in MS 
patients, with the order from the most to the least hyperreactive noted in primary 
progressive MS (PPMS), secondary progressive MS (SPMS) and relapsing-remitting MS 
(RRMS) patients (Morh, personal communication).  This may explain the different 
consequences of stress effect on MS.   
Stress and demyelination are indeed two conditions that display different kinetics of 
development and progression, and are regulated by different but interactive mechanisms. 
The HPA axis is believed to be the core factor involving both processes.  The outcome is 
dependent on many factors, such as the intensity, duration of stress, and the interval 
between the onset of stress and demyelination. For example, in the EAE model, stress 
prior to immunization ameliorated the disease, but not after the challenge (Correa et al., 
1998; Whitacre et al., 1998).  Acute stress was shown to be immunostimulating (Dhabhar 
and McEwen 1997), therefore we might expect an enhancing effect of acute restraint 
stress in the TVID model, due to activation of the immune response, increased viral 
clearance and subsequent attenuated demyelination.  However, the results showed a 
similar, but less suppressive, effect in the immune function, which resulted in an 
intermediate exacerbation of demyelination.  This requires a detailed dissection of the 
stress paradigm in terms of intensity, duration and the kinetics of stress hormone, CORT 
as well as catecholamines.  Additionally, CNS infection itself is a stressor that may 
impact the neuroendocrine circuit, thus making the stress-MS relation more intricate.   
However, the current study provides a model system with relevance to MS onset of those 
patients whose disease is triggered by virus infection during a stressful life event.  The 
establishment and effectiveness of this stress-MS model enables us to scrutinize the 
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endocrine and immune response in the development of demyelination and eventually 
shed light on the neuropathogenesis of MS. 
 
4. Future studies 
The key in the Theiler’s model is the establishment of persistent CNS infection and 
we are interested in the how stress affects the efficacy of the immune system in viral 
clearance. For future studies, we will focus on the following aspects:  
1) We showed decreased inflammation by stress at acute infection and selective 
reduction of chemokine expression; therefore, we will need to identify the phenotype of 
cellularity affected by restraint stress.  We will further focus on macrophage and 
microglia, because these cells are the major antigen presenting cells and the reservoir for 
harboring the virus in the chronic disease.  It is very important to examine how stress 
impacts viral antigen presentation at the early stage as well as myelin antigen 
presentation by these cells and astrocytes.  The identification dynamics of the changes by 
stress is necessary for further investigation of the effect of on the two distinct processes.  
2) We have demonstrated that pro-inflammatory cytokines are associated with viral 
clearance. The profile of cytokine expression, especially in the spinal cord, needs to be 
identified.  Apart from virus load, the cytokine level is expected to be linked to 
demyelination, which is mediated by Th1 cytokines. Since stress may exacerbate the 
demyelination (or possibly attenuated by acute stress, if we could find an appropriate 
paradigm for acute stress and the hypothesis is true in this model), an enhanced Th1 
cytokine (or decreased by acute stress, if any) expression is expected.    
3) Optimization of the duration, intensity and the timing introduced into the animal 
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(interval between infection and stress) for acute stress procedure.  It will be necessary, 
first, to identify the dynamics of release of stress hormone in response to acute stress, 
second, determine the consequence of stress by examining the viral clearance in the CNS 
following stress, especially around the initiation of demyelinating disease, and a more 
sensitive technique may be required.    
4) For the chronic stress, we observed a behavioral habituation to stress in the 
animals, as well as a diminished suppressive effect in the spleen, which may indicate an 
HPA responsiveness adaptation or blunted HPA axis activity by stress.  CRH has been 
suggested in the chronic stress adaptation; the role of this particular hormone, as well as 
ACTH in this model remains to be investigated.   
5) It is very interesting to notice that stress may even alter the tropism of virus and 
cause a novel disease.  In addition to altered immune response by stress which allows a 
novel infection, the nature of the virus (changed or not), and the receptors for the entry of 
virus (changed by stress hormone or utilizing different receptor) also need to be examined. 
This may give us a clue as to whether stress may alter the pathogenecity of a virus and 
increase the susceptibility of human or animal to some infectious disease which is usually 
less pathogenic.   
6) Another important indication from the current study is that some uninfected 
chronic and acute stressed mice developed autoantibodies to myelin. It may suggest an 
autoimmune mechanism for demyelination in MS.  Extensive and detailed research will 
be required to dissect the T cell response to myelin antigen following stress.  
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